matchedPattern,context,lineNumber,columnNumber,publicationName
c.1528A>G,2	14	c.1528A>G	p.K510E	39	M	15	Yes	Yes	B	No,38,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1561C>T,3	15	c.1561C>T	p.R521C	33	M	10	NA	Yes	NA	No,39,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1561C>T,4†	15	c.1561C>T	p.R521C	35	F	7	Yes	Yes	B	No†,40,7,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1561C>T,4†	15	c.1561C>T	p.R521C	35	F	7	Yes	Yes	B	No†,40,7,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1562G>A,5	15	c.1562G>A	p.R521H	35	F	>36	NA	Yes	L	No,41,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1562G>A,5	15	c.1562G>A	p.R521H	35	F	>36	NA	Yes	L	No,41,6,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.1574C>T,15	c.1574C>T	p.P525L,43,5,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
c.2392C>T,FA-1	EUFA1333	FANCJ	IVS11–498A>T c.2392C>T	Hematopoietic mosaicism	[25],69,34,Anemia_2010_Jul_18_2010_565268.txt
c.316G>A,(c.316G>A) was most strongly associated with WBSF i...,653,2,Anim_Genet_2012_Dec_27_43(6)_662-673.txt
c.316G>A,(c.316G>A) was most strongly associated with WBSF i...,653,2,Anim_Genet_2012_Dec_27_43(6)_662-673.txt
c.840+2T>A,"...C>T, p.Arg110*) and a donor splice‐site mutation (c.840+2T>A, p.Glu281_Leu282Ins8), both of which ca...",42,273,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.328C>T,... One of the SNPs constitutes a nonsense mutation (c.328C>T) causing a premature translational stop (...,80,656,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.328C>T,"...1001150.2) causing a premature translational stop c.328C>T, p.Arg110* at genomic position chr22: 32 ...",82,265,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"...(b) A donor splice‐site mutation (NM_001001150.2) c.840+2T>A, p.Glu281_Leu282Ins8 at position chr22:...",84,274,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.840+2T>A,"... (chr22: 32 322 242a) and the splice‐site variant c.840+2T>A, p.Glu281_Leu282Ins8 (chr22: 32 297 683...",88,128,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
c.1326T>G,"The SNP c.1326T>G in the non‐SMC condensin I complex, subu...",1143,9,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
c.2249C>A,...tions comprised c.1947dupC (p.Pro649Profs*11) and c.2249C>A (p.Ser750*). The most recently reported ...,33,503,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.2249C>A,...tions comprised c.1947dupC (p.Pro649Profs*11) and c.2249C>A (p.Ser750*). The most recently reported ...,33,503,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1538-1G>A,"..., had a homozygous acceptor splice site mutation, c.1538-1G>A. The third case, from Pakistan, had a ...",48,400,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1538-1G>A,"..., had a homozygous acceptor splice site mutation, c.1538-1G>A. The third case, from Pakistan, had a ...",48,400,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1045G>T,"...erlands) was also a homozygous missense mutation, c.1045G>T (p.Ala-349Ser)16, as was the mutation in...",48,703,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1045G>T,"...erlands) was also a homozygous missense mutation, c.1045G>T (p.Ala-349Ser)16, as was the mutation in...",48,703,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1387C>T,"...349Ser)16, as was the mutation in the fifth case, c.1387C>T (p.Arg463Trp)17. Clues to the molecular ...",48,770,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
c.1312C>T,"...5 gene was performed and the pathogenic mutation, c.1312C>T (p.Arg438Cys), was identified. Interesti...",3,1961,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
c.3766C>T,"...terozygous mutations, c.1153dupG (p.Val385fs) and c.3766C>T (p.Arg1256X), in EIF2AK4. Unaffected par...",18,394,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.3766C>T,"...pG, and the father carried the nonsense mutation, c.3766C>T).13 Ten additional sporadic PCH case pat...",18,607,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.860-1G>A,"...ient had a compound heterozygous splice mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p....",18,865,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.3438C>T,"...ce mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were identifi...",18,902,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
c.280A>G,"...s influencing beef flavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located...",8,550,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...ing beef flavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2...",8,560,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...lavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 ...",8,570,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...r types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 of the FABP4 ...",8,583,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"....91 in c.280A>G SNP (p<0.04), for marbling score, c.388G>A SNPs were the highest at 5.66 in GG genot...",45,619,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"....91 in c.280A>G SNP (p<0.04), for marbling score, c.388G>A SNPs were the highest at 5.66 in GG genot...",45,619,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...NP (p<0.05) and 44.56 and 53.84 in GG genotype of c.388G>A SNP (p<0.05). Also, they had higher conte...",47,245,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...es, since their composition in the CC genotype of c.408G>C SNP, GG genotype of c.456A>G SNP were 45....",47,405,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon ...",51,26,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon ...",51,26,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon ...",51,26,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon...",51,49,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...e block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon 4. Haplot...",51,59,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...e block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon 4. Haplot...",51,59,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon 4. Haplotypic associations of blo...",51,83,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"...sociation with back fat thickness, and in case of c.388G>A SNP, with marbling score. Also, it has be...",54,331,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...he nucleotide changes. Especially, in the case of c.280A>G SNP, as ATC nucleotide into GTC, changes ...",58,177,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...he nucleotide changes. Especially, in the case of c.280A>G SNP, as ATC nucleotide into GTC, changes ...",58,177,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,...the encoded amino acid from isoleucine to valine. c.388G>A SNP is also a non-synonymous SNP where va...,58,277,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,...the encoded amino acid from isoleucine to valine. c.388G>A SNP is also a non-synonymous SNP where va...,58,277,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,...the encoded amino acid from isoleucine to valine. c.388G>A SNP is also a non-synonymous SNP where va...,58,277,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...changes into ATG. On the other hand, c.408G>C and c.456A>G are synonymous SNPs, which do not have ch...",58,420,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...do have nucleotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an asso...",58,545,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...cleotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an association wi...",58,555,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...cleotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an association wi...",58,555,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,"...homozygous genotypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an i...",62,71,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"... genotypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased p...",62,81,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"... genotypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased p...",62,81,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,"... genotypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased p...",62,81,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"... and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion of oleic acid...",62,104,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"... and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion of oleic acid...",62,104,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"... and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion of oleic acid...",62,104,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,"...ected that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3, and 4 ar...",66,73,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,"...lotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3, and 4 are able to incr...",66,87,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	F1	TTGACATTTTTCTTTTCCCAAC	200,99,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	F1	TTGACATTTTTCTTTTCCCAAC	200,99,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.193T>G,c.193T>G	2	F	TTGACATTTTTCTTTTCCCAAC	200,102,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.212C>A,c.212C>A	2	F	TATAGGCGTGGGCTTTGCTA	202,105,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,c.280A>G	2	F	GGGGTGTGGTCACCATTAAA	178,108,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,c.388G>A	3	F	ATTATCCCCACAGAGCATCG	219,117,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,c.408G>C	3	F	CATCGTAAACTTAGATGAAGGTGCT	200,120,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	L41V	T,135,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.181T>G,c.181T>G	2	L41V	T,135,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.193T>G,c.193T>G	2	L45V	T,139,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.193T>G,c.193T>G	2	L45V	T,139,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.193T>G,c.193T>G	2	L45V	T,139,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,c.388G>A	3	V110M	G,159,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,c.456A>G	4	A132A	A,167,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,c.456A>G	4	A132A	A,167,1,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.280A>G,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,5,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,14,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.388G>A,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,14,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.408G>C,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,25,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.456A>G,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,34,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
c.349T>C,...o et al. (2011) reported that the polymorphism of c.349T>C in the CRBP II gene would be genetically ...,47,1289,Asian-Australas_J_Anim_Sci_2014_Mar_27(3)_310-315.txt
c.12669G>A,"...iginal ArticleRole of the APOB Gene Polymorphism (c.12669G>A, p. Gln4154Lys) in Coronary Artery Dise...",3,223,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...iginal ArticleRole of the APOB Gene Polymorphism (c.12669G>A, p. Gln4154Lys) in Coronary Artery Dise...",3,223,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...able variation in linking APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) with CAD risk in differen...",8,1384,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.12669G>A,"...nt study, the role of the APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) was studied in native Ind...",28,63,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
c.1523A>T,... in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive...,193,129,Biomed_Res_Int_2013_Jul_11_2013_283985.txt
c.1523A>T,... in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive...,193,129,Biomed_Res_Int_2013_Jul_11_2013_283985.txt
c.9C>G,"...ne whether there is a link between the rs2073618 (c.9C>G, G1181C) and rs3134069 (g.119964988A>C, T24...",22,107,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
c.9C>G,"...ne whether there is a link between the rs2073618 (c.9C>G, G1181C) and rs3134069 (g.119964988A>C, T24...",22,107,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
c.9C>G,(c.9C>G),143,2,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
c.34G>A, c.34G>A	p.G12S	1 (0.5),194,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61K	5 (2.7),197,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61K	5 (2.7),197,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	7 (3.7),199,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	8 (4.3),203,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61H	1 (0.5),204,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.181C>A, c.181C>A	p.Q61H	1 (0.5),204,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1799T>A, c.1799T>A	p.V600E	51,244,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1799T>A, c.1799T>A	p.V600E	51,244,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1801A>G, c.1801A>G	p.K601E	6,246,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.1801A>G, c.1801A>G	p.K601E	6,246,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	29,250,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	29,250,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	4,253,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	4,253,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	4,253,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	2,256,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.182A>G, c.182A>G	p.Q61R	2,256,2,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
c.80G>A,... on the absence of association between the common c.80G>A polymorphism (rs1051266) of the gene codin...,19,187,Biomed_Res_Int_2015_Jan_14_2015_135931.txt
c.769C>T,"A1	M	58	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,47,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A1	M	58	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,47,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"...58	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,56,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"...58	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,56,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"...58	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,56,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.879+1G>A,"A2	M	47	AADC, GAD, TPH	HP, D, V	c.879+1G>A/c.879+1G>A",22,33,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A3	F	54	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,45,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A3	F	54	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,45,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.1336T>G,"...	54	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,55,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A4	F	25	21OH, 17OH	A	c.769C>T / c.1242_1243insA",24,22,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A5	F	20	21OH, SCC, 17OH	C, A, V, N, G	c.769C>T/c.1242_1243insA",25,39,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.769C>T,"A6	M	21	21OH, SCC, 17OH, AADC	C, HP, A, K	c.769C>T/c.769C>T",26,43,Blood_2008_Oct_1_112(7)_2657-2666.txt
c.1273C>T,.... This means that a heterozygous carrier with the c.1273C>T mutation of C3 itself may not develop aH...,25,1189,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,...e suspect that the pathogenesis of aHUS caused by c.1273C>T is likely to be associated with dysregul...,27,144,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,...e suspect that the pathogenesis of aHUS caused by c.1273C>T is likely to be associated with dysregul...,27,144,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,...e suspect that the pathogenesis of aHUS caused by c.1273C>T is likely to be associated with dysregul...,27,144,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,"...the first Korean case of aHUS associated with the c.1273C>T mutation in the complement C3 gene, wher...",29,426,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.1273C>T,...orphism analysis of our patient with heterozygote c.1273C>T mutation in C3 gene showing 250 bp produ...,36,91,Blood_Res_2016_Sep_23_51(3)_210-213.txt
c.34G>C,"...tonin, somatostatin, gastrin	KRAS exon 1 (p.G12R; c.34G>C)",83,180,BMC_Cancer_2012_Dec_4_12_570.txt
c.35G>T,"..., negative: MUC2, CD10, CDX2	KRAS exon 1 (p.G12V; c.35G>T); CGH: gains at 1q, 6p11p22, 7p, 15q, 20p,...",96,160,BMC_Cancer_2012_Dec_4_12_570.txt
c.1699G>A,c.1699G>A	p.Ala567Thr	rs1803274,41,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.-238C>T,c.-238C>T		rs1800849,47,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.1307C>A,c.1307C>A	p.Thr436Lys	rs4588,65,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.81C>T,c.81C>T	p.Cys27=	rs2228671,74,2,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
c.1194A>G,Exon 12	c.1194A>G	NA	p.L398L	benign	AA 9/39; AG 12/39; GG ...,36,9,BMC_Gastroenterol_2012_Oct_15_12_141.txt
c.1814G>A,Exon 17	c.1814G>A	NA	p.R605Q	unknown	1/39 (het: Pt-7) (0.0...,37,9,BMC_Gastroenterol_2012_Oct_15_12_141.txt
c.1814G>A,Exon 17	c.1814G>A	NA	p.R605Q	unknown	1/39 (het: Pt-7) (0.0...,37,9,BMC_Gastroenterol_2012_Oct_15_12_141.txt
c.451C>T,"...ent (e.g. the allele frequency of the T allele of c.451C>T, p.R151C, was 1.9% in Greece but 10.2% in...",171,663,BMC_Genet_2008_Apr_10_9_31.txt
c.451C>T,"...ent (e.g. the allele frequency of the T allele of c.451C>T, p.R151C, was 1.9% in Greece but 10.2% in...",171,663,BMC_Genet_2008_Apr_10_9_31.txt
c.2881C>T,"...eceptor (EGFR) inhibitors; however, a KDR p.R961W c.2881C>T mutation was noted as a variant of unkno...",9,1250,Cureus_8(2)_e478.txt
c.2881C>T,"...eceptor (EGFR) inhibitors; however, a KDR p.R961W c.2881C>T mutation was noted as a variant of unkno...",9,1250,Cureus_8(2)_e478.txt
c.2881C>T,...biomarker of response to regorafenib. KDR p.R961W c.2881C>T mutation has been reported twice in COSM...,50,1099,Cureus_8(2)_e478.txt
c.2881C>T,...biomarker of response to regorafenib. KDR p.R961W c.2881C>T mutation has been reported twice in COSM...,50,1099,Cureus_8(2)_e478.txt
c.-964A>G,"rs153109, corresponding to position c.-964A>G of the IL-27 locus, was amplified from g...",7,37,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
c.475C>T,...T (p.Arg110>Cys) in two families (family A&B) and c.475C>T (p.Arg133>Cys) mutation in family C,12,447,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,A	Saudi	c.406C>T	3	p.Arg110>Cys	EGF2	ND,40,9,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,A	Saudi	c.406C>T	3	p.Arg110>Cys	EGF2	ND,40,9,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,B	Kuwait	c.406C>T	3	p.Arg110>Cys	EGF2	ND,41,10,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,"...OTCH3 gene, revealed the presence of heterozygous c.406C>T (p.Arg110>Cys) pathogenic mutation in exo...",55,804,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.406C>T,...OTCH3 gene; revealed the presence of heterozygous c.406C>T (p.Arg110>Cys) pathogenic mutation in exo...,58,729,BMC_Med_Genet_2007_Nov_9_8_67.txt
c.808-1G>C,"...sversion in the last base of intron 7, g.3912G>C (c.808-1G>C) so altering the consensus acceptor spl...",12,620,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,"...ngle nucleotide substitutions were transversions: c.101A>T, c.995G>C and c.670 T>G that result in p....",12,837,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,"...ngle nucleotide substitutions were transversions: c.101A>T, c.995G>C and c.670 T>G that result in p....",12,837,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.995G>C,"...otide substitutions were transversions: c.101A>T, c.995G>C and c.670 T>G that result in p.E34V, p.G3...",12,847,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,I	P	F	35	2.4	2.9	1212	8.80	896	+/-	c.471G>A/del exon5,47,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,M	F	64	1.2	1.1	120	1.21 (619)	70	-/-	c.471G>A/del exon5,48,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,M	F	64	1.2	1.1	120	1.21 (619)	70	-/-	c.471G>A/del exon5,48,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,Si	F	31	1.2	2.1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,Si	F	31	1.2	2.1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,So	M	19	0.9	0.6	86	120	ND	-/-	c.503G>A/p.R168H,112,32,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.503G>A,Si	F	35	ND	ND	ND	3.15	1281	+/-	c.503G>A/p.R168H,113,33,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,...e G to A transitions in the last bases of exon 5 (c.471G>A) (Figure 2a) and exon 7 (c.807 G>A) (Figu...,181,216,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,...e G to A transitions in the last bases of exon 5 (c.471G>A) (Figure 2a) and exon 7 (c.807 G>A) (Figu...,181,216,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,III	P	13.15	39.55	c.808-1G>C/r.spl?,193,19,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.808-1G>C,C	15.58	46.85	c.808-1G>C/r.spl?,194,16,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,20,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,20,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,D	18.12	54.19	c.670T>G/p.W224R,202,16,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.670T>G,...e was a T to G change at nucleotide position 670 (c.670T>G) leading to a tryptophan to a glycine sub...,209,583,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...ree of them were single nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other w...",238,292,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...ree of them were single nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other w...",238,292,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...ree of them were single nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other w...",238,292,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...cryptic splicing site [34]. However, only for the c.471G>A mutation (Figure 2a), which affects the d...",238,532,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...cryptic splicing site [34]. However, only for the c.471G>A mutation (Figure 2a), which affects the d...",238,532,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.471G>A,"...cryptic splicing site [34]. However, only for the c.471G>A mutation (Figure 2a), which affects the d...",238,532,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.101A>T,"...were transversions leading to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and...",240,91,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.995G>C,"...ng to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10 respectively. They w...",240,115,BMC_Med_Genet_2008_Jun_20_9_54.txt
c.-179A>G,"Three nucleotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to...",12,49,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"Three nucleotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to...",12,49,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...leotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T...",12,60,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...leotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T...",12,60,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...leotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T...",12,60,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...leotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T...",12,60,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...leotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T...",12,60,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...9A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C mutation, GALK1 activity in 13 subjects w...",12,104,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...9A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C mutation, GALK1 activity in 13 subjects w...",12,104,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"The c.-22T>C mutation, which was observed frequently i...",15,5,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,...-3') primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 healthy adults...,36,448,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...the promoter region of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the presence ...",49,430,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...as confirmed by performing PCR-RFLP (Fig. 1). For c.-179A>G, 56 subjects with A/A genotype, 5 with A...",49,554,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...type and 2 with G/G genotype were identified. For c.-27A>C, 61 individuals had A/A genotype and 2 sh...",49,661,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...7A>C, are benign sequence variations. In terms of c.-22T>C, 50 individuals with T/T, 12 with T/C, an...",49,964,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...orphism. Genotype distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate f...",49,1270,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...type distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate from those exp...",49,1283,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...type distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate from those exp...",49,1283,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,c.-27A>C	A/A	61	112.1 ± 41.7	0.173	1.34 ± 0.46	0.4...,60,1,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,c.-22T>C	T/T	50	96.1 ± 24.3	<0.001	1.16 ± 0.25	<0....,64,1,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...7 of GALK1 (Table 1), which further suggests that c.-27A>C is a nonfunctional polymorphism",71,980,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"To test if c.-22T>C affected transcription, reporter analysis...",80,12,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-179A>G,"...wo and a half fold increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase ac...",80,471,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-27A>C,"...fold increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase activity was not...",80,485,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,...E activities. We found that the nucleotide change c.-22T>C in the promoter region of GALK1 gene was ...,89,834,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.-22T>C,"...ar proteins that bind to the GALK1 promoter, with c.-22T>C, will be necessary to elucidate the mecha...",97,368,BMC_Med_Genet_2009_Mar_24_10_29.txt
c.574+1G>A,"...erozygote at this gene. One of these alterations, c.574+1G>A, is located at the splice donor site of...",7,750,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,...equencing analysis. It has been proposed that the c.574+1G>A mutation would cause exon 5 skipping du...,7,1085,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,...equencing analysis. It has been proposed that the c.574+1G>A mutation would cause exon 5 skipping du...,7,1085,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,...change that disrupts the 3'splice site of IVS 16 (c.2206-2A>G). Both the father and sister of the pa...,38,309,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,...t change affecting the first nucleotide of IVS 5 (c.574+1G>A) has been reported in an earlier study ...,38,694,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,...t change affecting the first nucleotide of IVS 5 (c.574+1G>A) has been reported in an earlier study ...,38,694,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>A,...t change affecting the first nucleotide of IVS 5 (c.574+1G>A) has been reported in an earlier study ...,38,694,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...deletion of the first 21 bp of exon 17. Thus, the c.2206-2A>G mutation leads to the production of tw...",42,1016,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,"...ents [6,14]. The skipping of exon 5 caused by the c.574+1G>C mutation introduces a frame shift that ...",44,1312,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.574+1G>C,"...ents [6,14]. The skipping of exon 5 caused by the c.574+1G>C mutation introduces a frame shift that ...",44,1312,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...ed, non-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the...",44,1456,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.2206-2A>G,"...ed, non-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the...",44,1456,BMC_Med_Genet_2011_Jun_27_12_86.txt
c.1313G>A,...wo missense mutations were identified in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp51...,37,636,BMC_Neurol_2011_Oct_1_11_119.txt
c.1531G>A,...ified in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in families MCP35 and MCP3...,37,668,BMC_Neurol_2011_Oct_1_11_119.txt
c.900C>A,5	c.900C>A	Cys300X	Exon 8	Indian	[4],55,3,BMC_Neurol_2011_Oct_1_11_119.txt
c.1204C>T,...ients with the Parkin mutations (the heterozygous c.1204C>T mutation in exon 11 and c.458C>G mutatio...,183,599,BMC_Neurosci_2016_Feb_1_17_6.txt
c.1204C>T,...ients with the Parkin mutations (the heterozygous c.1204C>T mutation in exon 11 and c.458C>G mutatio...,183,599,BMC_Neurosci_2016_Feb_1_17_6.txt
c.458C>G,...he heterozygous c.1204C>T mutation in exon 11 and c.458C>G mutation in exon 4 of Parkin). In the lit...,183,633,BMC_Neurosci_2016_Feb_1_17_6.txt
c.799G>A,"c.799G>A/c.85C > A		(mean 12.34, range 0.88-23.80)...",87,1,BMC_Pediatr_2010_Nov_17_10_82.txt
c.799G>A,"c.799G>A/c.85C > A		(mean 12.34, range 0.88-23.80)...",87,1,BMC_Pediatr_2010_Nov_17_10_82.txt
c.427G>A,4	GAG> AAG	c.427G>A	Glu143Lys	Acidic to basic	Polymorphism,91,12,BMC_Womens_Health_2005_May_26_5_8.txt
c.1406C>T,5	GCG>GTG	c.1406C>T	Ala469Val		Polymorphism,98,11,BMC_Womens_Health_2005_May_26_5_8.txt
c.1998C>T,11	CAC>CAT	c.1998C>T	His666His	Silent	Polymorphism,101,12,BMC_Womens_Health_2005_May_26_5_8.txt
c.1998C>T,11	CAC>CAT	c.1998C>T	His666His	Silent	Polymorphism,101,12,BMC_Womens_Health_2005_May_26_5_8.txt
c.2621T>A,16		c.2621T>A			3' untranslated region. Polymorphism,102,5,BMC_Womens_Health_2005_May_26_5_8.txt
c.154A>C,"...agic telangiectasia type 2 with a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL1 gene Neu...",240,139,Bone_Res_2015_Apr_14_3_15005.txt
c.154A>C,"...agic telangiectasia type 2 with a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL1 gene Neu...",240,139,Bone_Res_2015_Apr_14_3_15005.txt
c.564T>C,"... GTL2 promoter DMR, heterozygosity at a DLK1 SNP (c.564T>C) (n=−2) or at closely linked microsatelli...",36,572,Br_J_Cancer_2005_Apr_25_92(8)_1574-1580.txt
c.8672G>A,...tained kinase activity. One missense ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G substitution...,10,363,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"Two ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), were identified in the cells fr...",56,50,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...e 11, the c.8672G>A mutation was paternal and the c.1A>G mutation maternal in origin",56,431,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...e 11, the c.8672G>A mutation was paternal and the c.1A>G mutation maternal in origin",56,431,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...y result in expression of mutant ATM protein. The c.1A>G affects the first base in the coding sequen...,58,126,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...GUG in the RNA was able to allow translation. The c.8672G>A (p.Gly2891Asp) is a missense mutation lo...,58,433,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...omain. It was expected that at the cDNA level the c.8672G>A mutation might result in loss of exon 60...,58,597,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...omain. It was expected that at the cDNA level the c.8672G>A mutation might result in loss of exon 60...,58,597,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,"...lowing a severe reaction to radiotherapy (A-T109, c.7271T>G homozygous) (Stankovic et al, 1998). Alt...",63,229,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...n a truncated protein. In translational terms the c.1A>G mutation in A-T213 would be expected to beh...,66,506,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"... than that immunoprecipitated from cells from the c.2T>C patient A-T86 (Figure 5, lanes 7 and 8) but...",68,165,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...rotein in cells from patient A-T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncated ATM ass...,68,441,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...Truncated ATM associated with the presence of the c.1A>G mutation was not detected, probably because...",68,524,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,"...lele that was essentially full-length p.Arg3047X (c.9139C>T) (Figure 5, lanes 9 and 10)",68,965,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,"...precipitated from A-T cells carrying the mutation c.2T>C, which did not demonstrate any in vitro kin...",70,152,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...cDNA. Both the mutant protein associated with the c.1A>G and the p.Gly2891Asp mutant protein are sho...,72,242,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...rotein are shown in Figure 6A. Interestingly, the c.1A>G protein was of lower molecular weight than ...",72,328,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"... mutant protein was significantly higher than the c.1A>G protein (Figure 6A, lanes 4 and 5). We were...",72,643,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"... mutant protein was significantly higher than the c.1A>G protein (Figure 6A, lanes 4 and 5). We were...",72,643,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"... mutant protein was significantly higher than the c.1A>G protein (Figure 6A, lanes 4 and 5). We were...",72,643,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"... unlikely to be due to protein expressed from the c.1A>G mutation. Indeed, the mutant c.1A>G ATM clo...",74,269,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...ase-inactive truncated protein expressed from the c.2T>C ATM mutant,74,457,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,... ATM protein derived from the allele carrying the c.1A>G mutation affecting the initiating methionin...,81,54,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...ar weight of ATM immunoprecipitated from both the c.2T>C mutant cells and the modelled c.1A>G is con...,81,676,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,...rom both the c.2T>C mutant cells and the modelled c.1A>G is consistent with this,81,713,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...uncated ATM protein expressed from the c.1A>G and c.2T>C mutant alleles is the result of uncharacter...,83,151,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,"...east cancer, were homozygous for the ATM mutation c.7271T>G (p.Val2424Gly). The mutation was also id...",85,1041,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1918A>T,...utations in novel premature termination mutation (c.1918A>T (Lys640Stop)) and a (c.1066-6T>G (IVS10-...,87,284,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1918A>T,...utations in novel premature termination mutation (c.1918A>T (Lys640Stop)) and a (c.1066-6T>G (IVS10-...,87,284,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1066-6T>G,"...mination mutation (c.1918A>T (Lys640Stop)) and a (c.1066-6T>G (IVS10-6T-G)), which has previously be...",87,315,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...ons at these positions in patient A-T213; (A) the c.1A>G mutation, and (B) the c.8672G>A mutation. T...",108,205,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.1A>G,"...ons at these positions in patient A-T213; (A) the c.1A>G mutation, and (B) the c.8672G>A mutation. T...",108,205,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"...ient A-T213; (A) the c.1A>G mutation, and (B) the c.8672G>A mutation. The boxed sequence triplet in ...",108,234,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,"...ient A-T213; (A) the c.1A>G mutation, and (B) the c.8672G>A mutation. The boxed sequence triplet in ...",108,234,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...es 7 and 8). It is likely that truncated ATM from c.2T>C in patient AT187 is obscured by the p.Arg30...,112,659,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,...C in patient AT187 is obscured by the p.Arg3047X (c.9139C>T) mutant protein (lanes 9 and 10) and the...,112,714,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,...C in patient AT187 is obscured by the p.Arg3047X (c.9139C>T) mutant protein (lanes 9 and 10) and the...,112,714,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...n patient A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutant protein (lanes 5 and 6). Immunop...,112,842,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...n patient A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutant protein (lanes 5 and 6). Immunop...,112,842,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.8672G>A,...n patient A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutant protein (lanes 5 and 6). Immunop...,112,842,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...f A-T213 but not from ATM of patient A-T86 with a c.2T>C mutation and a second truncating mutation (...,112,1314,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...f A-T213 but not from ATM of patient A-T86 with a c.2T>C mutation and a second truncating mutation (...,112,1314,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.2T>C,...f A-T213 but not from ATM of patient A-T86 with a c.2T>C mutation and a second truncating mutation (...,112,1314,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,...or from patient A-T187 with a c.2T>C mutation and c.9139C>T (p.Arg3047X). (B) Histogram of relative ...,112,1422,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.9139C>T,...or from patient A-T187 with a c.2T>C mutation and c.9139C>T (p.Arg3047X). (B) Histogram of relative ...,112,1422,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.7271T>G,...st cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Br...,131,290,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
c.280C>T,"...A patient carrying a heterozygous RPS19 mutation (c.280C>T, p.Arg94X), and healthy control samples w...",77,279,Br_J_Haematol_2015_Nov_25_171(4)_517-529.txt
c.5882G>A,ARDM-135	42	24	0.4	0.6	STGD	c.5882G>A(42)	p.Gly1961Glu	c.1029_1030insT(8)	p.As...,76,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Y...,79,24,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.700C>T,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,51,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.700C>T,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,51,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.700C>T,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,51,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-162	50	16	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	Yes,80,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-162	50	16	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	Yes,80,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3056C>T,ARDM-146	32	13	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047...,86,30,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5929G>A,ARDM-90	26	8	Hand moving	STGD	c.5929G>A (43)	p.Gly1977Ser	IVS21-2A>T		Yes,88,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5929G>A,ARDM-90	26	8	Hand moving	STGD	c.5929G>A (43)	p.Gly1977Ser	IVS21-2A>T		Yes,88,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3323G>A,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,30,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.5172G>T,...GD	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,76,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.4919G>A,ARDM-205	NA	NA	NA	STGD	c.4919G>A(35)	p.Arg1640Gln	ND	ND	NP,98,24,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.3386G>T,ARDM-247	30	12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137...,99,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.6410G>A,...247	30	12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Tyr	Yes,99,56,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.466A>G,RP-959	53	10	0.1	0.1	RP	c.466A>G(5)	p.Ile156Val	ND	ND	Yes,105,25,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.4297G>A,RP-1058	37	6	0.2	0.6	RP	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,106,25,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.2832A>G,19	c.2832A>G	p.Pro944Pro	This study,121,4,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
c.1183A>T,...Exon 8: c.1114_1116del; p.(Val372del)	Exon 9: Het c.1183A>T; p.(Arg395*),99,167,Brain_2013_Jan_3_136(1)_269-281.txt
c.2T>G,...bres negative	Mild reduction	Exome/Sanger	Exon 1: c.2T>G; p.(M1_R59del)	Exon 2: c.377G>A; p.(Arg126H...,100,72,Brain_2013_Jan_3_136(1)_269-281.txt
c.677A>G,...Sanger	Exon 1: c.53dup; p.(Ser19Glufs*97)	Exon 3: c.677A>G; p.(Tyr226Cys),102,96,Brain_2013_Jan_3_136(1)_269-281.txt
c.677A>G,...dupT) in exon 1 and a missense mutation in exon 3 c.677A>G (p.Tyr226Cys). The heterozygous carrier s...,123,629,Brain_2013_Jan_3_136(1)_269-281.txt
c.7271T>G,...al population-based study of a specific mutation (c.7271T>G) in ATM [18] and the recent report of tw...,64,780,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
c.7271T>G,...st cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Br...,128,285,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
c.1066-6T>G,...s associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Fa...,128,299,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
c.4719C>T,...tions. Her genotype showed a splice-site mutation c.4719C>T in exon 27 of the SCN5A gene. This rare ...,35,779,Case_Rep_Anesthesiol_2016_Sep_7_2016_9278409.txt
c.4719C>T,...tions. Her genotype showed a splice-site mutation c.4719C>T in exon 27 of the SCN5A gene. This rare ...,35,779,Case_Rep_Anesthesiol_2016_Sep_7_2016_9278409.txt
c.2455C>T,"c.2455C>T, p.Arg630X",68,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2455C>T,"c.2455C>T, p.Arg630X",68,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2455C>T,"c.2455C>T, p.Arg630X",68,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2455C>T,"c.2455C>T, p.Arg630X",68,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.984C>A,"c.984C>A, p.Y328X	Ahmad et al., 2007 [15]",85,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.984C>A,"c.984C>A, p.Y328X	Ahmad et al., 2007 [15]",85,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.984C>A,"c.984C>A, p.Y328X	Ahmad et al., 2007 [15]",85,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2687G>A,"c.2687G>A, p.R896Q",89,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2687G>A,"c.2687G>A, p.R896Q",89,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1567C>T,"c.1567C>T, p.Arg523Ter	Kurban et al., 2010 [17]",96,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2697G>A,"c.2697G>A, p.Met899Ile",100,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.2697G>A,"c.2697G>A, p.Met899Ile",100,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.5155T>C,c.5155T>C; C1719R,106,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.1567C>T,"c.1567C>T, p.Arg523Ter",112,1,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
c.3598G>A,"...ected a heterozygous mutation in the COL2A1 gene (c.3598G>A; p.Gly1200Ser). This missense mutation, ...",26,163,Case_Rep_Obstet_Gynecol_2015_Sep_8_2015_935204.txt
c.3598G>A,"...ected a heterozygous mutation in the COL2A1 gene (c.3598G>A; p.Gly1200Ser). This missense mutation, ...",26,163,Case_Rep_Obstet_Gynecol_2015_Sep_8_2015_935204.txt
c.3598G>A,"...ected a heterozygous mutation in the COL2A1 gene (c.3598G>A; p.Gly1200Ser). This missense mutation, ...",26,163,Case_Rep_Obstet_Gynecol_2015_Sep_8_2015_935204.txt
c.1003C>T,...ting results confirmed the presence of the R335X (c.1003C>T) mutation in the PTEN gene and the patie...,33,62,Case_Rep_Oncol_Med_2015_Sep_10_2015_546297.txt
c.1622T>C,"... a mutation in the ABCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozyg...",15,659,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.1622T>C,"... a mutation in the ABCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozyg...",15,659,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.3113C>T,"...BCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,679,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.3113C>T,"... 12 and 21 of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous variant i...",29,608,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.227G>A,"...heterozygous variant in exon 2 of the NR2E3 gene (c.227G>A, p.R760), and (3) a heterozygous variant ...",29,686,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.747A>T,...a heterozygous variant in exon 6 of the RGR gene (c.747A>T p.K249N). Based on previous knowledge of ...,29,763,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.747A>T,...a heterozygous variant in exon 6 of the RGR gene (c.747A>T p.K249N). Based on previous knowledge of ...,29,763,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.1622T>C,"...disease-causing alleles in the ABCA4 gene, L541P (c.1622T>C, p.Leu541Pro, rs61751392) and A1038V (c....",33,182,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
c.335G>A,"... the nucleotide position 5234 (exon 2: g.5234G>A, c.335G>A, p.Arg112His) described in the literature...",46,381,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
c.335G>A,"... the nucleotide position 5234 (exon 2: g.5234G>A, c.335G>A, p.Arg112His) described in the literature...",46,381,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
c.1299G>A,... patient revealed a homozygous missense mutation (c.1299G>A) in the RAG1 gene leading to replacement...,28,1731,Cases_J_2009_Jul_30_2_8391.txt
c.1565C>T,"...prisingly, only 1 missense mutation (rs138651238; c.1565C>T and p.T522M) was discovered (Fig. 6). In...",87,217,Cell_Adh_Migr_2016_Feb_6_10(1-2)_395-55.txt
c.542G>A,"...nce of four and a half LIM domain 1 isoforms. The c.542G>A locates on exon 6, the resultant p.Trp181...",22,89,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
c.1615G>A,"...analysis showed the girl to be homozygous for the c.1615G>A, p.(Asp539Asn) missense mutation in GPI....",16,727,Clin_Case_Rep_2015_Oct_7_3(10)_862-865.txt
c.845G>A,"...n the seventh month of life. She was carrying the c.845G>A (p.C282Y) mutation in heterozygosis, conf...",27,202,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.845G>A,"...n the seventh month of life. She was carrying the c.845G>A (p.C282Y) mutation in heterozygosis, conf...",27,202,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.845G>A,"...n the seventh month of life. She was carrying the c.845G>A (p.C282Y) mutation in heterozygosis, conf...",27,202,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.742A>G,...these computer programs labeled it as pathogenic. c.742A>G was considered pathogenic by all but Poly...,33,628,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.742A>G,...these computer programs labeled it as pathogenic. c.742A>G was considered pathogenic by all but Poly...,33,628,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.760G>A,...red pathogenic by all but Polyphen‐2 software and c.760G>A by all but Pmut software. The other genes...,33,698,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
c.728G>T,"...munohistopathological features of two eyes with a c.728G>T, p.Arg243 Leu mutation in CAPN5.5 We foun...",22,720,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
c.731T>C,"...and one brother (Figure 1). This family carried a c.731T>C, p.Leu244Pro mutation in the CAPN5 gene.1...",28,211,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
c.731T>C,Notes: A c.731T>C mutation in CAPN5 was inherited in a domi...,61,10,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
c.2830G>A,c.2830G>,50,1,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
c.2830G>A,c.2830G>,50,1,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
c.-352A>T,"... (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), T...",9,105,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"...352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629...",9,158,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-488G>A,"...>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) polymorphisms with breast ca...",9,188,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"... of IL-8 polymorphism, GA and AA genotypes of TNF c.-418G>A polymorphism, and GA genotype of TNF c.-...",15,404,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"...49C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), a...",22,673,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"...352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629...",22,700,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-949C>T,"For NFKBIA c.-949C>T (rs2233406) polymorphism, the forward pr...",31,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-949C>T,"For NFKBIA c.-949C>T (rs2233406) polymorphism, the forward pr...",31,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-949C>T,"For NFKBIA c.-949C>T (rs2233406) polymorphism, the forward pr...",31,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-949C>T,"For NFKBIA c.-949C>T (rs2233406) polymorphism, the forward pr...",31,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-854T>C,"For IL-10 c.-854T>C (rs1800871) polymorphism, the forward pr...",35,11,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"For TNF c.-418G>A (rs361525) polymorphism, the primers use...",37,9,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"For TNF c.-418G>A (rs361525) polymorphism, the primers use...",37,9,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.-418G>A,"... of IL-8 polymorphism, GA and AA genotypes of TNF c.-418G>A polymorphism, and GA genotype of TNF c.-...",320,238,Croat_Med_J_2014_Dec_55(6)_638-646.txt
c.1A>T,"1	c.1A>T, c. 13G>A",288,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1A>T,"1	c.1A>T, c. 13G>A",288,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.29G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A...",289,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.52G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,30,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.95A>C,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,48,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.95A>C,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,48,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.98G>A,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>G",291,10,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.98G>A,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>G",291,10,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.101A>G,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>G",291,46,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.110C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.110C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.136G>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.16...",295,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.136G>C,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.136G>C,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.160T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,47,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.160T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,47,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.160T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,47,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.164C>T,"c.164C>T, c.167T>A",297,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.235G>T,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, ...",298,19,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.245C>A,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376d...",298,29,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.256G>A,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del40, c.39...",298,39,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.310C>T,"...221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del40, c.397_399delCCA, c.428A>...",298,59,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.428A>G,"...00G>C, c.310C>T, c.337_376del40, c.397_399delCCA, c.428A>G",298,102,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.497G>A,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.497G>A,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.500G>A,"c.500G>A, c.511C>T, c.518C>T",301,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.511C>T,"c.500G>A, c.511C>T, c.518C>T",301,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.518C>T,"c.500G>A, c.511C>T, c.518C>T",301,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.574A>C,"5	c.536delG, c.574A>C, c.574A>G, c.600C>G",302,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.574A>C,"5	c.536delG, c.574A>C, c.574A>G, c.600C>G",302,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.634T>G,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,34,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.634T>G,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,34,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.635G>A,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,44,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.688G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.688G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.701G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.701G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.714G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.714G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.730G>A,"c.719C>T, c.727G>A, c.730G>A",307,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.730G>A,"c.719C>T, c.727G>A, c.730G>A",307,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.758G>A,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, ...",308,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.758G>T,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.759C>G,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.759C>G,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.766C>T,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.794A>G,"...c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,53,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.799T>C,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, ...",310,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.804T>A,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,11,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.813A>T,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.818A>G,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.838G>A,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.850G>C,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.865T>G,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.892A>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.892A>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.892A>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.893T>G,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.930G>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.931C>T,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.983G>A,"9	c.968_973delGTGTCC, c.971delT, c.983G>A, c.1000C>T",314,34,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1000C>T,"9	c.968_973delGTGTCC, c.971delT, c.983G>A, c.1000C>T",314,44,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1051A>C,"c.1051A>C, c.1076G>A",318,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1076G>A,"c.1051A>C, c.1076G>A",318,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1096C>T,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1097G>A,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,15,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1183G>T,"11	c.1175_1176delGA, c.1180G>A, c.1183G>T, c.1186A>G",320,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1192G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1192G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1204C>T,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1205G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1205G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1244C>A,"c.1244C>A, c.1252T>C, c.1283_1284insA",324,1,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1252T>C,"c.1244C>A, c.1252T>C, c.1283_1284insA",324,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1252T>C,"c.1244C>A, c.1252T>C, c.1283_1284insA",324,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1286G>A,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321...",325,4,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1310C>T,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,37,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1310C>T,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,37,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1321T>C,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,48,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1330G>C,"...6G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,59,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.1330G>C,"...6G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,59,Curr_Genomics_2013_Dec_14(8)_502-517.txt
c.111G>A,"Screening for P37L and P37= (c.110C>T, c.111G>A) in exon 2 and E310D in exon 8 of PRKN wa...",28,40,Curr_Genomics_2015_Aug_16(4)_215-223.txt
c.99+1G>A,... novel heterozygous intron 1 splice site variant (c.99+1G>A) in both the index individual and the fa...,5,1885,Dev_Med_Child_Neurol_2014_Nov_29_56(11)_1124-1128.txt
c.742G>A,"...3His and c.203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), ...",34,167,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.675C>G,"...Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R and D217N (c.781...",34,193,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.649G>A,"...), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of these six mutations, fi...",34,264,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
c.263A>G,"2	c.263A>G	p.Asn88Ser	dHMN	[16,18,28]",99,3,Diagn_Pathol_2013_May_9_8_78.txt
c.269C>G,"2	c.269C>G	p.Ser90Trp	dHMN, CMT2	[22]",101,3,Diagn_Pathol_2013_May_9_8_78.txt
c.412C>T,3	c.412C>T	p.Arg138X	CGL2	[5],103,3,Diagn_Pathol_2013_May_9_8_78.txt
c.560A>G,4	c.560A>G	p.Tyr187Cys	CGL2	[15],104,3,Diagn_Pathol_2013_May_9_8_78.txt
c.565G>T,4	c.565G>T	p.Glu189X	CGL2	[14],105,3,Diagn_Pathol_2013_May_9_8_78.txt
c.565G>T,4	c.565G>T	p.Glu189X	CGL2	[14],105,3,Diagn_Pathol_2013_May_9_8_78.txt
c.565G>T,4	c.565G>T	p.Glu189X	CGL2	[14],105,3,Diagn_Pathol_2013_May_9_8_78.txt
c.684C>G,6	c.684C>G	p. Tyr228X	CGL2	[7],107,3,Diagn_Pathol_2013_May_9_8_78.txt
c.823C>T,7	c.823C>T	p.Arg275X	CGL2	[31],108,3,Diagn_Pathol_2013_May_9_8_78.txt
c.823C>T,7	c.823C>T	p.Arg275X	CGL2	[31],108,3,Diagn_Pathol_2013_May_9_8_78.txt
c.1171C>T,10	c.1171C>T	p.Gln391X	CGL2	[27],109,4,Diagn_Pathol_2013_May_9_8_78.txt
c.-2548G>A,"...imentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjec...",142,109,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
c.-2548G>A,"...imentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjec...",142,109,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
c.57C>T,"...tions in the DYF13 gene, a one-base substitution (c.57C>T) and a one-base deletion (c.59delC; Figure...",94,909,eLife_2014_Mar_4_3_e01566.txt
c.228-22T>A,"...425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Green (2008), Labauge et ...",24,189,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
c.228-22T>A,"...425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Green (2008), Labauge et ...",24,189,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
c.228-22T>A,"...425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Green (2008), Labauge et ...",24,189,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
c.673C>T,"...we found a homozygous nucleotide change in XRCC4 (c.673C>T), predicted to introduce a premature stop...",9,794,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
c.673C>T,...The most severe variant was the nucleotide change c.673C>T in XRCC4. Two different isoforms of XRCC4...,88,677,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
c.673C>T,...The most severe variant was the nucleotide change c.673C>T in XRCC4. Two different isoforms of XRCC4...,88,677,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
c.320C>T,c.320C>T	p.Ser107Leu	Ig-like C2-type 1 domain	Dise...,140,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.320C>T,c.320C>T	p.Ser107Leu	Ig-like C2-type 1 domain	Dise...,140,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.2314C>T,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-caus...,150,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.253C>T,c.253C>T	p.Arg85Cys	First intracellular loop	Disea...,153,2,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
c.1157C>A,...4.1) gene revealed two novel genetic alterations: c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p...,57,962,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
c.554G>A,"...	Newborn period	18 months	Inherited, heterozygous c.554G>A (R185Q)	Saline, phosphate, and cholecalci...",110,137,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.554G>A,"...	Newborn period	18 months	Inherited, heterozygous c.554G>A (R185Q)	Saline, phosphate, and cholecalci...",110,137,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, furosemide, and pamidrona...",114,22,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, furosemide, and pamidrona...",114,22,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, low calcium formula, phos...",119,22,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
c.2753T>C,"...n our case a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy) was detected by targeted n...",4,1178,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
c.2753T>C,"...h revealed a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy), further validated by Sang...",31,235,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
c.557C>T,"... mutations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R193X)) in the STAR gene, causing...",4,920,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
c.4154A>T,... for a novel missense mutation in the ABCC8 gene (c.4154A>T/p.Lys1385Thr). Since the lysine residue ...,31,384,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
c.1621G>A,"...nd direct DNA sequencing, we found a heterozygous c.1621G>A (Ala541Thr) mutation at exon 10 of the M...",56,91,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,"...nd direct DNA sequencing, we found a heterozygous c.1621G>A (Ala541Thr) mutation at exon 10 of the M...",56,91,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,...olyPhen-2 report indicates that the heterogeneous c.1621G>A (Ala541Thr) mutation is predicted to be ...,86,199,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,...olyPhen-2 report indicates that the heterogeneous c.1621G>A (Ala541Thr) mutation is predicted to be ...,86,199,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,...olyPhen-2 report indicates that the heterogeneous c.1621G>A (Ala541Thr) mutation is predicted to be ...,86,199,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.1621G>A,...olyPhen-2 report indicates that the heterogeneous c.1621G>A (Ala541Thr) mutation is predicted to be ...,86,199,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
c.582T>A,"...hermore, two other TMPRSS3 mutations (NM_024022.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.58...",10,977,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
c.582T>A,"...hermore, two other TMPRSS3 mutations (NM_024022.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.58...",10,977,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
c.582T>A,"...hermore, two other TMPRSS3 mutations (NM_024022.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.58...",10,977,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
c.521T>C,"..., the SNPs were different at different races. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130A...",148,187,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.388A>G,The c.388A>G and the c.521T>C variants occur in allele...,162,5,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.521T>C,The c.388A>G and the c.521T>C variants occur in alleles of OATP1B1*15. ...,162,22,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.521T>C,The c.388A>G and the c.521T>C variants occur in alleles of OATP1B1*15. ...,162,22,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
c.1513A>C,"...ymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-function ...",3,2020,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...P; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-function SNP (c.489C>T)...",3,2034,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...ects on P2X7R function.32 The most common variant c.1513A>C, produces an amino acid change at positi...",18,229,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...talloproteinase-9 from macrophages.17, 33, 34 The c.1729T>A variant (p.I568N) abolishes trafficking ...",18,507,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...talloproteinase-9 from macrophages.17, 33, 34 The c.1729T>A variant (p.I568N) abolishes trafficking ...",18,507,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...talloproteinase-9 from macrophages.17, 33, 34 The c.1729T>A variant (p.I568N) abolishes trafficking ...",18,507,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"...nding to the extracellular domain of P2X7R,36 the c.1096C>G variant (p.Thr357Ser) results in reduced...",18,697,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,...regulation of P2X7R expression32 and the intronic c.151+1G>T variant results in a null allele.37 The...,18,837,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"... minor allele for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while ...",34,79,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"...ele for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while having maj...",34,89,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"Overall, SNP call rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c....",41,38,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"... call rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>G (rs2230911) and c...",41,63,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,"...r c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>G (rs2230911) and c.1729T>A (rs1653624) an...",41,86,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,...(rs2230911) and c.1729T>A (rs1653624) and 95% for c.489C>T (rs208294) and c.1513A>C (rs3751143). Tab...,41,146,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lowe...,43,7,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lowe...,43,7,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lowe...,43,7,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,... change in LS-BMD did not differ significantly by c.946G>A genotype (−0.39%/year (SEM 0.06) for GG s...,44,735,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.151+1G>T,"...ions (n=84), subjects who had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.172...",47,135,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almost ninefold ...",47,167,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...ther c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almost ninefold greater annua...",47,180,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1729T>A,"...ther c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almost ninefold greater annua...",47,180,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,"...endorff et al22 demonstrated that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), a...",50,860,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...d an association of a major LOF SNP in P2RX7, the c.946G>A (p.Arg307Gln), with low BMD in the LS in ...",52,78,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...Permeability studies of subjects heterozygous for c.946G>A (Figure 1 in Gu et al, 200436) show compl...",52,979,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...Permeability studies of subjects heterozygous for c.946G>A (Figure 1 in Gu et al, 200436) show compl...",52,979,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...nt on function even in heterozygous dosage. Thus, c.946G>A may be classified as a dominant-negative ...",52,1173,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...found that subjects who were heterozygous for the c.946G>A (Arg307Gln variant) had >40% greater bone...,52,1501,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,... with total hip replacement revision and that the c.946G>A allele increased cumulative hazard of tot...,52,1875,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...fracture risk. As the observed effect size of the c.946G>A is quiet large (β=0.12) compared with pre...,60,178,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,...fracture risk. As the observed effect size of the c.946G>A is quiet large (β=0.12) compared with pre...,60,178,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,"...xamine rare genetic variants, including the P2RX7 c.946G>A, which has a population frequency of arou...",60,849,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,rs208294	c.489C>T (p.H155Y)	0.43	0.99 (0.01)	1.01 (0.01)	1....,89,10,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,rs208294	c.489C>T (p.H155Y)	0.43	0.99 (0.01)	1.01 (0.01)	1....,89,10,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,rs28360457	c.946G>A (p.R307Q)	0.02	1.00 (0.01)	0.88 (0.03)	*	...,90,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1096C>G,rs2230911	c.1096C>G (p.T357S)	0.07	1.00 (0.01)	1.03 (0.02)	1...,91,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,rs3751143	c.1513A>C (p.E496A)	0.17	1.00 (0.01)	1.00 (0.02)	1...,92,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,rs3751143	c.1513A>C (p.E496A)	0.17	1.00 (0.01)	1.00 (0.02)	1...,92,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.489C>T,rs208294	c.489C>T (p.H155Y)	0.43	0.96 (0.01)	0.98 (0.01)	0....,106,10,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.946G>A,rs28360457	c.946G>A (p.R307Q)	0.02	0.97 (0.01)	0.84 (0.04)	*	...,107,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.1513A>C,rs3751143	c.1513A>C (p.E496A)	0.17	0.97 (0.01)	0.97 (0.01)	0...,109,11,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
c.458C>T,... specific. The most common identified to date are c.458C>T (p.(Pro153Leu))1 and c.913G>T (p.(Glu305*...,21,475,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.613C>T,"...05*)),2 in individuals of European ethnicity, and c.613C>T (p.(Arg205Cys))3 and c.1498C>T (p.(Arg500...",21,572,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.472G>A,...occurs in cis with the common polymorphic variant c.472G>A (p.(Glu158Lys)) it severely affects enzym...,21,827,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
c.2988+1G>A,"... (legacy names) are designated as c.1585-1G>A and c.2988+1G>A, respectively, according to the HGVS n...",20,1218,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2988+1G>A,"... (legacy names) are designated as c.1585-1G>A and c.2988+1G>A, respectively, according to the HGVS n...",20,1218,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1624G>T, G542X	c.1624G>T	p.Gly542*,162,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3909C>G, N1303K	c.3909C>G	p.Asn1303Lys,164,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3846G>A, W1282X	c.3846G>A	p.Trp1282*,165,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3846G>A, W1282X	c.3846G>A	p.Trp1282*,165,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3846G>A, W1282X	c.3846G>A	p.Trp1282*,165,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.178G>T, E60X	c.178G>T	p.Glu60*,168,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.178G>T, E60X	c.178G>T	p.Glu60*,168,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.579+1G>T, 711+1G>T	c.579+1G>T	 ,171,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.579+1G>T, 711+1G>T	c.579+1G>T	 ,171,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1040G>C, R347P	c.1040G>C	p.Arg347Pro,172,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1040G>C, R347P	c.1040G>C	p.Arg347Pro,172,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1364C>A, A455E	c.1364C>A	p.Ala455Glu,173,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1364C>A, A455E	c.1364C>A	p.Ala455Glu,173,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1364C>A, A455E	c.1364C>A	p.Ala455Glu,173,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1477C>T, Q493X	c.1477C>T	p.Gln493*,174,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1766+1G>A, 1898+1G>A	c.1766+1G>A	 ,178,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1766+1G>A, 1898+1G>A	c.1766+1G>A	 ,178,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3484C>T, R1162X	c.3484C>T	p.Arg1162*,183,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.200C>T, P67L	c.200C>T	p.Pro67Leu,187,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.223C>T, R75X	c.223C>T	p.Arg75*,188,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.274-1G>A, 406-1G>A	c.274-1G>A	 ,190,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.274G>T, E92X	c.274G>T	p.Glu92*,191,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.292C>T, Q98X	c.292C>T	p.Gln98*,193,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.292C>T, Q98X	c.292C>T	p.Gln98*,193,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.328G>C, D110H	c.328G>C	p.Asp110His,195,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.349C>T, R117C	c.349C>T	p.Arg117Cys,196,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.532G>A, G178R	c.532G>A	p.Gly178Arg,201,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.532G>A, G178R	c.532G>A	p.Gly178Arg,201,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.595C>T, H199Y	c.595C>T	p.His199Tyr,205,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.595C>T, H199Y	c.595C>T	p.His199Tyr,205,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.658C>T, Q220X	c.658C>T	p.Gln220*,208,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.658C>T, Q220X	c.658C>T	p.Gln220*,208,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1000C>T, R334W	c.1000C>T	p.Arg334Trp,212,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1040G>A, R347H	c.1040G>A	p.Arg347His,217,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1116+1G>A, 1248+1G>A	c.1116+1G>A	 ,219,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1202G>A, W401X(TAG)	c.1202G>A	p.Trp401*,221,13,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1202G>A, W401X(TAG)	c.1202G>A	p.Trp401*,221,13,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1203G>A, W401X(TGA)	c.1203G>A	p.Trp401*,222,13,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1203G>A, W401X(TGA)	c.1203G>A	p.Trp401*,222,13,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1209+1G>A, 1341+1G>A	c.1209+1G>A	 ,223,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1209+1G>A, 1341+1G>A	c.1209+1G>A	 ,223,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1209+1G>A, 1341+1G>A	c.1209+1G>A	 ,223,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1397C>A, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1397C>G, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,21,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1397C>G, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,21,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1397C>G, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,21,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1466C>A, S489X	c.1466C>A	p.Ser489*,228,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1466C>A, S489X	c.1466C>A	p.Ser489*,228,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1475C>T, S492F	c.1475C>T	p.Ser492Phe,229,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1558G>T, V520F	c.1558G>T	p.Val520Phe,231,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1585-1G>A, 1717-1G>A	c.1585-1G>A	 ,232,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1585-8G>A, 1717-8G>A	c.1585-8G>A	 ,233,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1654C>T, Q552X	c.1654C>T	p.Gln552*,237,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1675G>A, A559T	c.1675G>A	p.Ala559Thr,238,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1679G>A, R560K	c.1679G>A	p.Arg560Lys,241,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1679G>A, R560K	c.1679G>A	p.Arg560Lys,241,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1679G>A, R560K	c.1679G>A	p.Arg560Lys,241,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1753G>T, E585X	c.1753G>T	p.Glu585*,242,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2125C>T, R709X	c.2125C>T	p.Arg709*,247,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2290C>T, R764X	c.2290C>T	p.Arg764*,252,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2490+1G>A, 2622+1G>A	c.2490+1G>A	 ,255,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2490+1G>A, 2622+1G>A	c.2490+1G>A	 ,255,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2537G>A, W846X	c.2537G>A	p.Trp846*,257,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2538G>A, W846X(2670TGG>TGA)	c.2538G>A	p.Trp846*,258,21,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2538G>A, W846X(2670TGG>TGA)	c.2538G>A	p.Trp846*,258,21,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2551C>T, R851X	c.2551C>T	p.Arg851*,259,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2834C>T, S945L	c.2834C>T	p.Ser945Leu,261,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2908G>C, G970R	c.2908G>C	p.Gly970Arg,266,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3197G>A, R1066H	c.3197G>A	p.Arg1066His,273,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3266G>A, W1089X	c.3266G>A	p.Trp1089*,275,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3276C>A, Y1092X	c.3276C>A	p.Tyr1092*,276,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3276C>A, Y1092X	c.3276C>A	p.Tyr1092*,276,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3611G>A, W1204X(3743G>A)	c.3611G>A	p.Trp1204*,280,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3612G>A, W1204X(3744G>A)	c.3612G>A	p.Trp1204*,281,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3718-2477C>T, 3849+10kbC>T	c.3718-2477C>T	p.(?),283,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3752G>A, S1251N	c.3752G>A	p.Ser1251Asn,286,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3873+1G>A, 4005+1G>A	c.3873+1G>A	 ,288,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3873+1G>A, 4005+1G>A	c.3873+1G>A	 ,288,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3937C>T, Q1313X	c.3937C>T	p.Gln1313*,290,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3209G>A, R1070Q	c.3209G>A	p.Arg1070Gln,306,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.1727G>C, G576A	c.1727G>C	p.Gly576Ala,317,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2002C>T, R668C	c.2002C>T	p.Arg668Cys,318,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2002C>T, R668C	c.2002C>T	p.Arg668Cys,318,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2260G>A, V754M	c.2260G>A	p.Val754Met,319,8,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3208C>T, R1070W	c.3208C>T	p.Arg1070Trp,322,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3485G>T, R1162L	c.3485G>T	p.Arg1162Leu,323,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.3208C>T,[R74W;R1070W;D1270N]c.[220C>T;c.3208C>T;3808G>A,341,31,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2657+5G>A,"...y542★…); LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable dise...",396,113,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.2657+5G>A,"...y542★…); LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable dise...",396,113,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
c.55G>C,...ously reported rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amino-acid variant is b...,92,771,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
c.161A>G,...eflecting an earlier report of NM_022437.2(ABCG8):c.161A>G (p.Tyr54Cys) (r2~0.2 between rs4299376:G>...,92,1069,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
c.5080G>T,18	c.5080G>T	1	10	c.1813insA	1,73,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5080G>T,18	c.5080G>T	1	10	c.1813insA	1,73,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.692C>T,11	c.692C>T	1	10	c.1385A>G	1,83,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1385A>G,11	c.692C>T	1	10	c.1385A>G	1,83,18,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1258G>T,11	c.1258G>T	1	15	c.7469T>C	1,84,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1486C>T,11	c.1486C>T	1	18	c.8111C>T	1,85,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8111C>T,11	c.1486C>T	1	18	c.8111C>T	1,85,19,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8723T>G,17	c.4987-3C>G	1	21	c.8723T>G	1,86,21,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5194-25A>C,19(I)	c.5194-25A>C	1,87,7,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5435C>G,23	c.5435C>G	1,89,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5435C>G,23	c.5435C>G	1,89,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5435C>G,23	c.5435C>G	1,89,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5435C>G,23	c.5435C>G	1,89,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1258G>T,11	c.1258G>T	p.D420Y	1	6.5	10.5	Y	N/Y	3	ND	N	Unknown	...,157,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5194-25A>C,20	c.5194-25A>C	NA	1	14.0	17.4	–	–	0	ND	ND,160,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.5194-25A>C,20	c.5194-25A>C	NA	1	14.0	17.4	–	–	0	ND	ND,160,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1385A>G,10	c.1385A>G	p.E462G	1	37.8	17.8	Y	Y/N	35	N	Y	Neutral...,165,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1385A>G,10	c.1385A>G	p.E462G	1	37.8	17.8	Y	Y/N	35	N	Y	Neutral...,165,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1385A>G,10	c.1385A>G	p.E462G	1	37.8	17.8	Y	Y/N	35	N	Y	Neutral...,165,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.1385A>G,10	c.1385A>G	p.E462G	1	37.8	17.8	Y	Y/N	35	N	Y	Neutral...,165,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.8723T>G,21	c.8723T>G	p.V2908G	1	1.2	9.8	N	Y/N	8	N	N	Neutral	[...,168,4,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
c.-32-13T>G,"...n mutation among Caucasian children and adults is c.-32-13T>G (IVS1), a splicing defect which allows...",23,65,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.-32-13T>G,"...n mutation among Caucasian children and adults is c.-32-13T>G (IVS1), a splicing defect which allows...",23,65,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.2560C>T,"...). The most common mutation in African-Americans, c.2560C>T (p.Arg854Ter), most likely originated in...",25,284,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.2560C>T,"...). The most common mutation in African-Americans, c.2560C>T (p.Arg854Ter), most likely originated in...",25,284,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.2560C>T,"...). The most common mutation in African-Americans, c.2560C>T (p.Arg854Ter), most likely originated in...",25,284,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
c.331A>G,"...2755:c.167A>C_p.Q56P (0.13,1125, PIK3CA:NM 006218:c.331A>G p.K111E [0.13,765]), and CTNNB1:NM_001904...",77,191,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
c.1015G>A,...S9 and S10 (both compound heterozygotes for MCCC2 c.1015G>A mutation) had dissimilar genotypes in th...,50,1709,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1015G>A,...S9 and S10 (both compound heterozygotes for MCCC2 c.1015G>A mutation) had dissimilar genotypes in th...,50,1709,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1315G>A,MCCC1	1	A2	F	Homozygous	c.1315G>A	p.Val438Met	Nonsyn	This study,88,25,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1894C>T,c.1894C>T	p.Gln584X,90,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1731+4A>G,"A4	F	Homozygous	c.1731+4A>G	Intronic, splice region	UNK	This study...",92,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1155A>C,A5	F	Compound Het.	c.1155A>C*,93,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1155A>C,A5	F	Compound Het.	c.1155A>C*,93,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.841C>T,A9	F	Compound Het.	c.841C>T; c.558delA	p.Arg281X,96,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.841C>T,A9	F	Compound Het.	c.841C>T; c.558delA	p.Arg281X,96,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.872C>T,A23	F	Compound Het.	c.872C>T; UND	p.Ala291Val	Nonsyn	This study,105,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.866C>T,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.974T>G,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,33,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1155A>C,"3	S4	F	Homozygous	c.1155A>C*	p.Arg385Ser	Nonsyn	Refs. 15,16",110,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1155A>C,"3	S4	F	Homozygous	c.1155A>C*	p.Arg385Ser	Nonsyn	Refs. 15,16",110,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1114C>T,S26	F	Compound Het.	c.1114C>T,113,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1882G>T,c.1882G>T	p.Gln372X,114,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1065A>T,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1065A>T,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.302C>T,A13	F	Compound Het.	c.302C>T; UND	p.Ser101Phe	Nonsyn	This study,120,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.599T>A,c.599T>A*	p.Ser173Phefs*25,124,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.929C>G,c.929C>G*	p.Arg155Gln,134,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.295G>C,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.295G>C,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.295G>C,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.295G>C,"3	S8	M	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Refs. 3,15",139,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1015G>A,S10	F	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Ref. 15,141,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1015G>A,S10	F	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Ref. 15,141,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.116C>T,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.116C>T,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,18,Genet_Med_2015_Aug_6_17(8)_660-667.txt
c.1543G>A,c.1543G>A	p.R512,228,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1921T>C,c.1921T>,281,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1051C>T,c.1051C>,300,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,315,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,325,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,325,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,325,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,335,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,335,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.1328T>A,c.1328T>,345,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2156A>G,K8103	2	H	c.2156A>G	p.D719G	Yes,370,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,420,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,431,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5668G>T,c.5668G>,447,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5824C>T,MTI-133	2 (2 died)	H	c.5824C>T	p.Q1942*	Yes,463,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.5824C>T,MTI-133	2 (2 died)	H	c.5824C>T	p.Q1942*	Yes,463,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2461G>A,ND	Ht	c.2461G>A	p.G821S	No	digenic	Egyptian,476,8,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2461G>A,ND	Ht	c.2461G>A	p.G821S	No	digenic	Egyptian,476,8,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2439+5G>C,JS-05	1	H	c.2439+5G>C	p.I775_A813del	ND,481,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2439+5G>C,JS-05	1	H	c.2439+5G>C	p.I775_A813del	ND,481,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.2161C>T,JBS-006	1	H	c.2161C>T	p.P721S	Yes,491,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.3364C>T,c.3364C>,521,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4652T>C,F871	1	H	c.4652T>C	p.L1551P	Yes,541,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.4582C>T,c.4582C>T	p.R1528C	Yes,548,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.342-2A>G,c.342-2A>,600,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.342-2A>G,c.342-2A>,611,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.869+1G>A,c.869+1G>,628,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.869+1G>A,c.869+1G>,628,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.33+2T>G,MTI-429	5 (1 died)	H	c.33+2T>G	ND	Yes,637,23,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.376G>A,c.376G>,650,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.376G>A,c.376G>,661,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.380C>T,c.380C>T	p.A127V	Yes,671,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.389A>G,c.389A>,677,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.389A>G,c.389A>,677,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.389A>G,c.389A>,697,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,706,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.128+5G>A,c.128+5G>,713,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.7978C>T,c.7978C>T	p.R2660*	Yes,717,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.7978C>T,c.7978C>T	p.R2660*	Yes,717,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.7978C>T,c.7978C>T	p.R2660*	Yes,717,2,Hum_Genome_Var_2014_Nov_6_1_14020.txt
c.875T>C,...characterized FRMD7 missense variant (NM_194277.2:c.875T>C) detected in a Japanese family with XLCIN...,17,1205,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,"...ons.9 Sequencing FRMD7 revealed a T>C transition (c.875T>C) in exon 9 (Figure 1b), which causes a co...",21,727,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,"...idelines.10,11 We accordingly speculated that the c.875T>C variant of FRMD7 is associated with ICN i...",21,1593,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,The c.875T>C variant in patients with congenital nysta...,25,5,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.875T>C,"... by II:1, II:2 and II:3. Arrow marks the variant, c.875T>C. (c) Cross-species multiple alignment of ...",39,398,Hum_Genome_Var_2015_Feb_12_2_15002.txt
c.207C>A,"...ase. Here, we report a novel hemizygous mutation, c.207C>A (Phe69 Leu), which caused a mild/late-ons...",14,1082,Hum_Genome_Var_2015_Nov_12_2_15044.txt
c.936+919G>A,... a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,171,111,Hum_Genome_Var_2015_Nov_12_2_15044.txt
c.949C>T,"... a normal ERG response. Patient no. 21, who had a c.949C>T mutation in PST, exhibited subnormal cone...",23,1296,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.949C>T,"... a normal ERG response. Patient no. 21, who had a c.949C>T mutation in PST, exhibited subnormal cone...",23,1296,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.949C>T,"... a normal ERG response. Patient no. 21, who had a c.949C>T mutation in PST, exhibited subnormal cone...",23,1296,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.79C>T,"...ings (data not shown). Novel mutations, including c.79C>T (p.Gln27X), c.109_110insG (p.Ala2GlyfsX19)...",26,696,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.131G>A,"...s previously reported, the two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) wer...",26,928,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.131G>A,"...s previously reported, the two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) wer...",26,928,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	...,51,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	...,51,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	...,51,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.50A>G,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	...,51,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.79C>T,3	 	Sporadic	Exon5	c.79C>T	Nonsense	p.Gln27X	PD	Yes	9	M	Total/total	−...,53,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.79C>T,3	 	Sporadic	Exon5	c.79C>T	Nonsense	p.Gln27X	PD	Yes	9	M	Total/total	−...,53,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.79C>T,3	 	Sporadic	Exon5	c.79C>T	Nonsense	p.Gln27X	PD	Yes	9	M	Total/total	−...,53,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.307C>T,12	 	Sporadic	Exon6	c.307C>T	Nonsense	p.Arg103X	PD	Yes	13	M	Total/tota...,63,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.718C>T,16	 	Sporadic	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	27	F	Total/tota...,67,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,19	 	Sporadic	Exon10	c.802G>T	Nonsense	p.Glu268X	PST	Yes	6	F	Total/tota...,70,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.802G>T,19	 	Sporadic	Exon10	c.802G>T	Nonsense	p.Glu268X	PST	Yes	6	F	Total/tota...,70,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.829C>T,20	 	Sporadic	Exon10	c.829C>T	Nonsense	p.Gln277X	PST	Yes	13	F	Total/tot...,71,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.949C>T,21	 	Sporadic	Exon11	c.949C>T	Nonsense	p.Arg317X	PST	Yes	10	M	Total/tot...,72,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
c.2386C>T,...ritance pattern. The first variant in PI4KA was a c.2386C>T mutation in exon 20 (NM_058004.3) that i...,46,1447,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,"...n of translation (p.R796X). The second variant, a c.5560G>A in exon 48 is predicted to result in a m...",46,1592,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...ng of pseudogene sequence. Reads that support the c.5560G>A variant (here shown on the +ve genomic s...,62,845,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,"... harbour the dinucleotide change, indicating that c.5560G>A is unlikely to be a mismapping artefact....",62,978,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...C>GT) (Fig. 2C). None of the reads supporting the c.5560G>A mutation had this dinucleotide alteratio...,67,614,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...udogene sequences at its 3′ end (Fig. 2D) and the c.5560G>A variant was still clearly visible (Suppl...,67,898,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...udogene sequences at its 3′ end (Fig. 2D) and the c.5560G>A variant was still clearly visible (Suppl...,67,898,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.5560G>A,...urther evidence (i) that the maternally inherited c.5560G>A mutation is present in the functional co...,70,228,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
c.1824C>T,...l nuclei after 70 weeks of expression of the LMNA c.1824C>T mutation showed severe distortion with m...,5,1579,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,"...ygous point mutation in exon 11 of the LMNA gene (c.1824C>T, p.G608G). Although this mutation does n...",10,321,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,"...ygous point mutation in exon 11 of the LMNA gene (c.1824C>T, p.G608G). Although this mutation does n...",10,321,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,Expression of the LMNA c.1824C>T mutation in mic,23,24,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,Expression of the LMNA c.1824C>T mutation in mic,23,24,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,Expression of the LMNA c.1824C>T mutation in mic,23,24,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,Expression of the LMNA c.1824C>T mutation in mic,23,24,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.1824C>T,HGPS animals expressed the LMNA c.1824C>T mutation from embryonic day 12.5 until p...,32,33,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
c.442G>A,"Active site	p.G148R	c.442G>A	1.31	1.80	B	3	ECE: tetramer, 0–5.82%WT ac...",17,21,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.913G>A,p.G305R	c.913G>A	3.58	4.90	B	1,18,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.919G>A,p.G307S	c.919G>A	0.16	0.50	B	88	ECE: undetectable activity...,19,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.919G>A,p.G307S	c.919G>A	0.16	0.50	B	88	ECE: undetectable activity...,19,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.430G>A,Other locations in active core	p.E144K	c.430G>A	0.10	0.20	B	12	ECE: <1%WT activity [Dawso...,23,40,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.146C>T,p.P49L	c.146C>T	35.01	61.90	S	3,27,9,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.306G>C,p.K102N	c.306G>C	17.74	43.40	S	1	ECE: 21–34%WT activity [d...,28,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.572C>T,p.T191M	c.572C>T	6.93	11.20	S	137	ECE: 1%WT activity [Klui...,30,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.572C>T,p.T191M	c.572C>T	6.93	11.20	S	137	ECE: 1%WT activity [Klui...,30,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.904G>A,p.E302K	c.904G>A	15.03	24.50	S	6	ECE: shorter product -par...,31,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.233C>G,Dimer-dimer interface	p.P78R	c.233C>G	47.79	65.80	S	2	ECE: 13–61%WT activity [d...,33,30,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.526G>A,"p.E176K	c.526G>A	16.35	26.60	S	2	ECE: aggregates, 0% WT ac...",35,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.526G>A,"p.E176K	c.526G>A	16.35	26.60	S	2	ECE: aggregates, 0% WT ac...",35,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.539T>C,p.V180A	c.539T>C	5.15	15.50	S	1	ECE: 3–8% WT activity [Klu...,36,10,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.526G>A,"...mely, the c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), r.1224_1358del; p.W409_G453del...",58,189,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.1265C>T,"...526G>A (p.E176K), r.1224_1358del; p.W409_G453del, c.1265C>T (p. P422L), C.1304T>C (p.I435T), and c.1...",58,241,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
c.4A>G,"...zzanti et al., 2003], and caused by the invariant c.4A>G missense change (p.Ser2Gly) in SHOC2 [Corde...",12,2258,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
c.4A>G,"... because of the invariant occurrence of the SHOC2 c.4A>G mutation underlying this disorder, and appe...",31,766,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
c.4A>G,"...OS1 mutation (SO-001–SO-006), and NS/LAH with the c.4A>G change (SH-001–SH-005). Four major transcri...",33,538,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
c.4A>G,...rticular relevance is the fact that the invariant c.4A>G (p.Ser2Gly) SHOC2 mutation was observed to ...,84,1143,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
c.4A>G,...rticular relevance is the fact that the invariant c.4A>G (p.Ser2Gly) SHOC2 mutation was observed to ...,84,1143,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
c.79G>A,...is a structural variant of normal hemoglobin (HBB c.79G>A; p.Glu26Lys) affecting the production rate...,29,55,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
c.-7C>T,...ity of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated region (UT...,8,787,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...omoter. Sequencing revealed that the c.-28A>G and c.-7C>T variants were the only potentially pathoge...,8,1202,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-53G>T,"...namely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, ...",15,155,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-53G>T,"...namely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, ...",15,155,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,"...-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, ...",15,165,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,"...-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, ...",15,165,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...el, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>...",15,175,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...el, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>...",15,175,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...el, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>...",15,175,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>T,"..._-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green e...",15,185,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>T,"..._-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green e...",15,185,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-11C>T,"...c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; Hitchin...",15,205,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...2C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; Hitchins et al., 2011...",15,219,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-27C>A,...nother genetic defect within MLH1. Studies of the c.-27C>A variant provide the most compelling evide...,15,510,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,"... of MLH1. In support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also sig...",15,1111,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-27C>A,"...In support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also significantly...",15,1121,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...no analysis of the potential pathogenicity of the c.-28A>G or c.-7C>T variants has been undertaken, ...",15,1390,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...no analysis of the potential pathogenicity of the c.-28A>G or c.-7C>T variants has been undertaken, ...",15,1390,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...y, we aimed to determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ u...",17,63,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...o determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ untranslated r...,17,76,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...o determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ untranslated r...,17,76,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...bands (Proband 32 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numb...,21,58,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...bands (Proband 32 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numb...,21,58,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...d 32 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numbering used th...,21,71,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,... 14/169) and Norway (HREC 2014/493/REK midt). The c.-28A>G and c.-7C>T variants studied in this manu...,21,287,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...Norway (HREC 2014/493/REK midt). The c.-28A>G and c.-7C>T variants studied in this manuscript have b...,21,300,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...detected in the MLH1 or PMS2 genes except for the c.-28A>G and c.-7C>T heterozygous variants in the ...,21,1202,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...he MLH1 or PMS2 genes except for the c.-28A>G and c.-7C>T heterozygous variants in the MLH1 5′UTR. T...,21,1215,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...d by cancer. Family N showed cosegregation of the c.-28A>G and c.-7C>T variants across two generatio...,23,381,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...Family N showed cosegregation of the c.-28A>G and c.-7C>T variants across two generations. See also ...,23,394,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655G>A,...) and allele specificity was determined using the c.655G>A site,35,819,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655G>A,"...ns 1a and 9 followed by pyrosequencing across the c.655G>A site [Kwok et al., 2010]",38,832,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"To confirm the presence of the c.-28A>G and c.-7C>T variants, we performed sequen...",48,32,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"To confirm the presence of the c.-28A>G and c.-7C>T variants, we performed sequencing of a 1,0...",48,45,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"To confirm the presence of the c.-28A>G and c.-7C>T variants, we performed sequencing of a 1,0...",48,45,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-93G>A,"...d identified three heterozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). ...",48,268,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-93G>A,"...ariants were identified in this region. While the c.-93G>A is a common and benign variant, the c.-28...",48,389,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"... the c.-93G>A is a common and benign variant, the c.-28A>G and c.-7C>T are described as Class 3 vari...",48,434,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"... is a common and benign variant, the c.-28A>G and c.-7C>T are described as Class 3 variants of uncer...",48,447,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,To determine whether the c.-28A>G and c.-7C>T variants were in cis with ano...,51,26,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,... across the MLH1 gene other than the c.-28A>G and c.-7C>T variants,51,958,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,... within the MLH1 gene other than the c.-28A>G and c.-7C>T variants. A: The locations of the 15 genes...,53,144,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,... within the MLH1 gene other than the c.-28A>G and c.-7C>T variants. A: The locations of the 15 genes...,53,144,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...n Supp. Figure S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del variants in ...",57,1564,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...gure S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del variants in the first-...",57,1574,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...s within or flanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to inves...,60,108,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...lanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to investigate their ...,60,121,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655G>A,... control PBMCs that were also heterozygous at the c.655G>A site (Fig. 3D; mean normal allelic balanc...,60,1188,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655G>A,... control PBMCs that were also heterozygous at the c.655G>A site (Fig. 3D; mean normal allelic balanc...,60,1188,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"... 0.0001, paired t-test). These data show that the c.-28A>G and c.-7C>T variants are associated with ...",60,1349,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ed t-test). These data show that the c.-28A>G and c.-7C>T variants are associated with partial loss ...,60,1362,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ed t-test). These data show that the c.-28A>G and c.-7C>T variants are associated with partial loss ...,60,1362,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ed t-test). These data show that the c.-28A>G and c.-7C>T variants are associated with partial loss ...,60,1362,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...d in the MS-MLPA assay) that was abolished by the c.-7C>T variant (Fig. 4A). Bisulfite sequencing of...,65,552,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...d in the MS-MLPA assay) that was abolished by the c.-7C>T variant (Fig. 4A). Bisulfite sequencing of...,65,552,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...vertical bars), and the sequence encompassing the c.-7C>T site. The presence of the c.-7C>T variant ...",67,309,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...vertical bars), and the sequence encompassing the c.-7C>T site. The presence of the c.-7C>T variant ...",67,309,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...ter were located in the immediate vicinity of the c.-28A>G and c.-7C>T variants. However, comparison...",69,1016,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ted in the immediate vicinity of the c.-28A>G and c.-7C>T variants. However, comparison of the initi...",69,1029,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...syndrome families. Specifically, the c.-28A>G and c.-7C>T variants were associated with ∼50% reducti...",72,186,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...syndrome families. Specifically, the c.-28A>G and c.-7C>T variants were associated with ∼50% reducti...",72,186,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ncy. These findings suggest that the c.-28A>G and c.-7C>T variants may be pathogenic due to allelic ...,72,950,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...ncy. These findings suggest that the c.-28A>G and c.-7C>T variants may be pathogenic due to allelic ...,72,950,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,...wild-type allele. Green et al. (2003) described a c.-42C>T variant within the MLH1 gene associated w...,74,398,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"... the transcriptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, in...",74,1757,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, including color...",74,1770,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, including color...",74,1770,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, including color...",74,1770,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, including color...",74,1770,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, including color...",74,1770,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, including color...",74,1770,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, including color...",74,1770,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...riable age of onset of cancer associated with the c.-28A>G and c.-7C>T variants was evident from the...,76,57,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,... onset of cancer associated with the c.-28A>G and c.-7C>T variants was evident from the two families...,76,70,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,... onset of cancer associated with the c.-28A>G and c.-7C>T variants was evident from the two families...,76,70,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...able to ascertain whether the grandfather had the c.-28A>G and c.-7C>T variants. This variable penet...,76,438,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,"... MLH1 expression, as described previously for the c.-42C>T variant, which was associated with drasti...",76,590,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,...analyses of the tumor from an individual with the c.-42C>T variant revealed deletion of the MLH1 all...,76,879,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-42C>T,...analyses of the tumor from an individual with the c.-42C>T variant revealed deletion of the MLH1 all...,76,879,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,Further evidence that the c.-28A>G and c.-7C>T variants are the most likely cause of canc...,78,40,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"... within or flanking the MLH1 gene, other than the c.-28A>G and c.-7C>T variants. This approach ident...",78,513,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...anking the MLH1 gene, other than the c.-28A>G and c.-7C>T variants. This approach identified a frame...",78,526,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...netic history of this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MA...",78,918,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...on because it was absent in Family N in which the c.-28A>G and c.-7C>T variants cosegregated. Theref...,78,1889,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...on because it was absent in Family N in which the c.-28A>G and c.-7C>T variants cosegregated. Theref...,78,1889,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...on because it was absent in Family N in which the c.-28A>G and c.-7C>T variants cosegregated. Theref...,78,1889,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...S2 negative and BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional m...",80,380,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"...rmation is provided. Therefore, the rarity of the c.-28A>G and c.-7C>T haplotype at the population l...",80,684,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...tain whether both or only one are pathogenic. The c.-7C>T variant was found in a member of a heredit...,82,118,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...tain whether both or only one are pathogenic. The c.-7C>T variant was found in a member of a heredit...,82,118,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>T,... c.-28A nucleotide may be pathogenic. Whether the c.-28A>T variant in this family was associated wit...,82,522,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>T,... c.-28A nucleotide may be pathogenic. Whether the c.-28A>T variant in this family was associated wit...,82,522,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-27C>A,"...urthermore, a variant of the adjacent nucleotide (c.-27C>A) also segregates with Lynch syndrome in s...",82,699,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both p...",84,31,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.655A>G,"... presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both probands allowed us to d...",84,54,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...factors. Due to the proximity of the c.-28A>G and c.-7C>T variants to transcription initiation sites...,84,1875,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,...s of suspected Lynch syndrome associated with the c.-28A>G and c.-7C>T variants. Our analysis shows ...,86,95,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,...d Lynch syndrome associated with the c.-28A>G and c.-7C>T variants. Our analysis shows that these va...,86,108,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-93G>A,"Figure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 va...",99,34,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"Figure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 variants in ...",99,44,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-28A>G,"Figure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 variants in ...",99,44,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.-7C>T,"...ure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 variants in a first de...",99,54,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
c.791C>A,"...utations of TFAP2B c.185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T were screened Table ...",35,215,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
c.865C>T,"...185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T were screened Table IIIin 100 CHD cases a...",35,236,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
c.1222A>G,"...d G allele. Conclusion: The presence of rs628031 (c.1222A>G, M408V) and rs2306283 (c.388A>G, N130D) ...",2391,1218,Indian_J_Pharmacol_2015_Dec_47(Suppl_1)_S57-S177.txt
c.1222A>G,"...d G allele. Conclusion: The presence of rs628031 (c.1222A>G, M408V) and rs2306283 (c.388A>G, N130D) ...",2391,1218,Indian_J_Pharmacol_2015_Dec_47(Suppl_1)_S57-S177.txt
c.388A>G,"...nce of rs628031 (c.1222A>G, M408V) and rs2306283 (c.388A>G, N130D) polymorphism significantly affect...",2391,1251,Indian_J_Pharmacol_2015_Dec_47(Suppl_1)_S57-S177.txt
c.388A>G,"...nce of rs628031 (c.1222A>G, M408V) and rs2306283 (c.388A>G, N130D) polymorphism significantly affect...",2391,1251,Indian_J_Pharmacol_2015_Dec_47(Suppl_1)_S57-S177.txt
c.10364A>G,... 10364A>G). The latter coding SNP (AAFC02034082.1:c.10364A>G) changes an amino acid from aspartic ac...,43,848,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.10364A>G,... 10364A>G). The latter coding SNP (AAFC02034082.1:c.10364A>G) changes an amino acid from aspartic ac...,43,848,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.10364A>G,... 10364A>G). The latter coding SNP (AAFC02034082.1:c.10364A>G) changes an amino acid from aspartic ac...,43,848,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.10364A>G,"...S, and a suggestive association of AAFC02034082.1:c.10364A>G with SFD (P=0.0739) (Table 1). Bayesian...",46,222,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.10364A>G,...rend was also observed for markers AAFC02034082.1:c.10364A>G and g.9419A>C (P=0.0055). The marbling ...,48,974,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.10364A>G,...rend was also observed for markers AAFC02034082.1:c.10364A>G and g.9419A>C (P=0.0055). The marbling ...,48,974,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
c.157G>T,c.157G>T (rs7208693)	Val53Phe,285,1,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
c.157G>T,c.157G>T (rs7208693)	Val53Phe,285,1,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
c.287C>T,c.287C>T (rs2856857)	Non-coding,310,1,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
c.2149T>C,c.2149T>C (rs2759)	Ile717Val,326,1,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
c.2149T>C,c.2149T>C (rs2759)	Ile717Val,326,1,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
c.2173A>C,"...morphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7, 8, 12, an...",42,321,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.2173A>C,"...morphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7, 8, 12, an...",42,321,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.2540T>C,"...G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7, 8, 12, and 15, respectiv...",42,336,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.2540T>C,"...G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7, 8, 12, and 15, respectiv...",42,336,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,"...15, respectively, were also detected in II-1. The c.1502T>G mutation was not found in 100 chromosome...",42,423,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,...In Silico Predictions of Functional Impact of the c.1502T>G on the TPO Protei,44,56,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,...In Silico Predictions of Functional Impact of the c.1502T>G on the TPO Protei,44,56,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,... normal unrelated individuals suggesting that the c.1502T>G alteration is not a polymorphism,51,518,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,"...n conclusion, we demonstrated a novel, homozygous c.1502T>G mutation (p.Val501Gly) in the TPO gene w...",58,52,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,"...n conclusion, we demonstrated a novel, homozygous c.1502T>G mutation (p.Val501Gly) in the TPO gene w...",58,52,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,"...ype allele (a), II-1 who was a homozygous for the c.1502T>G (b), and I-1 who was a heterozygous for ...",66,132,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,"...ype allele (a), II-1 who was a homozygous for the c.1502T>G (b), and I-1 who was a heterozygous for ...",66,132,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,"...02T>G (b), and I-1 who was a heterozygous for the c.1502T>G (c). The single nucleotide transition at...",66,186,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.1502T>G,...single nucleotide transition at location 1502 bp (c.1502T>G) is indicated by an arrow. The nucleotid...,66,255,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
c.5467-10C>A,"...         potential to affect splicing of exon 24, c.5467-10C>A (IVS23-10C>A)",134,58,Int_J_Med_Sci_2008_Jul_8_5(4)_197-202.txt
c.1043C>T,1	IDH3B	chr20:2640199	NM_174855	Exon11	c.1043C>T	p.A348V	Damaging	Het	–	AR	RP46,70,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.1043C>T,1	IDH3B	chr20:2640199	NM_174855	Exon11	c.1043C>T	p.A348V	Damaging	Het	–	AR	RP46,70,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.4405A>G,ABCA4	chr1:94495135	NM_000350	Exon30	c.4405A>G	p.N1469D	Tolerated	Het	–	AR	CORD3/STGD1/...,72,39,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.719-6G>A,TULP1	chr6:35477095	NM_003322	Intron7	c.719-6G>A	–	–	Het	–	AR	LCA15/RP14,73,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.50G>A,CNGB1	chr16:58001141	NM_001135639	Exon2	c.50G>A	p.R17Q	Tolerated	Het	–	AR	RP45,76,42,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.782G>A,HARS	chr5:140056309	NM_001289093	Exon7	c.782G>A	p.R261H	Tolerated	Het	0.0010	AD/AR	UHS3B,78,41,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.1082A>G,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,39,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.1082A>G,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,39,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.232G>A,SEMA4A	chr1:156126297	NM_001193300	Exon3	c.232G>A	p.V78M	Probably damaging	Het	–	AD/AR	CORD...,81,43,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.232G>A,SEMA4A	chr1:156126297	NM_001193300	Exon3	c.232G>A	p.V78M	Probably damaging	Het	–	AD/AR	CORD...,81,43,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.985T>A,WFS1	chr4:6302507	NM_001145853	Exon8	c.985T>A	p.F329I	Probably damaging	Het	–	AD/AR	Wol...,83,39,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
c.682T>G,...fferent populations. The only missense mutation 6 c.682T>G (p.Gly228Trp) was reported in an Italian ...,14,399,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
c.254A>G,"c.254A>G (A374G, p.Tyr85Cys)	Iranian Jewish	Björse...",98,1,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
c.231C>A,... amino acid positions are not drawn to scale. The c.231C>A mutation causes a premature stop within t...,46,618,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
c.231C>A,... amino acid positions are not drawn to scale. The c.231C>A mutation causes a premature stop within t...,46,618,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
c.231C>A,... amino acid positions are not drawn to scale. The c.231C>A mutation causes a premature stop within t...,46,618,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
c.775G>T,...lar finding of a heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. She and her mothe...,9,136,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
c.775G>T,...irmed MODY3 with heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. The patient was i...,16,126,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
c.775G>T,...irmed MODY3 with heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. The patient was i...,16,126,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
c.98C>T,...ned the association between of ACE I/D and GPIIIa c.98C>T polymorphisms in women from the northern o...,29,198,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ned the association between of ACE I/D and GPIIIa c.98C>T polymorphisms in women from the northern o...,29,198,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ned the association between of ACE I/D and GPIIIa c.98C>T polymorphisms in women from the northern o...,29,198,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...rphism was genotyped using two primers and GPIIIa c.98C>T polymorphism was genotyped using a TETRA-A...,42,205,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,"...sing a TETRA-ARMS PCR method (27, 28). The GPIIIa c.98C>T polymorphism primers were designed by Gene...",42,291,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...e and 190 bp for D allele (Figure 1A). The GPIIIa c.98C>T Alleles were also determined by bands; 395...,53,137,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...er) (Table I) (Figure 1B). The ACE I/D and GPIIIa c.98C>T genotypes in women with RPL and control gr...,53,415,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...tween genotypic and allelic frequencies of GPIIIa c.98C>T polymorphism and RPL in case and control g...,55,220,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...tween genotypic and allelic frequencies of GPIIIa c.98C>T polymorphism and RPL in case and control g...,55,220,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...tween genotypic and allelic frequencies of GPIIIa c.98C>T polymorphism and RPL in case and control g...,55,220,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ble II Genotype frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL. The risk ...,74,53,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ble II Genotype frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL. The risk ...,74,53,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ble II Genotype frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL. The risk ...,74,53,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,GPIIIa c.98C>T,94,8,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,GPIIIa c.98C>T,94,8,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,GPIIIa c.98C>T,119,8,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...ble IV Combination analysis of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RP,130,53,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,... as I allele and D allele respectively. (B)GPIIIa c.98C>T polymorphism. Band of 395 bp and 200 bp ar...,152,185,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,"Concerning the GPIIIa c.98C>T polymorphism, it seems to increase suscept...",159,23,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.98C>T,...al reported that heterozygous mutations of GPIIIa c.98C>T (CT) were associated with RPL (38). Goodma...,159,392,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
c.1757A>C,"...1; however, a novel de novo heterozygous missense c.1757A>C mutation in the desmoplakin gene (DSP) w...",13,86,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.1757A>C,"...1; however, a novel de novo heterozygous missense c.1757A>C mutation in the desmoplakin gene (DSP) w...",13,86,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.1757A>C,"...1; however, a novel de novo heterozygous missense c.1757A>C mutation in the desmoplakin gene (DSP) w...",13,86,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.6208G>A,"...he proband and his father were heterozygous for a c.6208G>A missense SNP in DSP, predicting the prot...",56,83,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.1757A>C,"...he proband has the heterozygous missense mutation c.1757A>C (indicated by the arrow), predicting the...",98,259,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.1757A>C,"...he proband has the heterozygous missense mutation c.1757A>C (indicated by the arrow), predicting the...",98,259,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.1757A>C,"...he proband has the heterozygous missense mutation c.1757A>C (indicated by the arrow), predicting the...",98,259,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
c.754+2T>C,"...loP: 4.97) canonical donor splice site of exon 4 (c.754+2T>C), which is absent from variant database...",58,689,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
c.754+2T>C,"...loP: 4.97) canonical donor splice site of exon 4 (c.754+2T>C), which is absent from variant database...",58,689,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
c.754+2T>C,...pected (p.Glu216_Lys251del). This TGFB3 mutation (c.754+2T>C) segregated with the clinical phenotype...,58,1064,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
c.1387C>T,"...tation in myosin-binding protein C (MYBPC3) gene (c.1387C>T, p.Q463X) (Figure5A) was identified in p...",72,64,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1387C>T,"...tation in myosin-binding protein C (MYBPC3) gene (c.1387C>T, p.Q463X) (Figure5A) was identified in p...",72,64,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1387C>T,"...tein C gene for (A) relative III4 and her family (c.1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A,...",74,90,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1387C>T,"...tein C gene for (A) relative III4 and her family (c.1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A,...",74,90,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1387C>T,"...tein C gene for (A) relative III4 and her family (c.1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A,...",74,90,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1387C>T,"...tein C gene for (A) relative III4 and her family (c.1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A,...",74,90,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.1000G>A,"...r family (c.1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A, p.E334K)",74,130,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
c.581C>T,11 Mostowska A  Biedziak B  Trzeciak WH   A novel c.581C>T transition localized in a highly conserve...,98,51,J_Appl_Oral_Sci_2007_Oct_15(5)_382-386.txt
c.530C>A,...ried a novel heterozygous nonsense SOST mutation (c.530C>A; p.Ser177X) predicted to prematurely trun...,51,1313,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.796C>T,"...issense LRP5 mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) as well as three previousl...",81,76,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.724G>A,"...issense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), a...",81,188,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.724G>A,"...Periodicals, Inc.The most frequent LRP5 mutation, c.724G>A; p.Ala242Thr, was identified in three unr...",354,74,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.266A>G,A heterozygous c.266A>G; p.Gln89Arg mutation was identified in an...,357,16,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.518C>T,...p osteoarthritis; he has never fractured. A novel c.518C>T; p.Thr173Met mutation was identified in a...,357,160,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.530C>A,... a novel heterozygous nonsense variant in exon 2 (c.530C>A; p.Ser177X) in a woman aged 70 years who ...,378,64,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.74Y>F,...vel missense mutation in the LRP5 inhibitor DKK1 (c.74Y>F) has recently been reported to segregate w...,405,1090,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.74Y>F,...vel missense mutation in the LRP5 inhibitor DKK1 (c.74Y>F) has recently been reported to segregate w...,405,1090,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
c.1372C>T,mutations (c.1349delT and c.1372C>T) within exon 6 of th,110,27,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
c.1372C>T,mutations (c.1349delT and c.1372C>T) within exon 6 of th,110,27,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
c.1372C>T,... identified four deleterious mutations in exon 6 (c.1372C>,286,61,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
c.1451T>G,c.1451T>G in patients with breast cancer) compared...,288,1,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
c.879+1G>A,...phenotype was associated with the splice mutation c.879+1G>A. Primary adrenocortical insufficiency a...,15,738,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.22C>T,"...nts from childhood and was compound heterozygous (c.22C>T/c.967_979del13) for two AIRE mutations, bu...",156,826,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
c.14678G>A,...irmed a previously reported mutation in exon 102 (c.14678G>A),8,430,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
c.14590T>C,...hich is slightly larger than the normal 'T' peak (c.14590T>C). The right chromatogram from case 2 sh...,53,256,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
c.14678G>A,"...peak, which is larger than the aberrant 'A' peak (c.14678G>A)",53,373,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
c.14678G>A,"...peak, which is larger than the aberrant 'A' peak (c.14678G>A)",53,373,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
c.1975T>C,"154	55	OC	Endometrioid	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,45,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.1975T>C,"...oid	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,70,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.743G>A,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,39,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.743G>A,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,39,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.743G>A,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,39,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.503A>G,"140	44	OC	Serous	IIIA	G3	TP53 p.H168R, c.503A>G	TP53 p.H168R, c.503A>G (3)",41,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.771G>T,"...IIC	G2	PPP2R1A p.W257C, c.771G>T	PPP2R1A p.W257C, c.771G>T (1)",47,69,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.771G>T,"...IIC	G2	PPP2R1A p.W257C, c.771G>T	PPP2R1A p.W257C, c.771G>T (1)",47,69,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.578A>C,"139	70	OC	Serous	IIIC	G3	TP53 p.H193P, c.578A>C	TP53 p.H193P, c.578A>C (1)",49,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.733G>A,"144	43	OC	Serous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.34G>T,"...erous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,62,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.818G>A,"168	58	OC	Serous	IIIC	G3	TP53 p.R273H, c.818G>A	TP53 p.R273H, c.818G>A (1)",52,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.818G>A,"...rous	IIIC	G3	TP53 p.R273H, c.818G>A	TP53 p.R273H, c.818G>A (1)",52,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.536A>G,"137	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.536A>G,"...rous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,63,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.182A>G,"...ant mixed Müllerian tumor	IIIC	G3	NA	NRAS p.Q61R, c.182A>G (1)",55,67,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.3074C>A,"...d Müllerian tumor	IIIA1(i)	G3	NA	PIK3CA p.T1025N, c.3074C>A (1)",56,75,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.38G>A,"...	Endometrioid, partly serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,60,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.38G>A,"... serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,81,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.38G>A,"... serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,81,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.38G>A,"... serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,81,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.35G>A,"147	60	OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,45,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.35G>A,"...etrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.785G>T,"172	55	OC	Serous	IV	G3	NA	TP53 p.G262V, c.785G>T (1)",61,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.785G>T,"172	55	OC	Serous	IV	G3	NA	TP53 p.G262V, c.785G>T (1)",61,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.49G>A,"...	Serous low malignant potential			NA	AKT1 p.E17K, c.49G>A (1)",62,64,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.844C>T,"...ring carcinoma, spread in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,73,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.844C>T,"...in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,96,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.844C>T,"...in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,96,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.388C>T,"199	73	EC	EC	IA	G2	PTEN p.R130*, c.388C>T	PTEN p.R130*, c.388C>T (1)",65,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.4405C>T,"...EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,58,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.4405C>T,"...EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,58,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.110C>T,"203	55	EC	EC	IA	G1	NA	CTNNB1 p.S37F, c.110C>T (1)",69,38,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.34G>T,"177	31	B	Secondary infertility			NA	KRAS p.G12C, c.34G>T (1)",72,50,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.34G>T,"177	31	B	Secondary infertility			NA	KRAS p.G12C, c.34G>T (1)",72,50,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.34G>T,"...	Uterus myomatosus, ovarian cyst			—	KRAS p.G12C, c.34G>T (1)",73,59,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.35G>T,"...ity, polyp of the cervix mucosa			NA	KRAS p.G12V, c.35G>T (1)",74,78,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.1042C>T,"190	58	B	Teratoma			—	PIK3R1 p.R348*, c.1042C>T (1)",76,39,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.35G>A,"193	54	B	Inclusion cysts			—	KRAS p.G12D, c.35G>A (1)",77,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.715A>G,"...noma, squamous cell carcinoma)			NA	TP53 p.N239D, c.715A>G (1)	Two or more malignant tumors",79,125,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.920-1G>A,"129	82	OC	Serous	IIIC	G2	TP53 c.920-1G>A, g.7576927C>T (splice site)	—",80,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.1024C>T,"174	69	OC	Serous	IV	G3	TP53 p.R342*, c.1024C>T	—",85,38,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.310C>T,"142*	58	OC	Serous	IIIC	G2	TP53 p.Q104*, c.310C>T	—	Tubal ligation",108,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.310C>T,"142*	58	OC	Serous	IIIC	G2	TP53 p.Q104*, c.310C>T	—	Tubal ligation",108,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.310C>T,"142*	58	OC	Serous	IIIC	G2	TP53 p.Q104*, c.310C>T	—	Tubal ligation",108,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
c.*237C>T,"...710218), VEGFA+936C>T (rs3025039) [NM_001025366.1:c.*237C>T], APEX1 Asp148Glu (T>G, rs1130409) [NM_0...",31,283,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
c.*237C>T,"...710218), VEGFA+936C>T (rs3025039) [NM_001025366.1:c.*237C>T], APEX1 Asp148Glu (T>G, rs1130409) [NM_0...",31,283,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
c.444T>G,"...T], APEX1 Asp148Glu (T>G, rs1130409) [NM_001641.2:c.444T>G], HIF1A Pro582Ser (C>T, rs11549465) [NM_0...",31,341,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
c.1744C>T,"...], HIF1A Pro582Ser (C>T, rs11549465) [NM_001530.2:c.1744C>T], and HIF1A Ala588Thr (G>A, rs11549467) ...",31,399,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
c.1744C>T,"...], HIF1A Pro582Ser (C>T, rs11549465) [NM_001530.2:c.1744C>T], and HIF1A Ala588Thr (G>A, rs11549467) ...",31,399,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
c.1762G>A,"...nd HIF1A Ala588Thr (G>A, rs11549467) [NM_001530.2:c.1762G>A]",31,462,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
c.244C>T,"...strains except the BN strain (Table I). Thus, the c.244C>T SNP in exon 1 of Vav1 is the only SNP tha...",29,1675,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
c.244C>T,...1996). The mutation in human VAV1 at the position c.244C>T (R63W) of the sequence coding for the R63...,96,406,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
c.2546T>C,BRCA2	c.2546T>C	p.V849A	33	Tolerated	Benign,33,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2546T>C,BRCA2	c.2546T>C	p.V849A	33	Tolerated	Benign,33,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.9966G>T,BRCA2	c.9966G>T	p.M3322I	36	Tolerated	Damaging (probably...,34,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.9966G>T,BRCA2	c.9966G>T	p.M3322I	36	Tolerated	Damaging (probably...,34,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.9966G>T,BRCA2	c.9966G>T	p.M3322I	36	Tolerated	Damaging (probably...,34,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1007A>T,CHEK2	c.1007A>T	p.Q336L	54	Damaging	Benign,35,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1628A>G,MSH6	c.1628A>G	p.K543R	29	Damaging	Benign,41,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.10252T>C,PRKDC	c.10252T>C	p.F3418L	31	Damaging	Damaging (probably...,43,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.400T>G,TP53	c.400T>G	p.F134V	47	Damaging	Damaging (probably),45,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.847A>G,XRCC5	c.847A>G	p.T283A	29	Damaging	Damaging (probably),48,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.847A>G,XRCC5	c.847A>G	p.T283A	29	Damaging	Damaging (probably),48,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.319+2T>A,"...hift insertion (p.D293X), a splice-site mutation (c.319+2T>A), and a missense mutation (p.I364T) loc...",61,503,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.319+2T>A,"...hift insertion (p.D293X), a splice-site mutation (c.319+2T>A), and a missense mutation (p.I364T) loc...",61,503,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1007A>T,c.1007A>T	p.Q336L	Novel	1/64	Somatic	Chinese	0	0	D...,68,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1007A>T,c.1007A>T	p.Q336L	Novel	1/64	Somatic	Chinese	0	0	D...,68,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1091T>C,c.1091T>C	p.I364T	Novel	1/171	ND	Swedish	0	0	Damag...,69,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.7C>T,c.7C>T	p.R3W	rs199708878	1/171	Germline	Swedish	0	...,70,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1582G>A,c.1582G>A	p.E528K	rs138040612	1/64	Germline	Chines...,74,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.470T>C,c.470T>C	p.I157T	rs17879961	3/171	Germline (1)	Swe...,75,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1111C>T,c.1111C>T	p.H371Y	Reported	2/64	Somatic/germline	C...,78,1,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1897A>T,PARP1	c.1897A>T	p.K633X	Sanger	Novel	Somatic	Chinese	0	-...,86,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2326A>G,c.2326A>G	p.S776G	Selector & Sanger	Novel	Germline...,88,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2326A>G,c.2326A>G	p.S776G	Selector & Sanger	Novel	Germline...,88,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2326A>G,c.2326A>G	p.S776G	Selector & Sanger	Novel	Germline...,88,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.3037C>A,c.3037C>A	p.L1013M	Sanger	rs138906127	ND	Swedish	0...,91,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.3037C>A,c.3037C>A	p.L1013M	Sanger	rs138906127	ND	Swedish	0...,91,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1619A>G,c.1619A>G	p.S540G	Selector & Sanger	Novel	Somatic	...,93,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1619A>G,c.1619A>G	p.S540G	Selector & Sanger	Novel	Somatic	...,93,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.505A>G,c.505A>G	p.I169V	Sanger	rs63750716	ND	Chinese	0	To...,95,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.505A>G,c.505A>G	p.I169V	Sanger	rs63750716	ND	Chinese	0	To...,95,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.26C>G,DDB1	c.26C>G	p.A9G	Selector	Novel	Somatic	Chinese	0	Dam...,96,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.3360G>A,c.3360G>A	p.M1120I	454 amplicon	Novel	ND	Swedish	0...,98,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.536G>A,DCLRE1C	c.536G>A	p.R179Q	454 amplicon	rs150854849	ND	Swedi...,99,9,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.119G>A,MLH3	c.119G>A	p.C40Y	Selector	Novel	Germline	Chinese	0	...,101,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.119G>A,MLH3	c.119G>A	p.C40Y	Selector	Novel	Germline	Chinese	0	...,101,6,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2837C>T,c.2837C>T	p.S946F	Selector	rs201441389	Germline	Ch...,104,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.2964C>G,c.2964C>G	p.I988M	Selector	Novel	Germline	Chinese	...,105,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.1046C>A,c.1046C>A	p.S349Y	454 amplicon	Novel	Germline	Chin...,108,2,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
c.524G>A,...sts were collected from a patient with homozygous c.524G>A mutation in the human AK2 gene (Henderson...,135,72,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
c.1791+2T>G,"...-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T; P4, p>R1...",96,262,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
c.1791+2T>G,"...-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T; P4, p>R1...",96,262,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
c.127C>T,"...letions and frameshift MPL mutations, such as MPL c.127C>T and c.378delT, may be responsible for thi...",43,174,J_Hematol_Oncol_2013_Jan_25_6_11.txt
c.127C>T,"...letions and frameshift MPL mutations, such as MPL c.127C>T and c.378delT, may be responsible for thi...",43,174,J_Hematol_Oncol_2013_Jan_25_6_11.txt
c.305G>C,"...PL mutations, such as the most frequent mutation, c.305G>C, are closely associated with CAMT II. Thi...",45,256,J_Hematol_Oncol_2013_Jan_25_6_11.txt
c.742C>T,The mutation c.742C>T in the HOXD13 gene generates a new restri...,29,14,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,"...haplotype A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene (F...",42,334,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,"...haplotype A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene (F...",42,334,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.742C>T,"...haplotype A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene (F...",42,334,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
c.7693C>T,5	EX53	c.7693C>T	p.Gln2565*	nonsence,89,8,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.434G>C,6	EX6	c.434G>C	p.Arg145Pro	missense,90,7,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.10011C>G,7	EX69	c.10011C>G	p.Cys3337Trp	missense,91,8,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.1732A>T,29	EX15	c.1732A>T	p.Lys578*	Nonsence,113,9,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
c.109G>T,P1	+	c.109G>T	6.72	Casale et al. 1998,35,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P3	+	c.109G>T/c504_5delCT	20.12a	Menao et al. 2009,37,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.144G>T,P4	+	c.144G>T/c.504_5delCT	5.61	Menao et al. 2009,39,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.575T>C,P6	+	c.575T>C	6.17	Menao et al. 2009,41,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P8	+	c.109G>T	7.85	Menao et al. 2009,43,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P9	+	c.109G>T/c.825C>G	5.80a	-----,44,6,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.825C>G,P9	+	c.109G>T/c.825C>G	5.80a	-----,44,15,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P11	+	c.109G>T/c.504_5delCT	5.35a	-----,47,7,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P11	+	c.109G>T/c.504_5delCT	5.35a	-----,47,7,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P11	+	c.109G>T/c.504_5delCT	5.35a	-----,47,7,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.109G>T,P11	+	c.109G>T/c.504_5delCT	5.35a	-----,47,7,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.242G>A,P12	+	c.242G>A	5.93a	-----,48,7,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.242G>A,P12	+	c.242G>A	5.93a	-----,48,7,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
c.1156C>T,"...hed to date are reported to be missense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), a...",164,725,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
c.901G>T,"...to be missense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe)...",164,750,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
c.901G>T,"...to be missense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe)...",164,750,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
c.337A>T,"...156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe) (Tomatsu et al 2005a). Howe...",164,778,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
c.34G>A,"...pplementary Methods). A somatic heterozygous HRAS c.34G>A, p.G12S substitution was found in each (Fi...",15,321,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
c.34G>A,"...pplementary Methods). A somatic heterozygous HRAS c.34G>A, p.G12S substitution was found in each (Fi...",15,321,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
c.683T>G,"2	75/M	70/70	2	1	rs142246283	c.683T>G, p.L228R	no data	Probably damaging	Tolera...",45,30,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
c.683T>G,"2	75/M	70/70	2	1	rs142246283	c.683T>G, p.L228R	no data	Probably damaging	Tolera...",45,30,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
c.2406C>A,"4	35/F	32/32	1	1	no data	c.2406C>A, p.S802R	no data	Benign	Damaging	Patholo...",47,26,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
c.1174-1G>A,"...s. Of these, c.64G>T, c.1699C>T, c.466_467 insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations....",4,1068,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1699C>T,"...related Korean patients (60%). Of these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768...",34,137,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1699C>T,"...related Korean patients (60%). Of these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768...",34,137,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1363G>T,Inspection of the mutations revealed that c.1363G>T (p. Glu455X) and c.1699C>T (p.Arg567X) w...,36,43,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1699C>T,"...utations revealed that c.1363G>T (p. Glu455X) and c.1699C>T (p.Arg567X) were nonsense mutations, and...",36,70,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1699C>T,"...utations revealed that c.1363G>T (p. Glu455X) and c.1699C>T (p.Arg567X) were nonsense mutations, and...",36,70,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1601C>T,"...C>T (p.Arg567X) were nonsense mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) ...",36,126,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.64G>T,"...e mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missense mutations. One...",36,154,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.64G>T,"...e mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missense mutations. One...",36,154,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.64G>T,"... in two unrelated Korean patients. Two mutations, c.64G>T and c.466_467insAC, are located in the N-t...",36,542,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.1601C>T,The c.1601C>T mutation has been observed in many studi...,43,5,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
c.679C>T,"...t. One was a C to T transition at nucleotide 679 (c.679C>T) in exon 7, resulting in a Pro to Ser sub...",25,104,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
c.679C>T,...ing of the DHCR7 gene. A novel missense mutation (c.679C>T; Pro227Ser) was identified in the patient...,39,76,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
c.6443T>G,...sis and craniofacial abnormalities. The mutation (c.6443T>G) of the NOTCH2 gene was found. The patie...,3,1623,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
c.6443T>G,"...is of DNA sequencing. DNA sequencing covering the c.6443T>G mutation of (A) the patient, (B) his mot...",32,64,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
c.1670C>G,"...>G [K508R]) and two nonsense (c.1065-6delGCinsTA, c.1670C>G) (table 1, fig 1). Splice site and misse...",46,847,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1670C>G,268		11	c.1670C>G	Y405X	Nonsense	1	1	DF	1	1	0,72,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1670C>G,268		11	c.1670C>G	Y405X	Nonsense	1	1	DF	1	1	0,72,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1755G>C,290*		11	c.1755G>C	E434Q	Splice site	1	1		1	0	0,94,10,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1755G>A,291*		11	c.1755G>A	E434K	Splice site	2	1	PFF	1	2	1 (n = 4),95,10,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1755G>A,291*		11	c.1755G>A	E434K	Splice site	2	1	PFF	1	2	1 (n = 4),95,10,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1755G>A,291*		11	c.1755G>A	E434K	Splice site	2	1	PFF	1	2	1 (n = 4),95,10,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,293		12	c.1844C>G	Y463X	Nonsense	2	2	AF	0	2	1 (n = 2),97,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,293		12	c.1844C>G	Y463X	Nonsense	2	2	AF	0	2	1 (n = 2),97,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,"294		12	c.1844C>G	Y463X	Nonsense	1	0	PFF, AF	0	0	0",98,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,"294		12	c.1844C>G	Y463X	Nonsense	1	0	PFF, AF	0	0	0",98,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,"294		12	c.1844C>G	Y463X	Nonsense	1	0	PFF, AF	0	0	0",98,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,"294		12	c.1844C>G	Y463X	Nonsense	1	0	PFF, AF	0	0	0",98,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,295		12	c.1844C>G	Y463X	Nonsense	1	1	AF	1	1	1 (n = 4),99,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1844C>G,295		12	c.1844C>G	Y463X	Nonsense	1	1	AF	1	1	1 (n = 4),99,9,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1978A>G,297*		13	c.1978A>G	K508R	Missense	1	0	0	1	0	0,101,10,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1978A>G,...ol. (B) Genomic sequence of BHDS patient with the c.1978A>G (K508R) mutation. (C) Multiple sequence ...,114,126,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1978A>G,...ol. (B) Genomic sequence of BHDS patient with the c.1978A>G (K508R) mutation. (C) Multiple sequence ...,114,126,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1398G>T,"...al 200510	11	Ukn 11/11	No 11/11	Pos 6/6	Yes 10/10	c.1398G>T, c.1884C>T",165,61,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1884C>T,"...1	Ukn 11/11	No 11/11	Pos 6/6	Yes 10/10	c.1398G>T, c.1884C>T",165,72,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1884C>T,"...1	Ukn 11/11	No 11/11	Pos 6/6	Yes 10/10	c.1398G>T, c.1884C>T",165,72,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1755G>C,"... frequent site of mutations (c.1733insC/1733delC, c.1755G>C) present in 125 individuals from 40 unre...",180,721,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
c.1207C>T,"...ll five pathogenic variants (MYH7 c.1436A>C, MYH7 c.1207C>T, MYBPC3 c.2373_2374dup, MYBPC3 c.676_701...",103,442,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1093-24C>T,...riants were variants at the same position (MYBPC3 c.1093-24C>T) and were not in the HCDiff list due ...,103,1260,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1093-24C>T,...riants were variants at the same position (MYBPC3 c.1093-24C>T) and were not in the HCDiff list due ...,103,1260,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.877C>T,"...variants of unknown clinical significance (TNNT2, c.877C>T,2",151,656,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.755A>G,"TPM1, c.755A>G and MYBPC3, c.3392T>C22), while the other...",153,7,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.755A>G,"TPM1, c.755A>G and MYBPC3, c.3392T>C22), while the other...",153,7,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1231G>A,...etected with Sanger sequencing (MYH7: NM_000257.2 c.1231G>A and MYH7: NM_000257.2: c.2967T>C). Re-ex...,181,569,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1178C>T,"...ith Sanger sequencing—that is, MYH7: NM_000257.2: c.1178C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G...",183,262,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1987C>T,"...78C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.282...",183,316,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1987C>T,"...78C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.282...",183,316,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.121G>A,"... c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.2827C>T,33 c.3...",183,327,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.2827C>T,"...G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.2827C>T,33 c.3004C>T (twice), c.2864_2865del, MY...",183,361,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.2827C>T,"...G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.2827C>T,33 c.3004C>T (twice), c.2864_2865del, MY...",183,361,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1804G>A,"43, LMNA: NM_170707.2: c.1804G>A,4",187,24,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1178C>T,...atients had two variants each (MYH7: NM_000257.2: c.1178C>T combined with SCN5A: NM_198056.2: c.3157...,189,129,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1178C>T,...atients had two variants each (MYH7: NM_000257.2: c.1178C>T combined with SCN5A: NM_198056.2: c.3157...,189,129,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.3004C>T,"... NM_198056.2: c.3157G>A, and MYBPC3: NM_000256.3: c.3004C>T combined with LMNA: NM_170707.2: c.1804G...",189,209,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.3004C>T,"... NM_198056.2: c.3157G>A, and MYBPC3: NM_000256.3: c.3004C>T combined with LMNA: NM_170707.2: c.1804G...",189,209,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1804G>A,"...256.3: c.3004C>T combined with LMNA: NM_170707.2: c.1804G>A), and one patient had three variants (MY...",189,252,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.935A>C,"...C3: NM_000256.3: c.3004C>T, and DES: NM_001927.3: c.935A>C). All variants were confirmed with Sanger...",189,383,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
c.1141+1G>A,...ternally inherited novel COL17A1 splice mutation (c.1141+1G>A) and a novel LAMA3 frameshift-inducing...,166,541,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
c.589G>T,"...ient is homozygous for a novel nonsense mutation, c.589G>T; p.E197X, in exon 3 of the UMOD gene (Fig...",30,342,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.589G>T,"...ient is homozygous for a novel nonsense mutation, c.589G>T; p.E197X, in exon 3 of the UMOD gene (Fig...",30,342,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.898T>G,3	c.898T>G (p.Cys300Gly)	Pathogeni,102,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.764G>A,5	c.764G>A (p.Cys255Tyr)	Pathogeni,106,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.743G>C,6	c.743G>C (p.Cys248Ser)	Pathogeni,108,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.649T>C,8	c.649T>C (p.Cys217Arg)	Pathogeni,112,3,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.383A>G,10	c.383A>G (p.Asn128Ser)	Pathogeni,116,4,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.383A>G,10	c.383A>G (p.Asn128Ser)	Pathogeni,116,4,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.376T>C,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,4,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.230G>A,13	c.230G>A (p.Cys77Tyr)	Pathogeni,122,4,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.230G>A,13	c.230G>A (p.Cys77Tyr)	Pathogeni,122,4,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.-1746T>C,14	c.-1746T>C	associatio,124,4,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
c.672+1G>T,"... somatic mutation database, with the exception of c.672+1G>T, c.783‐1G>A and R333C. There is no appa...",161,197,J_Pathol_Clin_Res_2015_Mar_30_1(3)_125-133.txt
c.286+2T>G,c.286+2T>G,160,1,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.175C>T,c.175C>T; p.Arg59X	0.56	0.04	0.5	49	1	2	0,167,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.175C>T,c.175C>T; p.Arg59X	0.56	0.04	0.5	49	1	2	0,167,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.470G>A,c.470G>A;p.Cys157Tyr	0.92,172,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.470G>A,c.470G>A;p.Cys157Tyr	1.31	0.27	0.58	62	2	1	2,176,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.191G>T,c.191G>T; p.Cys64Phe	1.17	0.17	0.78	84	2	1	0,179,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.191G>T,c.191G>T; p.Cys64Phe	1.17	0.17	0.78	84	2	1	0,179,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.3643C>T,c.3643C>T p.Arg1215X	0.85	0.31	0.42	73	2	2	1,187,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.3643C>T,c.3643C>T p.Arg1215X	0.85	0.31	0.42	73	2	2	1,187,2,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.2016A>G,"...292), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G; p.Gln672Gln (rs3753396), CFH IVS15 −543...",220,207,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.4070T>C,"...1962149), CD46 IVS12 +638G>A (rs859705), and CD46 c.4070T>C (rs7144) was used to determine CFH and C...",220,446,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.286+2T>C,"... 1) showed a compound heterozygote CD46 mutation (c.286+2T>C, c.286+2T>G), which resulted in complet...",246,96,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.286+2T>C,"..., which resulted in complete CD46 deficiency. The c.286+2T>C variant was of maternal origin, while t...",246,169,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.286+2T>G,"...86+2T>C variant was of maternal origin, while the c.286+2T>G was paternal. Flow cytometry analysis c...",246,222,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
c.1979C>T,"We identified a novel TMC1 mutation in exon 20, c.1979C>T, p.P660L, which segregated with prelingu...",11,49,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,"...y Sanger sequencing and found a missense variant, c.1979C>T, p.P660L, in exon 20 of TMC1 [NM_138691,...",66,117,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,...ily SH-02. a DNA sequences of homozygous missense c.1979C>T mutations and the wild-type control. b T...,66,804,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,...ily SH-02. a DNA sequences of homozygous missense c.1979C>T mutations and the wild-type control. b T...,66,804,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,"...tified a novel TMC1 missense mutation in exon 20, c.1979C>T, p.P660L",81,1019,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,"...tified a novel TMC1 missense mutation in exon 20, c.1979C>T, p.P660L",81,1019,J_Transl_Med_2016_Jan_28_14_29.txt
c.1979C>T,"...tified a novel TMC1 missense mutation in exon 20, c.1979C>T, p.P660L",81,1019,J_Transl_Med_2016_Jan_28_14_29.txt
c.714T>G,...9) Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of de...,104,135,Mamm_Genome_2011_Feb_11_22(1-2)_55-65.txt
c.884T>C,...e c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation for HFE. The latter mu...,317,160,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.884T>C,...e c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation for HFE. The latter mu...,317,160,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.265T>C,...s (II-10 and II-11) were heterozygous for the HJV c.265T>C (p.C89R) mutation and the mother was also...,317,658,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.265T>C,The HJV c.265T>C (p.C89R) mutation is a novel mutation and...,336,9,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
c.1987C>T,...fferences reported in TT pigs (Table 5). The LEPR c.1987C>T mutation involves a L663F amino acid cha...,279,312,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
c.4933C>T,"...ted genomic DNA revealed an SCN1A point mutation, c.4933C>T [GenBank: NM_001165963.1] (Figure 1A) as...",23,745,Mol_Brain_2013_May_2_6_19.txt
c.4933C>T,...ated cell material. Solid arrowheads point to the c.4933C>T substitution. (B) iPSC morphology and im...,25,159,Mol_Brain_2013_May_2_6_19.txt
c.4933C>T,...ated cell material. Solid arrowheads point to the c.4933C>T substitution. (B) iPSC morphology and im...,25,159,Mol_Brain_2013_May_2_6_19.txt
c.676C>T,10.	m	49	-	-	c.676C>T	-	+,85,14,Mol_Cancer_2014_Jan_24_13_11.txt
c.583A>T,11.	f	44	-	-	c.583A>T	-	+,87,14,Mol_Cancer_2014_Jan_24_13_11.txt
c.1723G>T,"...tient and a nonsense mutation in another patient (c.1723G>T, p.Glu575*). None of these mutations wer...",12,115,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
c.1723G>T,"...tient and a nonsense mutation in another patient (c.1723G>T, p.Glu575*). None of these mutations wer...",12,115,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
c.3871C>T,"...ngle gene, MYO15A, remained (Table 1). These were c.3871C>T (p.L 1291F) in exon 6 and c.5835T>G (p.Y...",47,645,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...) and the father (SB156-327) was heterozygous for c.5835T>G (p.Y1945*) (Figs. 1D and 1E). These two ...,47,850,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,... phenylalanine at residue 1291 of myosin XVA. The c.3871C>T and c.5835T>G mutations resided in the m...,47,1365,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,... the motor domain demonstrated how the p. L1291F (c.3871C>T) mutation altered the structure of the a...,62,672,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...13). Therefore it seems likely that the p.Y1945* (c.5835T>G) mutation that results in a shorter prot...,64,718,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...13). Therefore it seems likely that the p.Y1945* (c.5835T>G) mutation that results in a shorter prot...,64,718,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5835T>G,...13). Therefore it seems likely that the p.Y1945* (c.5835T>G) mutation that results in a shorter prot...,64,718,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,...(SB156-327). (E) Sanger sequencing traces for the c.3871C>T carrier (SB156-328). (F) Conservation of...,79,663,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,...om humans to zebrafish. (G) The sequence variants c.3871C>T and c.5835T>G reside in exon 6 (motor do...,79,868,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,...om humans to zebrafish. (G) The sequence variants c.3871C>T and c.5835T>G reside in exon 6 (motor do...,79,868,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3313G>T,c.3313G>T	p.Glu1105*	N-terminal	Homozygous	Severe ...,98,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3313G>T,c.3313G>T	p.Glu1105*	N-terminal	Homozygous	Severe ...,98,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3313G>T,c.3313G>T	p.Glu1105*	N-terminal	Homozygous	Severe ...,98,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3685C>T,c.3685C>T	p.Gln1229*	Motor	Homozygous	Profound	Lib...,100,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3685C>T,c.3685C>T	p.Gln1229*	Motor	Homozygous	Profound	Lib...,100,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3756+1G>T,"c.3756+1G>T			Homozygous	Profound	Liburd et al., 2...",101,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3758C>T,c.3758C>T	p.Thr1253Ile	Motor	Homozygous	Severe to ...,102,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3866+1G>A,c.3866+1G>A			Homozygous	Severe to profound	Nal et...,103,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3866+1G>A,c.3866+1G>A			Homozygous	Severe to profound	Nal et...,103,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.3871C>T,c.3871C>T	p.Leu1291Phe	Motor	Heterozygous	Profound...,104,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4176C>A,c.4176C>A	p.Tyr1392*	Motor	Homozygous	Severe to pr...,105,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4176C>A,c.4176C>A	p.Tyr1392*	Motor	Homozygous	Severe to pr...,105,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4198G>A,c.4198G>A	p.Val1400Met	Motor	Homozygous	Severe to ...,106,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4240G>A,c.4240G>A	p.Glu1414Lys		Homozygous	Profound	Browns...,107,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4351G>A,c.4351G>A	p.Asp1451Asn	Motor	Homozygous	Severe to ...,109,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4669A>G,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to ...,111,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4669A>G,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to ...,111,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.4669A>G,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to ...,111,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.5913G>A,c.5913G>A			Heterozygous	Severe to profound	Gao et...,118,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6061C>T,c.6061C>T	p.Gln2021*		?	Severe to profound	Nal et ...,119,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6061C>T,c.6061C>T	p.Gln2021*		?	Severe to profound	Nal et ...,119,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6340G>A,c.6340G>A	p.Val2114Met	MyTH4 1	Heterozygous	Severe...,122,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6340G>A,c.6340G>A	p.Val2114Met	MyTH4 1	Heterozygous	Severe...,122,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6371G>A,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe t...,123,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6371G>A,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe t...,123,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6437G>A,c.6437G>A	p.Arg2146Gln	MyTH4 1	Heterozygous	Severe...,124,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6437G>A,c.6437G>A	p.Arg2146Gln	MyTH4 1	Heterozygous	Severe...,124,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6956+9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang...,128,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6956+9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang...,129,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6956+9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang...,129,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.6956+9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang...,129,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8148G>T,c.8148G>T	p.Gln2716His		Homozygous	Profound	Liburd...,131,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8158G>C,c.8158G>C	p.Asp2720His		Homozygous	Severe to profo...,132,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8158G>C,c.8158G>C	p.Asp2720His		Homozygous	Severe to profo...,132,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8324G>A,c.8324G>A	p.Arg2775His		Heterozygous	Severe to pro...,133,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8375T>C,c.8375T>C	p.Val2792Ala		Heterozygous	Severe to pro...,134,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8375T>C,c.8375T>C	p.Val2792Ala		Heterozygous	Severe to pro...,134,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8375T>C,c.8375T>C	p.Val2792Ala		Heterozygous	Severe to pro...,134,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.8767C>T,c.8767C>T	p.Arg2923*	SH3	Heterozygous	Severe to pr...,135,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.9478C>T,c.9478C>T	p.Leu3160Phe	MyTH4 2	Homozygous	Severe t...,139,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.10474C>T,c.10474C>T	p.Gln3492*	FERM	Homozygous	Severe to pr...,143,1,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
c.366G>A,"...of which 3 (D85V, R175W & N372Y) are missense, 3 (c.366G>A, c.381G>A & c.384C>T) are in 5’UTR, 1 syn...",12,361,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.366G>A,"...of which 3 (D85V, R175W & N372Y) are missense, 3 (c.366G>A, c.381G>A & c.384C>T) are in 5’UTR, 1 syn...",12,361,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.682G>T,"...>A & c.384C>T) are in 5’UTR, 1 synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.128...",12,427,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.1140+14G>A,"... synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+68G>A) are intronic variants...",12,457,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.1140+14G>A,"... synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+68G>A) are intronic variants...",12,457,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.1289+68G>A,"...nge (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+68G>A) are intronic variants. In BMP4, 3 se...",12,472,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.1695A>C,"... variants are found, out of which only one novel (c.1695A>C) in 3’UTR region has been found in one i...",12,578,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
c.662C>T,...*24) and a separate point mutation within exon 5 (c.662C>T; p.Pro221Leu). Neither mutation has been ...,10,622,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
c.735+1C>T,"...2+5G>A) and six heterozygous in GNAQ (NM_002072.2:c.735+1C>T), ABCC3 (NM_003786.3:c.1783-1G>A), KLHD...",5,1078,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.735+1C>T,"...2+5G>A) and six heterozygous in GNAQ (NM_002072.2:c.735+1C>T), ABCC3 (NM_003786.3:c.1783-1G>A), KLHD...",5,1078,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"...C3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD...",5,1144,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"...C3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD...",5,1144,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"...C3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD...",5,1144,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,"... (NM_015888.4:c.1662-1G>A), SMAD9 (NM_001127217.2:c.1004-1C>T), and DNAH9 (NM_001372.3:c.10242+5G>A)...",5,1212,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,"..._001127217.2:c.1004-1C>T), and DNAH9 (NM_001372.3:c.10242+5G>A). Integrating whole-exome and RNA seq...",5,1249,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,"..._001127217.2:c.1004-1C>T), and DNAH9 (NM_001372.3:c.10242+5G>A). Integrating whole-exome and RNA seq...",5,1249,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,"HOOK1	Ph-006	1,60103421,60103422,1,G/A	c.1662-1G>A	186 (153)	87 (0)	47% (0%)	Acceptor los...",75,40,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,"DNAH9	Ph-007	17,11715832,11715833,1,G/A	c.10242+5G>A	37 (43)	19 (0)	51% (0%)	Donor lost",76,41,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.735+1C>T,"...e GNAQ (OMIM# 600998) proto-oncogene (NM_002072.2:c.735+1C>T, NCBI36.1 nomenclature). The somatic va...",79,201,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.735+1C>T,GNAQ	Ph+001	c.735+1C>T	1	1.00/–	0.997/–	2160	2843	32.938	22% w...,84,13,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.735+1C>T,GNAQ	Ph+001	c.735+1C>T	1	1.00/–	0.997/–	2160	2843	32.938	22% w...,84,13,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,ABCC3	Ph+004	c.1783-1G>A	1	0.91/–	0.390/–	5155	859	6.109	58% wt...,85,14,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,KLHDC1	Ph+005	c.568-2A>G	1	0.93/–	0.946/–	2644	72	0.939	Low expr...,86,15,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,KLHDC1	Ph+005	c.568-2A>G	1	0.93/–	0.946/–	2644	72	0.939	Low expr...,86,15,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,SMAD9	Ph-005	c.1004-1C>T	1	0.98/–	0.988/–	5558	42	0.379	Low exp...,87,14,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,SMAD9	Ph-005	c.1004-1C>T	1	0.98/–	0.988/–	5558	42	0.379	Low exp...,87,14,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,DNAH9	Ph-007	c.10242+5G>A	0.999	0.95/–	0.949/–	14087	0	0	Not ex...,89,14,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,DNAH9	Ph-007	c.10242+5G>A	0.999	0.95/–	0.949/–	14087	0	0	Not ex...,89,14,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.735+1C>T,Figure 1 GNAQ (NM_002072.2:c.735+1C>T) splicing mutation near the 5’ donor sp...,94,28,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,...3 and 14 of ABCC3 (OMIM#604323) gene (NM_003786.3:c.1783-1G>A); it was present with a frequency of 5...,100,171,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"...ion in the KLHDC1 (OMIM#611281) gene (NM_172193.1:c.568-2A>G), near the 3’ acceptor splice site at p...",102,86,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.568-2A>G,"...ion in the KLHDC1 (OMIM#611281) gene (NM_172193.1:c.568-2A>G), near the 3’ acceptor splice site at p...",102,86,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,"...6 of the SMAD9 (OMIM#603295) gene (NM_001127217.2:c.1004-1C>T), causing a loss of acceptor site. Des...",106,178,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,"...6 of the SMAD9 (OMIM#603295) gene (NM_001127217.2:c.1004-1C>T), causing a loss of acceptor site. Des...",106,178,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,"...6 of the SMAD9 (OMIM#603295) gene (NM_001127217.2:c.1004-1C>T), causing a loss of acceptor site. Des...",106,178,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1312+5G>A,...le for our newly identified splicing variant. The c.1312+5G>A variation in APC was absent from dbSNP...,119,365,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1312+2T>C,"...he transversion (c.1312+4T>G) and the transition (c.1312+2T>C) affected, respectively, position +4 (...",119,646,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,...f intron retention in HOOK1 caused by NM_015888.4:c.1662-1G>A mutation was functionally validated by...,129,65,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,...f intron retention in HOOK1 caused by NM_015888.4:c.1662-1G>A mutation was functionally validated by...,129,65,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,"...resulting aberrant mRNA. However, the NM_015888.4:c.1662-1G>A mutation has not been reported in lite...",129,346,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1783-1G>A,Figure S3. (A) ABCC3 (NM_003786.3:c.1783-1G>A) splicing mutation near the 3’ accepto...,150,35,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1004-1C>T,... the Sanger validation. (B) SMAD9 (NM_001127217.2:c.1004-1C>T) splicing mutation near the 3’ accepto...,153,256,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,"...ow, the Sanger validation. (C) DNAH9 (NM_001372.3:c.10242+5G>A) splicing mutation near the 5’ donor ...",153,449,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,"...ow, the Sanger validation. (C) DNAH9 (NM_001372.3:c.10242+5G>A) splicing mutation near the 5’ donor ...",153,449,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.10242+5G>A,"...ow, the Sanger validation. (C) DNAH9 (NM_001372.3:c.10242+5G>A) splicing mutation near the 5’ donor ...",153,449,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.1662-1G>A,Figure S5. (A) HOOK1 (NM_015888.4:c.1662-1G>A) splicing mutation near the 3’ accepto...,155,35,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
c.313G>C,...tGene2/) for mutations affecting splice sites and c.313G>C,16,1748,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.313G>C,...tGene2/) for mutations affecting splice sites and c.313G>C,16,1748,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.313G>C,...tGene2/) for mutations affecting splice sites and c.313G>C,16,1748,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,"In order to analyze the effects of the CCM1:c.2025+1G>A splice site mutation, RNA was extracte...",19,45,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,"In order to analyze the effects of the CCM1:c.2025+1G>A splice site mutation, RNA was extracte...",19,45,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.406C>T,8	c.406C>T	p.Q136*	f	Novel	46,37,3,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.729+5G>A,IVS9	c.729+5G>A	p.Q201Rfs*23	f	Novel	44,39,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.730-1G>A,IVS9	c.730-1G>A	p.?	i	Davenport et al. (2001)	27,40,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.1093G>T,12	c.1093G>T	p.G365*	f	Novel	1,45,4,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.1255-1G>A,IVS13	c.1255-1G>A	p.Y419Ffs*153	f	Cavé-Riant et al. (200...,48,7,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.1431T>A,15	c.1431T>A	p.Y477*	i	Novel	24,53,4,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.1431T>A,15	c.1431T>A	p.Y477*	i	Novel	24,53,4,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.1564-1G>A,IVS15	c.1564-1G>A	p.?	f	Novel	32,55,7,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.1564-1G>A,IVS15	c.1564-1G>A	p.?	f	Novel	32,55,7,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.1619T>A,16	c.1619T>A	p.L540*	f	Novel	10,56,4,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,IVS18	c.2025+1G>A	p.N607_K675del3	f	Denier et al. (2004)...,63,7,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.475-2A>G,IVS8	c.475-2A>G	p.A119Gfs*423	i	Novel	22,78,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.475-2A>G,IVS8	c.475-2A>G	p.A119Gfs*423	i	Novel	22,78,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.586C>T,10	c.586C>T	p.R196*	i	Bergametti et al. (2005)	17,81,4,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.598C>T,10	c.598C>T	p.Q200*	f	Schröder et al. (2014)	50,82,4,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,The mutation c.2025+1G>A within CCM1 (CCM1:p.N607_K675del) was ...,103,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,...o turned out to be a heterozygous carrier of CCM1:c.2025+1G>A (Fig. 2B and C),103,541,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,...o turned out to be a heterozygous carrier of CCM1:c.2025+1G>A (Fig. 2B and C),103,541,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,...rect sequencing revealed the splice site mutation c.2025+1G>A within CCM1 likely resulting in skippi...,105,555,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.313G>C,"... within exon 7 is also conceivable. However, CCM1:c.313G>C cannot be considered to be a disease-caus...",116,461,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.598C>T,...tation carriers: c.317delA (unpublished data) and c.598C>T (Schröder et al. 2014),125,1090,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.598C>T,...tation carriers: c.317delA (unpublished data) and c.598C>T (Schröder et al. 2014),125,1090,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2025+1G>A,"...tion (e.g., 2 years for the proband carrying CCM1:c.2025+1G>A; Fig. 2) has previously been much earl...",129,674,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
c.2860C>T,"...g 8.7%. Other frequent mutations included SH3TC2 (c.2860C>T; p.Arg954* [4.8%]), FIG4 (c.122T>C; p.Il...",82,1146,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
c.305A>G,"...]), FIG4 (c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p.Glu102Gly [2.5%]) (Table S6). The dist...",82,1222,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
c.1505T>A,"... Furthermore, F8 compound heterozygote mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile...",12,199,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
c.3279G>A,"...eterozygote mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile) were identified using mul...",12,226,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
c.1505T>A,"...sly reported mutation (15) was detected (exon 10, c.1505T>A, p.Val502Asp), and a novel unreported mi...",31,96,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
c.3279G>A,"...ovel unreported missense point mutation (exon 14, c.3279G>A, p.Met1093Ile) (Fig. 1)",31,178,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
c.574C>T,"...f RS1 gene revealed five mutations in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C...",15,70,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,"... revealed five mutations in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respec...",15,80,Mol_Vis_2007_Apr_19_13_611-617.txt
c.608C>T,"...five mutations in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, am...",15,90,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"...ions in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them f...",15,100,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,"... like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them four missense m...",15,114,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,"... like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them four missense m...",15,114,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,"... like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them four missense m...",15,114,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,"...ive genetic variations were identified: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T. Two of...",58,210,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"...ns were identified: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T. Two of these, c.583A>G and...",58,230,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,"...fied: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T. Two of these, c.583A>G and c.617G>A, are...",58,244,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"....617G>A, and c.637C>T. Two of these, c.583A>G and c.617G>A, are novel. Similar to previous reports, ...",58,281,Mol_Vis_2007_Apr_19_13_611-617.txt
c.574C>T,Patient 1 with c.574C>T mutatio,80,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,Patient 2 with c.583A>G novel genetic variatio,83,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,"...e temporal schisis. To the best of our knowledge, c.583A>G transition leading to the replacement of ...",84,344,Mol_Vis_2007_Apr_19_13_611-617.txt
c.608C>T,Patient 3 with c.608C>T mutatio,86,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.608C>T,A c.608C>T mutation was observed in a 20-year-old ma...,87,3,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,Patient 4 with c.617G>A novel nonsense variatio,89,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,A c.617G>A nonsense mutation was found in a 10-year-...,90,3,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,A c.617G>A nonsense mutation was found in a 10-year-...,90,3,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,...on analysis of RS1 and sequencing result showed a c.617G>A transition that resulted in a nonsense mu...,94,264,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"...mily pedigree of patient 4, who exhibited a novel c.617G>A mutation. The arrow indicates proband. Th...",96,133,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,Patient 5 with c.637C>T transitio,98,16,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,A c.637C>T transition was observed in a 17-year-old ...,99,3,Mol_Vis_2007_Apr_19_13_611-617.txt
c.637C>T,A c.637C>T transition mutation was also identified i...,104,3,Mol_Vis_2007_Apr_19_13_611-617.txt
c.617G>A,"... be sporadic cases, and one novel genetic variant c.617G>A was identified in a family",107,916,Mol_Vis_2007_Apr_19_13_611-617.txt
c.618G>A,...n-sense mutation involving a different nucleotide c.618G>A in the same codon was previously reported...,109,541,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,"Patient 2 was found to have a c.583A>G novel genetic variation, leading to the r...",111,31,Mol_Vis_2007_Apr_19_13_611-617.txt
c.583A>G,"Patient 2 was found to have a c.583A>G novel genetic variation, leading to the r...",111,31,Mol_Vis_2007_Apr_19_13_611-617.txt
c.718+2T>C,Intron 7	c.718+2T>C	Aberrant splicing	Juvenile RP		 [16],48,10,Mol_Vis_2008_Apr_21_14_675-682.txt
c.999+5G>C,Intron 10	c.999+5G>C	Aberrant splicing	Juvenile RP		 [16],50,11,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1204G>T,Exon 12	c.1204G>T	p.E402X	LCA	Found in compound heterozygo...,54,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1204G>T,Exon 12	c.1204G>T	p.E402X	LCA	Found in compound heterozygo...,54,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1204G>T,Exon 12	c.1204G>T	p.E402X	LCA	Found in compound heterozygo...,54,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1224+4A>G,"Intron 12	c.1224+4A>G, (IVS12+4A>G)	Aberrant splicing	RP	Fou...",55,11,Mol_Vis_2008_Apr_21_14_675-682.txt
c.99+1G>A,...ly onset RP	Found in compound heterozygosity with c.99+1G>A	 [11],57,81,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1381C>G,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1381C>G,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1444C>T,Exon 14	c.1444C>T	p.R482W	Early onset RP	Found in compound...,60,9,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1495+1G>A,"Intron 14	c.1495+1G>A, (IVS14+1G>A)	Aberrant splicing	Early ...",63,11,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1496-6C>A,"Intron 14	c.1496-6C>A, (IVS14-6C>A)	Aberrant splicing	RP		 [...",65,11,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1496-6C>A,"Intron 14	c.1496-6C>A, (IVS14-6C>A)	Aberrant splicing	RP		 [...",65,11,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1495+1G>A,"...3insT mutation identified in family TB13; and the c.1495+1G>A (IVS14+1G>A) mutation, which was previ...",95,608,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1495+1G>A,"...3insT mutation identified in family TB13; and the c.1495+1G>A (IVS14+1G>A) mutation, which was previ...",95,608,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1495+1G>A,...splice-site of intron 14: c.1495+2_1495+3insT and c.1495+1G>A. Also shown are the locations of prime...,99,415,Mol_Vis_2008_Apr_21_14_675-682.txt
c.1495+1G>A,"...ations of TULP1 which have been reported to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C...",102,722,Mol_Vis_2008_Apr_21_14_675-682.txt
c.575C>T,"...ilies: six known and one novel missense mutation (c.575C>T, p.Pro192Leu), one insertion mutation (c....",15,1478,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.78+1G>C,"...and one frameshift, causing splice site mutation (c.78+1G>C) were detected. These mutations were abs...",15,1610,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.78+1G>C,"...and one frameshift, causing splice site mutation (c.78+1G>C) were detected. These mutations were abs...",15,1610,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.78+1G>C,c.78+1G>C	splice site	frameshift→ truncated protei...,88,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.214G>A,c.214G>A	missense	p.Glu72Lys	exon 4	5	5	2	17.86,89,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.214G>A,c.214G>A	missense	p.Glu72Lys	exon 4	5	5	2	17.86,89,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.418G>A,c.418G>A	missense	p.Gly140Arg	exon 5	4	3	2	12.5%,90,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.418G>A,c.418G>A	missense	p.Gly140Arg	exon 5	4	3	2	12.5%,90,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.418G>A,c.418G>A	missense	p.Gly140Arg	exon 5	4	3	2	12.5%,90,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.574C>T,c.574C>T	missense	p.Pro192Ser	exon 6	3	2	2	8.93,93,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.575C>T,c.575C>T *	missense	p.Pro192Leu	exon 6	-	1	1	1.79,94,1,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,"...I:2 in family 4, who had two different mutations (c.421C>T, c.574C>T) in the RS1 gene, which resulte...",98,500,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,"...I:2 in family 4, who had two different mutations (c.421C>T, c.574C>T) in the RS1 gene, which resulte...",98,500,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.575C>T,"...cular testing revealed a novel missense mutation (c.575C>T, p.Pro192Leu) in exon 6 of family 7. In a...",121,855,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,"...4, two different mutations were found: a de novo (c.421C>T, Arg141Cys) mutation and a maternal inher...",121,1196,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,"...4, two different mutations were found: a de novo (c.421C>T, Arg141Cys) mutation and a maternal inher...",121,1196,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.574C>T,"...Arg141Cys) mutation and a maternal inherited one (c.574C>T, Pro192Ser). The pathogenic effects of th...",121,1256,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.422G>A,"...e worst BCVA belonged to two adjoining mutations (c.422G>A, c.421C>T). B: FT values change irrespect...",126,505,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.422G>A,"...e worst BCVA belonged to two adjoining mutations (c.422G>A, c.421C>T). B: FT values change irrespect...",126,505,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,"...VA belonged to two adjoining mutations (c.422G>A, c.421C>T). B: FT values change irrespectively of t...",126,515,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,...etected most frequently. That a de novo mutation (c.421C>T) was found in patient II:2 of family 4 to...,147,135,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,...etected most frequently. That a de novo mutation (c.421C>T) was found in patient II:2 of family 4 to...,147,135,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.421C>T,...etected most frequently. That a de novo mutation (c.421C>T) was found in patient II:2 of family 4 to...,147,135,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.574C>T,"...r with the already known disease-causing variant (c.574C>T, inherited from his mother), illustrates ...",147,240,Mol_Vis_2008_Dec_12_14_2321-2332.txt
c.2197C>T,...1 protein. A novel heterozygous nonsense mutation c.2197C>T(p.R733X)was detected in family F2,17,491,Mol_Vis_2008_Dec_29_14_2451-2457.txt
c.2197C>T,...Sequence shows the heterozygous nonsense mutation c.2197C>T (p. R733X). The 2 sequences given are in...,113,199,Mol_Vis_2008_Dec_29_14_2451-2457.txt
c.2197C>T,...Sequence shows the heterozygous nonsense mutation c.2197C>T (p. R733X). The 2 sequences given are in...,113,199,Mol_Vis_2008_Dec_29_14_2451-2457.txt
c.2109C>T,"...Using pyrosequencing of an RT–PCR amplified cSNP (c.2109C>T) in OPA1, they found that mutant transcr...",126,938,Mol_Vis_2008_Dec_29_14_2451-2457.txt
c.2109C>T,"...Using pyrosequencing of an RT–PCR amplified cSNP (c.2109C>T) in OPA1, they found that mutant transcr...",126,938,Mol_Vis_2008_Dec_29_14_2451-2457.txt
c.448G>A,... direct sequencing of RHO identified a homozygous c.448G>A mutation resulting in the p.Glu150Lys ami...,13,255,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,"..., in a consanguineous Indian family, a homozygous c.448G>A (p.Glu150Lys) mutation in exon 2 was repo...",23,797,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,"...t sequencing of RHO resulted in identification of c.448G>A, a previously reported mutation in exon 2...",141,56,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,...RP21-IV-1) showing the homozygous mutant sequence c.448G>A. B: Sequencing results of RP21-IV-7 showi...,143,164,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,...ing results of RP21-IV-7 showing the heterozygous c.448G>A sequence. C: Sequence trace of an unaffec...,143,234,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,Founder effect analysis of the c.448G>A mutation in the two Pakistani families (R...,158,32,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,"In this study, we identified the c.448G>A mutation in the RHO gene in two different...",165,34,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,...lies from our RP panel that were screened for the c.448G>A mutation. Further investigations of the f...,165,449,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,...lies from our RP panel that were screened for the c.448G>A mutation. Further investigations of the f...,165,449,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.448G>A,...lies from our RP panel that were screened for the c.448G>A mutation. Further investigations of the f...,165,449,Mol_Vis_2009_Dec_3_15_2526-2534.txt
c.1944G>A,"... Accordingly, five SNPs in OPTN (c.603T>A [M98K], c.1944G>A [R545Q], IVS5+38T>G, IVS8–53T>C, and IVS...",40,287,Mol_Vis_2009_Jan_16_15_89-98.txt
c.388T>C,...3/ε4 polymorphisms in exon 4 (c.526C>T for ε2 and c.388T>C for ε4) were investigated by the TaqMan g...,40,1061,Mol_Vis_2009_Jan_16_15_89-98.txt
c.388T>C,...3/ε4 polymorphisms in exon 4 (c.526C>T for ε2 and c.388T>C for ε4) were investigated by the TaqMan g...,40,1061,Mol_Vis_2009_Jan_16_15_89-98.txt
c.526C>T,...iated with POAG. When the ε2/ε3/ε4 polymorphisms (c.526C>T and c.388T>C) were included in haplotype ...,130,337,Mol_Vis_2009_Jan_16_15_89-98.txt
c.388T>C,"...AG. When the ε2/ε3/ε4 polymorphisms (c.526C>T and c.388T>C) were included in haplotype analysis, no ...",130,350,Mol_Vis_2009_Jan_16_15_89-98.txt
c.34C>T,...ygous C>T transition at the 34th coding position (c.34C>T) in exon 1 of CRYAA (NM_000394) was identi...,290,434,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.34C>T,"...results showed a substitution of C to T in CRYAA (c.34C>T), which led to a R12C amino acid change. I...",292,103,Mol_Vis_2009_Jun_4_15_1127-1138.txt
c.413C>G,A de novo heterozygous c.413C>G p.S138X stop mutation was identified in a...,31,24,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.93C>G,c.93C>G	p.Tyr31X	Microphthalmia	[20],56,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.289C>T,c.289C>T	p.Gln97X	Extreme microphthalmia	[20],59,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.537T>A,"c.537T>A	p.Tyr179X	bilateral mild microphthalmia, ...",68,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.537T>A,"c.537T>A	p.Tyr179X	bilateral mild microphthalmia, ...",68,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.295C>T,c.295C>T	p.Gln99X	bilateral anopthalmia	[11],70,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.400C>G,c.400C>G	p.Pro134Ala	anophthalmia OS/ OD normal	[1...,72,1,Mol_Vis_2009_Nov_21_15_2442-2447.txt
c.718C>T,...7fs17] and c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations in the affected...,13,420,Mol_Vis_2009_Oct_17_15_2074-2083.txt
c.529C>T,"...r recurrent mutation in SOX2; one other mutation, c.529C>T, has been noted in three unrelated famili...",56,1699,Mol_Vis_2010_Apr_28_16_768-773.txt
c.43A>T,C20orf72 (NM_018152)	c.43A>T	p.Ser15Cys	rs11551768	Y (hetero) Score=18	...,82,22,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.415T>C, 	c.415T>C	p.Leu139Leu	-	N*	N*	Y (homo)	Y (homo),88,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.415T>C, 	c.415T>C	p.Leu139Leu	-	N*	N*	Y (homo)	Y (homo),88,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.843C>T, 	c.843C>T	p.Cys281Cys	rs3748492	N*	Y (homo) Score=4...,90,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.327C>A,OVOL2 (NM_021220)	c.327C>A	p.Thr109Thr	rs6111803	Y (hetero) Score=17...,92,19,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.327C>A,OVOL2 (NM_021220)	c.327C>A	p.Thr109Thr	rs6111803	Y (hetero) Score=17...,92,19,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1499C>T, 	c.1499C>T	p.Ala500Val	rs41276418	Y (hetero) Score=...,97,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.2223T>C, 	c.2223T>C	p.Pro741Pro	rs2747404	Y (homo) Score=25	...,98,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.89T>C,MGC44328 (NM_001004344)	c.89T>C	p.Leu30Pro	rs1883938	Y (homo) Score=27	Y (...,101,25,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.89T>C,MGC44328 (NM_001004344)	c.89T>C	p.Leu30Pro	rs1883938	Y (homo) Score=27	Y (...,101,25,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.89T>C,MGC44328 (NM_001004344)	c.89T>C	p.Leu30Pro	rs1883938	Y (homo) Score=27	Y (...,101,25,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.40T>C,C20orf12 (NM_018152)	c.40T>C	p.Leu14Leu	rs6035051	Y (hetero) Score=25	Y...,102,22,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.801T>C, 	c.801T>C	p.Cys267Cys	rs6035042	Y (homo) Score=29	Y...,103,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.840A>G,POLR3F (NM_006466)	c.840A>G	p.Thr280Thr	rs1055171	Y (homo) Score=26	Y...,106,20,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.167G>A, 	c.167G>A	p.Arg56Gln	-	N*	N*	Y (hetero)	N,110,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.490G>A,SEC23B (NM_032985)	c.490G>A	p.Val164Met	rs36023150	N	N	N	N,111,20,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1198T>C, 	c.1198T>C	p.Phe400Leu	-	N	Y (hetero) Score=8	N	Y(h...,112,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1198T>C, 	c.1198T>C	p.Phe400Leu	-	N	Y (hetero) Score=8	N	Y(h...,112,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1467C>G, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score...,114,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1467C>G, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score...,114,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1467C>G, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score...,114,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1467C>G, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score...,114,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.48A>G,LOC388789 (XM_939954)	c.48A>G	p.Arg16Arg	rs12624935	N*	N*	N	Y (hetero),115,23,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.447A>C,DUXAP7 (NG_004846)	c.447A>C	p.Gln149His	rs6132094	N*	N*	Y (hetero)	Y ...,117,20,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.664A>G, 	c.664A>G	p.Thr222Ala	rs6081271	N*	N*	Y (homo)	Y (h...,118,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.664A>G, 	c.664A>G	p.Thr222Ala	rs6081271	N*	N*	Y (homo)	Y (h...,118,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.716T>A, 	c.716T>A	p.Ile239Lys	-	N*	N*	Y (hetero)	Y (hetero)...,120,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.716T>A, 	c.716T>A	p.Ile239Lys	-	N*	N*	Y (hetero)	Y (hetero)...,120,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.943G>C, 	c.943G>C	p.Val315Leu	rs6132093	N*	N*	Y (hetero)	Y ...,126,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.943G>C, 	c.943G>C	p.Val315Leu	rs6132093	N*	N*	Y (hetero)	Y ...,126,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1156C>T, 	c.1156C>T	p.Pro386Ser	rs6075382	N*	N*	Y (hetero)	Y...,128,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1156C>T, 	c.1156C>T	p.Pro386Ser	rs6075382	N*	N*	Y (hetero)	Y...,128,3,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.138C>G,LOC100128496 (XM_001725705)	c.138C>G	p.Leu46Leu	rs56743271	Y (hetero) Score=19...,136,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.138C>G,LOC100128496 (XM_001725705)	c.138C>G	p.Leu46Leu	rs56743271	Y (hetero) Score=19...,136,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.255C>T,C20orf79 (NM_178483)	c.255C>T	p.Thr85Thr	rs1053834	Y (hetero) Score=25	...,137,22,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.295C>T,c.295C>T	p.Pro99Ser	rs1053839	Y (hetero) Score=20	...,138,2,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.369G>A,c.369G>A	p.Ala123Ala	rs3790261	Y (Hetero) Score=26...,141,2,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.369G>A,c.369G>A	p.Ala123Ala	rs3790261	Y (Hetero) Score=26...,141,2,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.846T>C,"...tional screening criterion, with the exception of c.846T>C in C20orf72 (inadequate coverage, 4 reads...",168,1296,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.843C>T,...wn genes. Two variants (c. 846T>C in C20orf72 and c.843C>T in PTMAP3) that were identified by Sanger...,168,1694,Mol_Vis_2010_Dec_18_16_2829-2838.txt
c.1876A>G,"...n hotspot mutations, c. 531C>T (p. Arg124Cys) and c.1876A>G (p.His572Arg), were revealed in Family 2...",13,169,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1702G>C,"...onserved c.1702G and c.1706T, suggesting that the c.1702G>C and 1706T>A substitutions were not polym...",69,122,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1702G>C,"...onserved c.1702G and c.1706T, suggesting that the c.1702G>C and 1706T>A substitutions were not polym...",69,122,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1702G>C,...the TGFBI locus markers D5S816 and D5S393 and the c.1702G>C and 1706T>A variants could not conclusiv...,69,294,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1702G>C,...the TGFBI locus markers D5S816 and D5S393 and the c.1702G>C and 1706T>A variants could not conclusiv...,69,294,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1702G>C,"...bjects. In this present study, 2 novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu),...",81,351,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1702G>C,"...bjects. In this present study, 2 novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu),...",81,351,Mol_Vis_2010_Feb_15_16_224-230.txt
c.1222A>C,Exon 4	c.1222A>C	p.I408L	Novel	20090	0/190,54,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2615G>A,Exon 4	c.2615G>A	p.R872H	rs444772	43/55	130/190,56,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2615G>A,Exon 4	c.2615G>A	p.R872H	rs444772	43/55	130/190,56,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2953A>T,Exon 4	c.2953A>T	p.N985Y	rs2293869	20149	27/190,57,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.3024G>A,Exon 4	c.3024G>A	p.Q1008Q	 [26]	20090	1/190,58,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.5071T>C,Exon 4	c.5071T>C	p.S1691P	rs414352	44/55	106/190,62,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.6045A>G,Exon 4	c.6045A>G	p.L2015L	Novel	20090	0/190,64,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.6098G>A,Exon 4	c.6098G>A	p.C2033Y	rs61739567	20149	27/190,65,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.6542C>T,"... variants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both the case and control s...",69,80,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.6542C>T,"... variants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both the case and control s...",69,80,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.787+34T>C,"...reas of China. Two of them (p.L2015L and intronic c.787+34T>C) did not lead to amino acid change, wh...",69,280,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.787+34T>C,"...reas of China. Two of them (p.L2015L and intronic c.787+34T>C) did not lead to amino acid change, wh...",69,280,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.4108A>G,Exon 4	c.4108A>G	p.K1370E	sRP	F	61	0/552	Potentially dama...,77,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.4955G>T,Exon 4	c.4955G>T	p.R1652L	sRP	F	50	0/552	Possibly damagin...,78,8,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.1118C>T,p.T373I*	c.1118C>T	Pakistan	ARRP	[18],105,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2005G>A,p.A669T	c.2005G>A	Pakistan	ARRP	[18],107,9,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2005G>A,p.A669T	c.2005G>A	Pakistan	ARRP	[18],107,9,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2005G>A,p.A669T	c.2005G>A	Pakistan	ARRP	[18],107,9,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2951A>G,p.D984G	c.2951A>G	Chinese	ADRP	[21],108,9,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.2954A>T,p.N985Y	c.2954A>T	Chinese	ADRP	[39],109,9,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.5423T>C,p.L1808P	c.5423T>C	U.S.A.	ADRP	[16],112,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.5423T>C,p.L1808P	c.5423T>C	U.S.A.	ADRP	[16],112,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
c.319G>A,... junction-forming interactions of AQP0. The novel c.319G>A transition results in the substitution of...,75,491,Mol_Vis_2010_Mar_25_16_534-539.txt
c.471G>A,This study identified a disease-causing mutation c.471G>A in CRYGC in a Chinese family with catarac...,16,50,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,This study identified a disease-causing mutation c.471G>A in CRYGC in a Chinese family with catarac...,16,50,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,"In this study, we report a nonsense mutation (c.471G>A) in exon 3 of CRYGC resulting in autosoma...",93,47,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,"...The mutant transcripts of this nonsense mutation (c.471G>A, p.W157X) may escape the NMD pathway and ...",97,447,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,"...The mutant transcripts of this nonsense mutation (c.471G>A, p.W157X) may escape the NMD pathway and ...",97,447,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,"...RYGC. The mutation detected in our present study, c.471G>A, creates a premature stop codon (W157X) a...",97,1008,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,"... as listed in Table 2 [21-27]. In addition to the c.471G>A mutation, the other phenotypes described ...",99,153,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,"... as listed in Table 2 [21-27]. In addition to the c.471G>A mutation, the other phenotypes described ...",99,153,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,"... as listed in Table 2 [21-27]. In addition to the c.471G>A mutation, the other phenotypes described ...",99,153,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.470G>A,...proximately 9 mm. The previous W157X report was a c.470G>A transition and the clinical phenotype als...,99,1324,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.13A>C,c.13A>C	T5P	GKM1	Coppock-like	[21],103,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.502C>T,c.502C>T	R168W	GKM4	Nuclear	[24],106,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.502C>T,c.502C>T	R168W	GKM4	Nuclear	[24],106,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.502C>T,c.502C>T	R168W	GKM4	Nuclear	[24],106,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.327C>A,c.327C>A	C109X	GKM3	Nuclear	[25],107,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.327C>A,c.327C>A	C109X	GKM3	Nuclear	[25],107,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.385G>T,c.385G>T	G129C	GKM4	Nuclear	[27],109,1,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,"...present study has identified a nonsense mutation (c.471G>A, p.W157X) in CRYGC associated with autoso...",113,70,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.471G>A,"...present study has identified a nonsense mutation (c.471G>A, p.W157X) in CRYGC associated with autoso...",113,70,Mol_Vis_2012_Jul_11_18_1874-1880.txt
c.813C>A,"...decay (NMD), therefore, the heterozygous mutation c.813C>A of FBN1 could cause haploinsufficiency of...",98,1132,Mol_Vis_2013_Apr_5_19_751-758.txt
c.1910G>A,...otype was the consequence of a missense mutation (c.1910G>A) of the FBN1 gene. This mutation is loca...,100,316,Mol_Vis_2013_Apr_5_19_751-758.txt
c.1910G>A,...otype was the consequence of a missense mutation (c.1910G>A) of the FBN1 gene. This mutation is loca...,100,316,Mol_Vis_2013_Apr_5_19_751-758.txt
c.700G>A,CA4	17–58235763	c.700G>A,34,17,Mol_Vis_2013_Mar_21_19_654-664.txt
c.700G>A,CA4	17–58235763	c.700G>A,34,17,Mol_Vis_2013_Mar_21_19_654-664.txt
c.641C>T,PRPH2	6–42672290	c.641C>T,38,18,Mol_Vis_2013_Mar_21_19_654-664.txt
c.313C>A,"... including c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c....",12,104,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"... including c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c....",12,104,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"... including c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c....",12,104,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,...B: Mutation of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The upper panel is the chromat...,55,211,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,...B: Mutation of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The upper panel is the chromat...,55,211,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,...tein. These results suggest that the mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are nov...,67,606,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,...est that the mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are novel mutations in the FOXL...,67,630,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,...est that the mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are novel mutations in the FOXL...,67,630,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"... mutations—c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the ...",82,82,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"... mutations—c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the ...",82,82,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,"...0 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene in four Han C...",82,106,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,"...0 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene in four Han C...",82,106,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"...BPES type II, while the two missense mutations of c.313C>A and c.430G>T are novel mutations detected...",82,298,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.313C>A,"...BPES type II, while the two missense mutations of c.313C>A and c.430G>T are novel mutations detected...",82,298,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.430G>T,... while the two missense mutations of c.313C>A and c.430G>T are novel mutations detected in the other...,82,311,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.402C>G,...or-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 20098707,106,273,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.402C>G,...or-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 20098707,106,273,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.402C>G,...or-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 20098707,106,273,Mol_Vis_2013_Nov_16_19_2298-2305.txt
c.4325T>C,"... type 2A (USH2A) compound heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), lo...",10,71,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.4325T>C,"... type 2A (USH2A) compound heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), lo...",10,71,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.15188T>G,"... heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in exons 20 and 70,...",10,96,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.15188T>G,"... heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in exons 20 and 70,...",10,96,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.4325T>C,... the USH2A gene at genomic positions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other ...,60,826,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.15188T>G,...ositions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other pathogenic mutations were fo...,60,854,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.15188T>G,...ositions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other pathogenic mutations were fo...,60,854,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.15188T>G,...ositions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other pathogenic mutations were fo...,60,854,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.4325T>C,...d control individuals were screened for the USH2A c.4325T>C and c.15188T>G mutations. Sanger sequenc...,72,215,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.15188T>G,...viduals were screened for the USH2A c.4325T>C and c.15188T>G mutations. Sanger sequencing confirmed ...,72,229,Mol_Vis_2013_Nov_7_19_2187-2195.txt
c.992A>C,"...s with BCD include c.802_810del17insGC in exon 7, c.992A>C in exon 8, and c.1091–2A>G in an intronic...",22,513,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.992A>C,"...s with BCD include c.802_810del17insGC in exon 7, c.992A>C in exon 8, and c.1091–2A>G in an intronic...",22,513,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.283G>A,"31	43/F	30	11	RE: —10.5	RE:20/200	c.283G>A, p.G95R+ c.1027T>G, p.Y343D﹡",46,35,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.283G>A,"31	43/F	30	11	RE: —10.5	RE:20/200	c.283G>A, p.G95R+ c.1027T>G, p.Y343D﹡",46,35,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.1027T>G,"...	43/F	30	11	RE: —10.5	RE:20/200	c.283G>A, p.G95R+ c.1027T>G, p.Y343D﹡",46,53,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.31C>T,1	c.31C>T	p.Q11X	1/0	0/200	2/184	novel,66,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.31C>T,1	c.31C>T	p.Q11X	1/0	0/200	2/184	novel,66,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.64C>G,1	c.64C>G	p.L22V	1/4	ND	6/184	Reported,67,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.283G>A,2	c.283G>A	p.G95R	0/5	ND	5/184	Reported,70,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,3	c.413+2T>G	Splicing acceptor	0/1	0/200	1/184	novel...,71,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,3	c.413+2T>G	Splicing acceptor	0/1	0/200	1/184	novel...,71,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,3	c.413+2T>G	Splicing acceptor	0/1	0/200	1/184	novel...,71,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.1027T>G,8	c.1027T>G	p.Y343D	0/1	0/200	1/184	novel,77,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.1027T>G,8	c.1027T>G	p.Y343D	0/1	0/200	1/184	novel,77,3,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.31C>T,"...p.Tyr343Asp). In patient 60, a nonsense mutation (c.31C>T) that converts a glutamine (CAG) into a pr...",84,552,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,"...WT). G: DNA-MT of the heterozygous splice change (c.413+2T>G). H: Control (WT). I: cDNA sequence, fr...",88,338,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,"...WT). G: DNA-MT of the heterozygous splice change (c.413+2T>G). H: Control (WT). I: cDNA sequence, fr...",88,338,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,...). J: The cDNA of the heterozygous splice change (c.413+2T>G). The deletion is indicated with an arr...,88,478,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,"...ing that these four novel mutations, p.Tyr343Asp, c.413+2T>G, c.791delT, and p.Gln11X, segregated wi...",103,182,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.413+2T>G,"...802–8_810del17insGC) and a novel splice mutation (c.413+2T>G), exhibited a late age of onset, rapid ...",107,109,Mol_Vis_2014_Dec_31_20_1806-1814.txt
c.873+1G>T,"...2). One of the variants, the splice-site mutation c.873+1G>T in intron 5, was in a known WMS-like sy...",51,854,Mol_Vis_2014_Jun_12_20_790-796.txt
c.873+1G>T,"...2). One of the variants, the splice-site mutation c.873+1G>T in intron 5, was in a known WMS-like sy...",51,854,Mol_Vis_2014_Jun_12_20_790-796.txt
c.873+1G>T,ADAMTS17	NM_139057.2	c.873+1G>T	-	Disease causin,55,22,Mol_Vis_2014_Jun_12_20_790-796.txt
c.326G>A,CAMK1D	NM_020397.2	c.326G>A (p.R109Q)	Probably damagin,57,20,Mol_Vis_2014_Jun_12_20_790-796.txt
c.847G>A,PYROXD2	NM_032709.2	c.847G>A (p.V283I)	Probably damagin,61,21,Mol_Vis_2014_Jun_12_20_790-796.txt
c.847G>A,PYROXD2	NM_032709.2	c.847G>A (p.V283I)	Probably damagin,61,21,Mol_Vis_2014_Jun_12_20_790-796.txt
c.326G>A,...nts of unknown significance in three other genes [c.326G>A (p.R109Q) in CAMK1D located on chromosome...,70,85,Mol_Vis_2014_Jun_12_20_790-796.txt
c.326G>A,...nts of unknown significance in three other genes [c.326G>A (p.R109Q) in CAMK1D located on chromosome...,70,85,Mol_Vis_2014_Jun_12_20_790-796.txt
c.326G>A,...nts of unknown significance in three other genes [c.326G>A (p.R109Q) in CAMK1D located on chromosome...,70,85,Mol_Vis_2014_Jun_12_20_790-796.txt
c.1721+1G>A,2	c.1721+1G>A	Intron 12	Splice site	Homozygous	Saudi...,90,3,Mol_Vis_2014_Jun_12_20_790-796.txt
c.873+1G>T,6	c.873+1G>T	Intron 5	Splice site	Homozygous	Indian	...,96,3,Mol_Vis_2014_Jun_12_20_790-796.txt
c.1184A>G,...rt cognitive defects. NGS identified a homozygous c.1184A>G mutation in the MKKS/BBS6 gene in both p...,10,214,Mol_Vis_2016_Jan_24_22_73-81.txt
c.1184A>G,...vered that both patients share a novel homozygous c.1184A>G missense mutation in the MKKS/BBS6 gene ...,24,236,Mol_Vis_2016_Jan_24_22_73-81.txt
c.1184A>G,...vered that both patients share a novel homozygous c.1184A>G missense mutation in the MKKS/BBS6 gene ...,24,236,Mol_Vis_2016_Jan_24_22_73-81.txt
c.7228+1G>A,"...yes shut homolog (EYS) gene, involving two novel (c.7228+1G>A and c.9248G>A) and three recurrent mut...",12,236,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"... (EYS) gene, involving two novel (c.7228+1G>A and c.9248G>A) and three recurrent mutations (c.4957du...",12,252,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,"...48G>A) and three recurrent mutations (c.4957dupA, c.6416G>A and c.6557G>A), were found as RP causati...",12,306,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6557G>A,"...ee recurrent mutations (c.4957dupA, c.6416G>A and c.6557G>A), were found as RP causative in the four...",12,320,Mol_Vis_2016_Jun_16_22_646-657.txt
c.5093T>C,...sative in the four families. The missense variant c.5093T>C was determined to be a variant of unknow...,12,402,Mol_Vis_2016_Jun_16_22_646-657.txt
c.5093T>C,...sative in the four families. The missense variant c.5093T>C was determined to be a variant of unknow...,12,402,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,...same allele with the reported pathogenic mutation c.6416G>A. The two novel variants were further con...,12,566,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6557G>A,...hydrogen bonds by the missense mutation p.G2186E (c.6557G>A) and elongation of its neighboring β-she...,12,883,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6557G>A,...hydrogen bonds by the missense mutation p.G2186E (c.6557G>A) and elongation of its neighboring β-she...,12,883,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6557G>A,"...milies. A homozygous recurrent missense mutation, c.6557G>A, was found carried by patient ARRP07-II:...",45,691,Mol_Vis_2016_Jun_16_22_646-657.txt
c.5093T>C,"ARRP08	RP	6: 65,300,667	c.5093T>C	p.I1698T	missense	Het	E26	DA (0)	B (0.08...",69,25,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"6: 64,430,679	c.9248G>A	p.G3083D	missense	Het	E43	DA (0.02)	DA (...",70,15,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"6: 64,430,679	c.9248G>A	p.G3083D	missense	Het	E43	DA (0.02)	DA (...",70,15,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,"6: 64,940,493	c.6416G>A	p.C2139Y	missense	Het	E31	DA (0)	PD (0.7...",71,15,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,"6: 64,940,493	c.6416G>A	p.C2139Y	missense	Het	E31	DA (0)	PD (0.7...",71,15,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"...ARRP08-II:2 (Figure 1A,C–E). The missense variant c.9248G>A was novel, while c.5093T>C was determine...",78,143,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"...ARRP08-II:2 (Figure 1A,C–E). The missense variant c.9248G>A was novel, while c.5093T>C was determine...",78,143,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"...ARRP08-II:2 (Figure 1A,C–E). The missense variant c.9248G>A was novel, while c.5093T>C was determine...",78,143,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,...thogenic mutation c.6416G>A. The missense variant c.9248G>A would induce a change from the neutral g...,78,353,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,"... properties (Figure 3D,E). The recurrent mutation c.6416G>A would lead to an amino acid change from ...",78,709,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,"... properties (Figure 3D,E). The recurrent mutation c.6416G>A would lead to an amino acid change from ...",78,709,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,"... properties (Figure 3D,E). The recurrent mutation c.6416G>A would lead to an amino acid change from ...",78,709,Mol_Vis_2016_Jun_16_22_646-657.txt
c.7228+1G>A,...ient ARRP07-II:1. The novel splice-site variation c.7228+1G>A was predicted to abolish the regular s...,80,251,Mol_Vis_2016_Jun_16_22_646-657.txt
c.9248G>A,"...se NMD. The two novel variations, c.7228+1G>A and c.9248G>A, were further confirmed absent in the 10...",80,695,Mol_Vis_2016_Jun_16_22_646-657.txt
c.7492G>C,3$	c.7492G>C (Hom)	p.A2498P (Hom)	W159–1	IRDs	34/M	20...,110,4,Mol_Vis_2016_Jun_16_22_646-657.txt
c.6416G>A,3$	c.6416G>A (Hom)	p.C2139Y (Hom)	W75–1	IRDs	31/M	20	...,113,4,Mol_Vis_2016_Jun_16_22_646-657.txt
c.5093T>C,"...on of its neighboring β-sheet, and a missense VUS c.5093T>C colocalized in the same allele with the ...",118,684,Mol_Vis_2016_Jun_16_22_646-657.txt
c.7228+1G>A,"...patient ARRP10-II:3, the same patient who carries c.7228+1G>A. This mutation has not been previously...",118,905,Mol_Vis_2016_Jun_16_22_646-657.txt
c.148C>G,c.148C>G (p.His50Asp)	Damagin,80,1,Mol_Vis_2016_May_16_22_491-502.txt
c.338G>A,Exon 3	c.338G>A (p.Gly113Asp)	Damaging 0	Probably damagin...,86,8,Mol_Vis_2016_May_16_22_491-502.txt
c.376T>C,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damagin...,89,1,Mol_Vis_2016_May_16_22_491-502.txt
c.376T>C,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damagin...,89,1,Mol_Vis_2016_May_16_22_491-502.txt
c.376T>C,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damagin...,89,1,Mol_Vis_2016_May_16_22_491-502.txt
c.376T>C,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damagin...,89,1,Mol_Vis_2016_May_16_22_491-502.txt
c.*522T>C,"...ngs. Further, two novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two pati...",92,675,Mol_Vis_2016_May_16_22_491-502.txt
c.1194+2T>C,"... CTR9 minigene splicing constructs containing the c.1194+2T>C mutation identified in Fam3727, showin...",91,174,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+3A>C,"...from Fam0484 (proband 2), who is heterozygous for c.1194+3A>C, demonstrates that exon 9 is deleted o...",91,326,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+3A>C,"...from Fam0484 (proband 2), who is heterozygous for c.1194+3A>C, demonstrates that exon 9 is deleted o...",91,326,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+2T>C,...ratricopeptide repeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations ...,91,519,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+2T>C,...ratricopeptide repeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations ...,91,519,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+2T>C,...ratricopeptide repeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations ...,91,519,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+3A>C,...epeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result in an in-...,91,535,Nat_Commun_2014_Aug_7_5_4398.txt
c.1194+3A>C,...epeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result in an in-...,91,535,Nat_Commun_2014_Aug_7_5_4398.txt
c.75G>A,c.75G>A(p.=)	rs138850547	 	 	No effect	 	1,167,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.303G>C,c.303G>C; p.Lys101Asn	 	Possibly damaging	Tolerate...,168,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.304A>G,c.304A>G; p.Asn102Asp	 	Benign	Tolerated	No effect...,169,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1329G>T,c.1329G>T; p.Glu443Asp	 	Benign	Tolerated	No effec...,173,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1461C>T,c.1461C>T(p.=)	 	 	 	No effect	Common	Common,174,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1687-3C>T,c.1687-3C>T	rs76650154	 	 	No effect	5	 ,176,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.1873-4A>G,c.1873-4A>G	 	 	 	No effect	 	3,178,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2097C>T,c.2097C>T(p.=)	rs140813178	 	 	No effect	1	8,179,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2487C>T,c.2487C>T(p.=)	 	 	 	No effect	 	1,182,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2745A>G,c.2745A>G(p.=)	 	 	 	No effect	1	 ,185,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2953C>T,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect ...,187,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.2953C>T,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect ...,187,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3149A>G,c.3149A>G; p.Lys1050Arg	rs141131642	Benign	Tolerat...,189,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3149A>G,c.3149A>G; p.Lys1050Arg	rs141131642	Benign	Tolerat...,189,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3195G>A,c.3195G>A(p.=)	rs34200650	 	 	No effect	1	 ,191,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3244G>A,c.3244G>A; p.Asp1082Asn	rs138871050	Benign	Tolerat...,193,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3284G>A,c.3284G>A; p.Arg1095Lys	rs141434094	Possibly damag...,194,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3292G>A,c.3292G>A; p.Gly1098Ser	rs376210239	Benign	Tolerat...,195,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3292G>A,c.3292G>A; p.Gly1098Ser	rs376210239	Benign	Tolerat...,195,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3292G>A,c.3292G>A; p.Gly1098Ser	rs376210239	Benign	Tolerat...,195,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3292G>A,c.3292G>A; p.Gly1098Ser	rs376210239	Benign	Tolerat...,195,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3402G>A,c.3402G>A(p.=)	rs147016884	 	 	No effect	1	1,196,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3449A>G,c.3449A>G; p.Glu1150Gly	rs35023148	Benign	Tolerate...,197,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3449A>G,c.3449A>G; p.Glu1150Gly	rs35023148	Benign	Tolerate...,197,1,Nat_Commun_2014_Aug_7_5_4398.txt
c.3551T>C,"...by both individuals, a missense change in SCN11A, c.3551T>C, p.V1184A (chr3:38913144A>G, hg19), was ...",20,1188,Nat_Commun_2015_Dec_8_6_10049.txt
c.3551T>C,...014139.2) in pcDNA3.1 was used as template15. The c.3551T>C (p.Val1184Ala) mutation was introduced b...,67,73,Nat_Commun_2015_Dec_8_6_10049.txt
c.993+1G>A,"...03A, were heterozygous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affe...",20,198,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+3A>G,"...terozygous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect splicing ...",20,210,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+1G>A,R01-013A	0/1	c.993+1G>A	Intron 12	4.37			16.1		0.00008,148,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.349C>G,R07-628A	0/1	c.349C>,151,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.349C>G,R07-628A	0/1	c.349C>,151,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.349C>G,R07-628A	0/1	c.349C>,151,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.1000G>T,R03-303A	0/1	c.1000G>,155,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.1000G>T,R03-303A	0/1	c.1000G>,155,14,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+3A>G,0/1	c.993+3A>G	Intron 12	4.37			10.8,157,5,Nat_Commun_2015_Jun_16_6_7092.txt
c.993+3A>G,0/1	c.993+3A>G	Intron 12	4.37			10.8,157,5,Nat_Commun_2015_Jun_16_6_7092.txt
c.1861A>G,"...). As such, we have shown segregation of the CCNF c.1861A>G mutation in seven ALS patients from fami...",17,1663,Nat_Commun_2016_Apr_15_7_11253.txt
c.2758-2A>G,"...cient to cause JATD. However, a similar genotype (c.2758-2A>G/P209L or C552X/P209L) leads to early-o...",44,784,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
c.2758-2A>G,"...cient to cause JATD. However, a similar genotype (c.2758-2A>G/P209L or C552X/P209L) leads to early-o...",44,784,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
c.2322+3A>G,BBS	13881/VI.24	N. European	c.2322+3A>G		0/440	0/356	BBS2:L209fsX229 hom,138,29,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
c.2322+3A>G,BBS	13881/VI.24	N. European	c.2322+3A>G		0/440	0/356	BBS2:L209fsX229 hom,138,29,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
c.711G>T,BBS	10172/I.25	N. European	c.711G>T/Y255C		0/440	0/356	BBS10: C91fsX95 het; B...,145,28,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
c.2931G>A,c.2931G>A	p.Trp977X	UK	4 wks	+	+	10.52	1.1/1.0 [0....,184,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.2588C>T,c.2588C>T	p.Ser863Phe	NL	5 wks	+	+	27.52	11.8/38 [...,233,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.2588C>T,c.2588C>T	p.Ser863Phe	NL	5 wks	+	+	27.52	11.8/38 [...,233,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.3518G>A,c.3518G>A	p.Trp1173X	NL	14.1 yrs	+	+	16.69	19/17 [...,248,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.2309G>A,c.2309G>A	p.Ser770Asn	IT	10.6 yrs	+	+	26.54	21.5/2...,257,2,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
c.272T>C,"...kistani families, we found a homozygous mutation (c.272T>C; p.Phe91Ser) of CIB2 (Figs. 1 and 2a; Sup...",24,425,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.272T>C,"...kistani families, we found a homozygous mutation (c.272T>C; p.Phe91Ser) of CIB2 (Figs. 1 and 2a; Sup...",24,425,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.368T>C,"...bles 1 and 2). In addition, a transition mutation c.368T>C (p.Ile123Thr) of CIB2 co-segregated with ...",24,775,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.192G>C,...PKDF117 (Fig. 1c) were found to be homozygous for c.192G>C (p.Glu64Asp) in CIB2. This new locus is d...,26,319,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.192G>C,...PKDF117 (Fig. 1c) were found to be homozygous for c.192G>C (p.Glu64Asp) in CIB2. This new locus is d...,26,319,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.368T>C,... have normal hearing. No carriers of c.192G>C and c.368T>C were found among 676 and 724 ethnically m...,26,588,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.368T>C,... have normal hearing. No carriers of c.192G>C and c.368T>C were found among 676 and 724 ethnically m...,26,588,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.272T>C,...ively (Supplementary Table 4). Heterozygosity for c.272T>C and c.297C>G was identified in one and fi...,26,723,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.297C>G,...mentary Table 4). Heterozygosity for c.272T>C and c.297C>G was identified in one and five representa...,26,736,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.272T>C,"...282) at D15SA975 (78.56 Mb). CIB2 mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c...",118,599,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.297C>G,"... Mb). CIB2 mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p.Ile123Thr)] ...",118,622,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.297C>G,"... Mb). CIB2 mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p.Ile123Thr)] ...",118,622,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
c.553C>T,...gous for the paternally derived nonsense p.Q185X (c.553C>T) mutation in exon 5 of HOIL1 (Fig. 1c),14,1558,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
c.553C>T,...gous for the paternally derived nonsense p.Q185X (c.553C>T) mutation in exon 5 of HOIL1 (Fig. 1c),14,1558,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
c.553C>T,...gous for the paternally derived nonsense p.Q185X (c.553C>T) mutation in exon 5 of HOIL1 (Fig. 1c),14,1558,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
c.3059G>A,"...ve two heterozygous missense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both cases (PD21...",29,207,Nature_2011_Jan_27_469(7331)_539-542.txt
c.1376+2T>C,...atient. The second trace is a normal control. The c.1376+2T>C mutation occurs 2 base pairs into intr...,18,161,NDT_Plus_2008_Jun_27_1(3)_171-175.txt
c.1376+2T>C,...atient. The second trace is a normal control. The c.1376+2T>C mutation occurs 2 base pairs into intr...,18,161,NDT_Plus_2008_Jun_27_1(3)_171-175.txt
c.1376+2T>C,...atient. The second trace is a normal control. The c.1376+2T>C mutation occurs 2 base pairs into intr...,18,161,NDT_Plus_2008_Jun_27_1(3)_171-175.txt
c.143+3G>C,"...e donor splice site in intron 2 of the GYG1 gene (c.143+3G>C, p.Asp3Glufs*4), either in homozygous (...",542,519,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
c.143G>C,The c.143G>C homozygous mutation has been identified i...,547,5,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
c.143G>C,The c.143G>C homozygous mutation has been identified i...,547,5,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
c.1448T>C,...atic patients with the L444P/L444P GBA1 genotype (c.1448T>C) who were on ERT were included in this s...,342,119,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
c.1448T>C,...atic patients with the L444P/L444P GBA1 genotype (c.1448T>C) who were on ERT were included in this s...,342,119,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
c.1342G>C,"...+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>...",342,669,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
c.1342G>C,"...+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>...",342,669,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
c.464G>A,"...athogenic due to a frameshift, and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys),...",1220,418,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.464G>A,"...athogenic due to a frameshift, and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys),...",1220,418,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.902C>G,"...ft, and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys), affect highly conserved si...",1220,445,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.902C>G,"...ft, and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys), affect highly conserved si...",1220,445,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.79G>C,...This can be attributed to the allele carrying the c.79G>C mutation because the c.859C>T mutation has...,1230,139,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.79G>C,...This can be attributed to the allele carrying the c.79G>C mutation because the c.859C>T mutation has...,1230,139,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.859C>T,... allele carrying the c.79G>C mutation because the c.859C>T mutation has been shown to yield no prote...,1230,168,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.79G>C,It has been suggested that the c.79G>C mutation leads to a mild phenotype of LGMD...,1232,32,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.859C>T,...tion leads to a mild phenotype of LGMD2T5 and the c.859C>T to a severe one.6 Three cases were compou...,1232,94,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
c.2040G>C,"...4Ile, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177...",22,664,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.2040G>C,"...4Ile, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177...",22,664,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.1105C>T,"...A>G, rs104895094) in exon 10; P369S (p.Pro369Ser, c.1105C>T, rs11466023) in exon 3; and E148Q (p.Glu...",22,857,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
c.80A>G,...mons.org/licenses/by/3.0/).A common polymorphism (c.80A>G) in the gene coding for the reduced folate...,3,1046,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
c.677C>T,...th the methylenetetrahydrofolate reductase (MTHFR c.677C>T) and the methionine synthase reductase (M...,12,1033,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
c.80A>G,"...00, Chango and coworkers [18] identified a common c.80A>G polymorphism in the gene coding for RFC-1 ...",14,56,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
c.80A>G,"...anguages, evaluating the association of the RFC-1 c.80A>G polymorphism and maternal risk for having ...",20,1499,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
c.80A>G,...shows allele and genotype distributions for RFC-1 c.80A>G in the selected studies. Deviations from H...,22,216,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
c.80G>A,...cNulty H.    The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell f...,187,186,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
c.80G>A,...cNulty H.    The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell f...,187,186,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
c.385G>C,"... missense mutation in exon 7 was identified (EYA4:c.385G>C, p.Gly129Arg), which is shown along with ...",93,234,Oncogene_2014_Sep_4_33(36)_4464-4473.txt
c.34G>A,"1	63	M	R (asc)	5,0 cm	T3	Not tested	KRAS c.34G>A (p.G12S)	Reg Ascending LN & metachr Liver:...",36,42,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.34G>A,"1	63	M	R (asc)	5,0 cm	T3	Not tested	KRAS c.34G>A (p.G12S)	Reg Ascending LN & metachr Liver:...",36,42,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.34G>A,...A (p.G12S)	Reg Ascending LN & metachr Liver: KRAS c.34G>A (p.G12S)	None,36,98,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"2	74	M	NS	5,8 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Paraaortic LN & metachr Brain & m...",38,34,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"2	74	M	NS	5,8 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Paraaortic LN & metachr Brain & m...",38,34,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"2	74	M	NS	5,8 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Paraaortic LN & metachr Brain & m...",38,34,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,...araaortic LN & metachr Brain & metachr Lung: KRAS c.35G>A	None,38,102,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,...araaortic LN & metachr Brain & metachr Lung: KRAS c.35G>A	None,38,102,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>T,"4	83	M	R (cecum)	10,0 cm	T3	MLH-1/PMS2	KRAS c.35G>T (p.G12V)	Reg LN WT	Multiple CBC, RCC",42,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"5	79	M	L (desc)	3,5 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Synchr lung WT	Prostate Cancer",44,40,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>T,R (transv)	Biopsy	NA	NA	KRAS c.35G>T (p.G12V),49,30,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"...les, 77%). Three mutations were noted: 3 cases of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35...",57,286,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>A,"...les, 77%). Three mutations were noted: 3 cases of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35...",57,286,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>T,"... of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>T (p.G12V) in KRAS codon 12, and 1 case of c...",57,332,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.34G>A,"... c.35G>T (p.G12V) in KRAS codon 12, and 1 case of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.3...",57,381,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.38G>A,"...of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G13D]) was observed in 1 patient, and a...",57,428,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.38G>A,"...of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G13D]) was observed in 1 patient, and a...",57,428,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.34G>A,"... a mutation in KRAS codon 12 c.35G>A (p.G12D) and c.34G>A (p.G12S), respectively. Of the 2 cases tha...",59,442,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.34G>A,"... a mutation in KRAS codon 12 c.35G>A (p.G12D) and c.34G>A (p.G12S), respectively. Of the 2 cases tha...",59,442,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.35G>T,"...had WT RAS in both lesions, and patient 7 had the c.35G>T KRAS mutation in both lesions",59,640,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.34G>A,...oth the LN and liver metastases had the same KRAS c.34G>A (p.G12S) mutation. See Table 1 for RAS mut...,61,511,Oncoscience_2015_Feb_9_2(2)_125-130.txt
c.395G>A,The wild-type human IDH1 and IDH1-R132H mutant (c.395G>A) were generously provided by Dr. Kun-Lian...,148,49,Oncotarget_2014_Aug_16_5(17)_7342-7356.txt
c.395G>A,The wild-type human IDH1 and IDH1-R132H mutant (c.395G>A) were generously provided by Dr. Kun-Lian...,148,49,Oncotarget_2014_Aug_16_5(17)_7342-7356.txt
c.4335A>G,"... three SNPs (c.2211A>G (5/31), c.3522A>T (14/31), c.4335A>G (4/31)) (Figure 4, Supplement table 2), ...",86,525,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.4335A>G,"... three SNPs (c.2211A>G (5/31), c.3522A>T (14/31), c.4335A>G (4/31)) (Figure 4, Supplement table 2), ...",86,525,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.4335A>G,"...tic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectively",89,87,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.4335A>G,"...tic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectively",89,87,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
c.501A>G,"...encing of exon 7 in DJ-1 including the Ala167Ala (c.501A>G, rs71653621) mutation using a reverse seq...",40,97,Open_Neurol_J_2011_Mar_22_5_8-11.txt
c.550C>T,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,1,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.1250A>G,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,12,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.1250A>G,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,12,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.550C>T,"...orresponding to a severe mutation (c.1361 A>G and c.550C>T, respectively), the other being a mild mu...",182,189,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.571G>A,"..., respectively), the other being a mild mutation (c.571G>A) [18]. In patients 4 and 5, only one hete...",182,247,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.571G>A,"..., respectively), the other being a mild mutation (c.571G>A) [18]. In patients 4 and 5, only one hete...",182,247,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.571G>A,"...3 carry two heterozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.136...",209,74,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.571G>A,"...3 carry two heterozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.136...",209,74,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.1361A>G,"...ate (c.571G>A or c.526G>A), the other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a...",209,119,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.648+1G>A,"...>A), the other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a common situation in no...",209,142,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
c.622-2A>T,...e found a novel heterozygous splice site mutation c.622-2A>T (g.30100162 T>A) in two patients (Figur...,75,199,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.622-2A>T,... of TBX6 in two MA patients. Splice site mutation c.622-2A>T (g.30100162 T>A) in two MA patients com...,77,86,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.622-2A>T,...of exon 5 or the use of cryptic splice sites. The c.622-2A>T mutation resides within the highly cons...,79,551,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.118+6C>T,c.118+6C>T	 	 	CT: 5 (4.5%)	CT: 13 (6.5%),90,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.622-2A>T,c.622-2A>T	 	 	AT: 2 (1.8%)	AT: 0 (0%),99,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
c.3163A>G,"...se model of NPC disease, Npc1 (nmf164) carrying a c.3163A>G mutation that results in an aspartate to...",28,684,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.3182T>C,...PC1 gene. The two affected siblings presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype...,44,335,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.3182T>C,"...ected siblings presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype, while the third unr...",44,356,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.3182T>C,"...ected siblings presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype, while the third unr...",44,356,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.2795+1G>C,...ile the third unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This st...,44,439,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.3493G>A,...d unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This study was appr...,44,451,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
c.575G>A,"... novel mutations (c.468_469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G)...",12,930,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G) were identified",12,954,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.752-2A>G,"..._800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G) were identified",12,969,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...rmal	Low	37% of LLR	Mb, pons	c.312_320del10insAT, c.751+5G>A",49,138,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,...id	NA	UD	CT brain: GP and cerebellar atrophy	Homo c.516-2A>G,55,195,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,"...PW, ataxia, RF	4	24 m	T1FP	Low	50% of LLR	NA	Homo c.516-2A>G",59,92,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.574C>T,"...ter involvement of cerebellum, Mb, Pu	c.240+1G>T, c.574C>T",73,216,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.324-11T>G,"... pons, Scp, Dt, Me, WM tracts of spinal cord	Homo c.324-11T>G",75,209,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.240+1G>T,"...WM in cerebellar hemispheres	c.312_320del10insAT, c.240+1G>T",78,199,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.240+1G>T,"...educed COX	Normal	UD	CT brain: BG	c.845_846delCT, c.240+1G>T",79,100,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.516-2A>G,...00delCT mutation or the c.324-11T>G mutation. The c.516-2A>G mutation segregated in two different In...,160,943,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.324-11T>G,...ecified mixed Caucasian Asian parenthood [7]. The c.324-11T>G genotype was observed in 4 individuals...,160,1128,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.324-11T>G,...ecified mixed Caucasian Asian parenthood [7]. The c.324-11T>G genotype was observed in 4 individuals...,160,1128,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.575G>A,"...ogenic mutations (c.468_469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G...",163,146,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.575G>A,"...ogenic mutations (c.468_469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G...",163,146,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,170,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.752-2A>G,"...800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,186,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"... birth and died at 2 years. The novel splice site c.751+5G>A mutation, generating an aberrant transc...",167,215,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"... birth and died at 2 years. The novel splice site c.751+5G>A mutation, generating an aberrant transc...",167,215,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...was a compound heterozygote (c.312_321del10insAT, c.751+5G>A). She had an atypical milder clinical c...",167,441,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.751+5G>A,"...was a compound heterozygote (c.312_321del10insAT, c.751+5G>A). She had an atypical milder clinical c...",167,441,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.752-2A>G,...cle and play the violin. The splice site mutation c.752-2A>G was found in a patient (case 37) of Aus...,167,1238,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
c.985A>G,1	c.985A>G	c.199T>C	2.85	2.3	Normal	39	36	-	-	-	-	-	...,56,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"2	c.985A>G	c.199T>C	0.67	2.7	DC, HG	44	29	58	-	-	-	-...",57,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.199T>C,"2	c.985A>G	c.199T>C	0.67	2.7	DC, HG	44	29	58	-	-	-	-	-	-	-	-	...",57,12,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.199T>C,"3	c.985A>G	c.199T>C	0.35	2.3	Trace N-HG, SG, DC	48	43	48	-	-	...",58,12,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,4	c.985A>G	c.199T>C	0.74	2.8	Trace HG	36	34	44	10	18...,59,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.473A>G,5	c.985A>G	c.473A>G	0.39	2.3	Normal	38	25	39	6	18.5	2.8	0.3	0...,60,12,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.473A>G,5	c.985A>G	c.473A>G	0.39	2.3	Normal	38	25	39	6	18.5	2.8	0.3	0...,60,12,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.734C>T,"6	c.985A>G	c.734C>T	1.41	3.0	Trace DC, 5-OH-C, HG, SG	41	17	1...",61,12,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,8	c.985A>G	Not found	0.70	1.3	Normal	28	-	-	25	18.5	...,63,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,9	c.985A>G	Not found	0.50	0.8	Normal	15	11	86	27	16....,64,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,9	c.985A>G	Not found	0.50	0.8	Normal	15	11	86	27	16....,64,3,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"...assical ACADM genotypes, and from carriers of the c.985A>G mutation (i.e. siblings or parents of pat...",73,760,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"...assical ACADM genotypes, and from carriers of the c.985A>G mutation (i.e. siblings or parents of pat...",73,760,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"...assical ACADM genotypes, and from carriers of the c.985A>G mutation (i.e. siblings or parents of pat...",73,760,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"...assical ACADM genotypes, and from carriers of the c.985A>G mutation (i.e. siblings or parents of pat...",73,760,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.985A>G,"...ery low birth weight [17], heterozygosity for the c.985A>G mutation [18], and the time at which NBS ...",106,782,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
c.571G>A,"...ntified a homozygous DHCR24 mutation (NM_014762.3:c.571G>A; p.E191K), a recognized cause of desmoste...",26,111,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
c.571G>A,...o sisters with the biallelic mutation NM_014762.3:c.571G>A in DHCR24. The recurrence of this mutatio...,31,64,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
c.571G>A,...o sisters with the biallelic mutation NM_014762.3:c.571G>A in DHCR24. The recurrence of this mutatio...,31,64,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
c.571G>A,...o sisters with the biallelic mutation NM_014762.3:c.571G>A in DHCR24. The recurrence of this mutatio...,31,64,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
c.628C>T,"2	CHILD syndrome	NSDHL: c.628C>T, p.Q210X (heterozygous)	Yes",37,25,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
c.628C>T,"2	CHILD syndrome	NSDHL: c.628C>T, p.Q210X (heterozygous)	Yes",37,25,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
c.262C>T,"3	CHILD syndrome	NSDHL: c.262C>T, p.R88X (heterozygous)	Yes",40,25,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
c.262C>T,"3	CHILD syndrome	NSDHL: c.262C>T, p.R88X (heterozygous)	Yes",40,25,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
c.1516C>G,...alized to the chromosome 12 candidate region: The c.1516C>G (p.Arg506Gly) variant in SLC11A2 has bee...,115,232,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
c.1738A>C,"...118420, with an MAF of 0.04%. A variant in DIDO1 (c.1738A>C; p.Thr580Pro), also affects a non-conser...",117,299,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
c.1738A>C,"...118420, with an MAF of 0.04%. A variant in DIDO1 (c.1738A>C; p.Thr580Pro), also affects a non-conser...",117,299,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
c.287C>G,"A nonsense mutation, c.287C>G (p.Ser96*), was found in both patients in...",119,22,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
c.289C>T,"2		34,3	3		c.289C>T heterozygous de novo (both parents wildty...",36,12,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.961G>T,"4		31,8	2	0	c.961G>T heterozygous	p.Glu321",40,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.961G>T,"4		31,8	2	0	c.961G>T heterozygous	p.Glu321",40,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.2565+2T>G,"12		30,0	2	1	c.2565+2T>G heterozygous	IVS17+2T>G ds	Splice site...",54,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.2565+2T>G,"12		30,0	2	1	c.2565+2T>G heterozygous	IVS17+2T>G ds	Splice site...",54,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.4576G>T,"21		18,0			c.4576G>T heterozygous	p.Gly1526",68,12,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.4576G>T,"21		18,0			c.4576G>T heterozygous	p.Gly1526",68,12,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.5686G>A,"30,7	1	0	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splic...",76,11,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.5686G>A,"62,2	2	0	c.5686G>A mosaicism	p.Gly1896Arg/Splice	Splicesite...",80,11,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.6898C>T,"26		17,8			c.6898C>T heterozygous	p.Gln2300",83,12,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.6908-2A>G,"27		24,9	1	2	c.6908-2A>G heterozygous	IVS42-2A>G	Splice site mu...",85,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.6908-2A>G,"27		24,9	1	2	c.6908-2A>G heterozygous	IVS42-2A>G	Splice site mu...",85,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.7255C>T,"34		1,0	4	2	c.7255C>T heterozygous	p.Arg2419",97,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.7714G>A,"36		7,9	4	1	c.7714G>A heterozygous; unclassified variant	p.Val...",101,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
c.986G>A,(NM_001605.2)	3	c.986G>A	p.Arg329His,141,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.2981C>T,(NM_000052.6)	1	c.2981C>T	p.Thr994Ile,144,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.2981C>T,(NM_000052.6)	1	c.2981C>T	p.Thr994Ile,144,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1231G>A,(NM_000399.3)	1	c.1231G>A	p.Asp411Asn,159,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1231G>A,(NM_000399.3)	1	c.1231G>A	p.Asp411Asn,159,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1117C>T,(NM_006329.3)	1	c.1117C>T	p.Arg373Cys,162,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.88A>T,(NM_000166.5)	1	c.88A>T	p.Ile30Phe,174,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.622G>A,(NM_000166.5)	1	c.622G>A	p.Glu208Lys,180,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.212T>C,(NM_000166.5)	1	c.212T>C	p.Ile71Thr,183,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.233T>C,(NM_022489.3)	1	c.233T>C	p.Leu78Pro,201,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.334G>A,(NM_001136472.1)	1	c.334G>A	p.Gly112Ser,207,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.334G>A,(NM_001136472.1)	1	c.334G>A	p.Gly112Ser,207,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.701T>A,(NM_014874.3)	1	c.701T>A	p.Met234Lys,219,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.839G>A,(NM_014874.3)	1	c.839G>A	p.Arg280His,222,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.839G>A,(NM_014874.3)	1	c.839G>A	p.Arg280His,222,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1081C>T,(NM_014874.3)	1	c.1081C>T	p.His361Tyr,228,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1574A>G,(NM_014874.3)	1	c.1574A>G	p.Asn525Ser,234,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.134T>A,(NM_030962.3)	1	c.[134T>A];[c.134T>A]	p..[Ile45Asn];[Ile45Asn],255,30,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.279G>A,(NM_024577.3)	1	c.[2860C>T];[c.279G>A]	p.[Arg954*];[Lys93Lys],261,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.2812C>T,(NM_024577.3)	1	c.[2860C>T];[c.2812C>T]	p.[Arg954*];[His938Tyr],267,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.986G>A,AARS (NM_001605.2): c.986G>,289,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.986G>A,AARS (NM_001605.2): c.986G>,289,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.3190A>G,(NM_002224.3)	c.3190A>G	p.Met1064Val	SIFT:,356,16,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.1298C>T,(NM_138361.5)	c.1298C>T	p.Ser433Leu	SIFT:,361,16,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.5825T>C,(NM_015046.5)	c.5825T>C	p.Ile1942Thr	SIFT:,371,16,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.5825T>C,(NM_015046.5)	c.5825T>C	p.Ile1942Thr	SIFT:,371,16,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
c.*229C>T,...9737-7ResearchTopoisomerase IIβ Binding Protein 1 c.*229C>T (rs115160714) Gene Polymorphism and Endo...,3,192,Pathol_Oncol_Res_2014_Dec_18_20(3)_597-602.txt
c.*229C>T,...eziańska E  Krześlak A    Association between the c.*229C>T polymorphism of the topoisomerase IIβ bi...,186,66,Pathol_Oncol_Res_2014_Dec_18_20(3)_597-602.txt
c.*229C>T,...eziańska E  Krześlak A    Association between the c.*229C>T polymorphism of the topoisomerase IIβ bi...,186,66,Pathol_Oncol_Res_2014_Dec_18_20(3)_597-602.txt
c.446T>G,"... case of an exon4 heterozygous nucleotide change, c.446T>G, leading to the missense amino acid subst...",15,254,Pediatr_Rheumatol_Online_J_2015_Sep_28_13(Suppl_1)_P57.txt
c.446T>G,"... case of an exon4 heterozygous nucleotide change, c.446T>G, leading to the missense amino acid subst...",15,254,Pediatr_Rheumatol_Online_J_2015_Sep_28_13(Suppl_1)_P57.txt
c.516G>T,"...altham, MA, USA) were used to genotype the CYP2B6 c.516G>T (assay ID C_7817765_60), c.64C>T (assay I...",41,105,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
c.64C>T,"...type the CYP2B6 c.516G>T (assay ID C_7817765_60), c.64C>T (assay ID C_2818162_20), c.499C>G (assay I...",41,139,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
c.1459C>T,"...C_2752377_10), c.1375A>G (assay ID C_2741754_10), c.1459C>T (assay ID C_30634242_40), g.3003T>C (ass...",41,241,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
c.1459C>T,"...C_2752377_10), c.1375A>G (assay ID C_2741754_10), c.1459C>T (assay ID C_30634242_40), g.3003T>C (ass...",41,241,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
c.388T>C,"... the single‐nucleotide polymorphisms, NM_000041.2:c.388T>C (p.Cys130Arg; rs429358) and c.526C>T (p.A...",170,737,Physiol_Rep_2016_Apr_25_4(8)_e12733.txt
c.526C>T,... NM_000041.2:c.388T>C (p.Cys130Arg; rs429358) and c.526C>T (p.Arg176Cys; rs7414) as follows: at nucl...,170,774,Physiol_Rep_2016_Apr_25_4(8)_e12733.txt
c.58+181G>A,"...e identified a noncoding nucleotide substitution, c.58+181G>A, in the first intron of the Tw allele ...",5,1352,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
c.58+181G>A,"...allele of Zeb1 (Zeb1Tw). A knockin mouse model of c.58+181G>A recapitulated the Tw phenotype, wherea...",5,1445,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
c.58+181G>A,...ritical region. A single nucleotide substitution (c.58+181G>A) was detected in the Tw allele in the ...,61,225,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
c.58+181G>A,...ritical region. A single nucleotide substitution (c.58+181G>A) was detected in the Tw allele in the ...,61,225,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
c.58+181G>A,...nd Zeb1os cDNA transcripts confirmed no effect of c.58+181G>A on splicing,67,1352,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
c.58+181G>A,c.58+181G>A disrupts a predicted site for Myb prot...,70,1,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
c.2278C>T,"...impact on splicing (Table S1). Significantly, the c.2278C>T mutational change was observed as a hete...",157,769,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...impact on splicing (Table S1). Significantly, the c.2278C>T mutational change was observed as a hete...",157,769,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...the WT (c.2278C) (P1 and P3C) versus the mutated (c.2278C>T) (P2 and P3C) alleles. The WT PCR produc...,162,921,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...eles. The WT PCR product is shown in blue and the c.2278C>T PCR product in red. The exon 12 mutated ...,162,998,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...ent probes were used to distinguish the WT versus c.2278C>T allele (probe1 and probe2, respectively)...",162,2237,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...tive amplification of the WT and mutant products (c.2278C>T mutant as well as the mis-spliced produc...,164,136,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...tive amplification of the WT and mutant products (c.2278C>T mutant as well as the mis-spliced produc...,164,136,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...tive amplification of the WT and mutant products (c.2278C>T mutant as well as the mis-spliced produc...,164,136,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...elled ‘mother’ in Figure 2C), suggesting that the c.2278C>T ATRIP mRNA is not subject to nonsense me...",164,1088,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...ion levels of the wild type (c.2278C) and mutant (c.2278C>T) alleles in the mother (Figure 2C, compa...",166,875,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...P6C would be equally derived from the c.2278C and c.2278C>T alleles, which have, therefore, been dep...",166,1093,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...ther columns in Figure 2D). Similarly, the mutant c.2278C>T allele is likely to be expressed at an e...",166,1255,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"... left hand panel in Figure 2D). Assuming that the c.2278C>T allele is fully inactivated (see below),...",166,1623,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...l (probe 1) allele. We confirmed detection of the c.2278C>T allele exclusively in the patient and mo...,168,555,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,It is likely that ATRIP c.2278C>T causes an impacting mutational change si...,173,25,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...the low ATRIP protein level in CV1720 cells). The c.2278C>T mutational change was introduced into AT...,173,598,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...have low ATR and ATRIP expression. Significantly, c.2278C>T ATRIP cDNA was unable to rescue ATR–SS c...",173,1443,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...have low ATR and ATRIP expression. Significantly, c.2278C>T ATRIP cDNA was unable to rescue ATR–SS c...",173,1443,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...ble to rescue ATR–SS cells. Finally expression of c.2278C>T ATRIP cDNA in WT cells did not affect G2...,173,1521,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...760* ATRIP can interact with ATR, HA-tagged WT or c.2278C>T (ATRIP R760*) cDNA was co-expressed with...",180,224,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...ent after HA-R760* ATRIP expression (derived from c.2278C>T ATRIP cDNA) was substantially lower than...,180,563,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.3477G>T,...ression. Sequencing of ATR cDNA revealed the same c.3477G>T mutational change in both patients (Figu...,184,810,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.3477G>T,...ression. Sequencing of ATR cDNA revealed the same c.3477G>T mutational change in both patients (Figu...,184,810,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.6897+464C>G,"The second ATR mutation identified was c.6897+464C>G;p.Val2300Gly fs75*, which, surprisin...",189,40,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.6897+464C>G,"The second ATR mutation identified was c.6897+464C>G;p.Val2300Gly fs75*, which, surprisin...",189,40,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.6897+464C>G,"The second ATR mutation identified was c.6897+464C>G;p.Val2300Gly fs75*, which, surprisin...",189,40,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.6897+464C>G,"The second ATR mutation identified was c.6897+464C>G;p.Val2300Gly fs75*, which, surprisin...",189,40,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,...robes that specifically recognize the c.2278C and c.2278C>T alleles were used for the assay. qPCR re...,234,482,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.2278C>T,"...unaffected mother, CV1780, are heterozygous for a c.2278C>T mutational change in exon12 of ATRIP. Th...",263,204,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.3477G>T,...observed in ATR in patients 27-4BI and 19-8BI. A) c.3477G>T mutational change in patients 27-4BI and...,275,81,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
c.3034T>C,"... and was found to carry a de novo USP9X mutation (c.3034T>C, p.Ser1012Pro) at a highly conserved res...",131,275,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
c.341G>A,...M represents the allele change from the wild type c.341G>A for RETR114H; T represents the high risk ...,57,472,PLoS_One_2010_Jun_2_5(6)_e10918.txt
c.52-47A>G,"...like males. However, two novel intronic variants, c.52-47A>G and c.105-179G>T, were identified in FM...",66,148,PLoS_One_2010_Mar_5_5(3)_e9476.txt
c.105-179G>T,Intron 2	c.105-179G>T	0.01	1.06	1/51,71,10,PLoS_One_2010_Mar_5_5(3)_e9476.txt
c.371+8C>T,"MVK (N = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(...",110,29,PLoS_One_2010_Nov_23_5(11)_e14096.txt
c.885+24G>A,"...D(1)(2),c.632−18A>G (1)(2), c.769-7_769-6dupT(1)*,c.885+24G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I...",110,127,PLoS_One_2010_Nov_23_5(11)_e14096.txt
c.3005+25C>T,"...p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1...",111,191,PLoS_One_2010_Nov_23_5(11)_e14096.txt
c.1043C>T,...ntal retardation); 2) One patient with a p.T348M (c.1043C>T) mutation in NLRP3 in whom we performed ...,146,344,PLoS_One_2010_Nov_23_5(11)_e14096.txt
c.820C>T,...and grandfather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three i...,20,211,PLoS_One_2011_Dec_14_6(12)_e29248.txt
c.820C>T,...and grandfather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three i...,20,211,PLoS_One_2011_Dec_14_6(12)_e29248.txt
c.820C>T,...and grandfather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three i...,20,211,PLoS_One_2011_Dec_14_6(12)_e29248.txt
c.2832A>G,"... more relaxed threshold of P = 0.05. The SNP CAST:c.2832A>G, which is not part of the Bovine SNP50 a...",30,843,PLoS_One_2011_Dec_28_6(12)_e29601.txt
c.3293A>G,...a homozygous A-to-G nucleotide change in exon 22 (c.3293A>G) (Figure 1A). The mutation caused a glut...,21,153,PLoS_One_2011_Jun_9_6(6)_e20854.txt
c.3293A>G,A. Mutation c.3293A>G (p.G1069R) in homozygous state in our pr...,24,13,PLoS_One_2011_Jun_9_6(6)_e20854.txt
c.5210+5G>C,...the results are shown in Table S3. One variation (c.5210+5G>C) was predicted as a loss of strength o...,70,356,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5210+5G>C,...d supported the prediction results. The variation c.5210+5G>C caused exon skipping as a result of sp...,72,172,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5405-7G>A,...s a result of splice donor site deterioration and c.5405-7G>A introduced a 5-bp intronic sequence by...,72,256,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.5405-7G>A,"...is of splice site variation, c.5405-7G>A. For the c.5405-7G>A variation, exon 26 of CHD7 was introdu...",176,82,PLoS_One_2011_Sep_13_6(9)_e24511.txt
c.786G>C,"...mous BACE1 polymorphism at codon 262 (NM_012104.3:c.786G>C, rs638405) with sporadic CJD (sCJD)",18,391,PLoS_One_2012_Aug_30_7(8)_e43926.txt
c.786G>C,"...mous BACE1 polymorphism at codon 262 (NM_012104.3:c.786G>C, rs638405) with sporadic CJD (sCJD)",18,391,PLoS_One_2012_Aug_30_7(8)_e43926.txt
c.188-31G>A,...ntified the first heterozygous intronic mutation (c.188-31G>A) in the INS gene causing neonatal diab...,32,84,PLoS_One_2012_Jan_3_7(1)_e29205.txt
c.325C>T,"A homozygous c.325C>T transition, introducing a premature stop ...",37,14,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.1468C>T,"... unaffected sisters did not carry the mutation. A c.1468C>T transition, resulting in R490X in exon 3...",37,247,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.1468C>T,"... unaffected sisters did not carry the mutation. A c.1468C>T transition, resulting in R490X in exon 3...",37,247,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.1068G>A,"...y proband from family #237, it was accompanied by c.1068G>A, resulting in W356X in exon 3. In two af...",37,428,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.325C>T,"...able 4). As expected, two alleles carrying Q109X (c.325C>T) in homozygous siblings #337 and #340 had...",72,316,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.325C>T,"...able 4). As expected, two alleles carrying Q109X (c.325C>T) in homozygous siblings #337 and #340 had...",72,316,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.1468C>T,... backgrounds. Since the mutation results from the c.1468C>T transition at a fast-mutating CpG dinucl...,157,729,PLoS_One_2012_Mar_20_7(3)_e33667.txt
c.1510+118T>C,"rs3771280, c.1510+118T>C	TT vs CC/CT	1.99(0.47−8.39)	0.350	0....",59,12,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1510+118T>C,"rs3771280, c.1510+118T>C	TT vs CC/CT	1.99(0.47−8.39)	0.350	0....",59,12,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1510+118T>C,"rs3771280, c.1510+118T>C	TT vs CC/CT	1.99(0.47−8.39)	0.350	0....",59,12,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1341-12568A>G,"rs1428030, c.1341-12568A>G	GG vs AA/AG	0.90(0.48−1.69)	0.747	...",63,12,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1341-12568A>G,"rs1428030, c.1341-12568A>G	GG vs AA/AG	0.90(0.48−1.69)	0.747	...",63,12,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1341-12568A>G,"rs1428030, c.1341-12568A>G	GG vs AA/AG	0.90(0.48−1.69)	0.747	...",63,12,PLoS_One_2012_May_18_7(5)_e36962.txt
c.699+3331G>A,"rs13404927, c.699+3331G>A	AA vs GG/GA	0.56(0.23−1.38)	0.210	0....",71,13,PLoS_One_2012_May_18_7(5)_e36962.txt
c.699+3331G>A,"rs13404927, c.699+3331G>A	AA vs GG/GA	0.56(0.23−1.38)	0.210	0....",71,13,PLoS_One_2012_May_18_7(5)_e36962.txt
c.546-191T>C,"rs13320360, c.546-191T>C	CC vs TT/CT	0.54(0.17−1.73)	0.299	7.1...",73,13,PLoS_One_2012_May_18_7(5)_e36962.txt
c.380A>G,"... three SNPs were selected (rs17217772, Asn127Ser, c.380A>G; rs10188090, c.2635-765G>A; and rs3771280...",204,888,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1341-12568A>G,"... MSH3 (rs26279, Ala1045Thr, c.3133G>A; rs1428030, c.1341-12568A>G; and rs1805355, Pro231Pro, c.693G>...",204,1014,PLoS_One_2012_May_18_7(5)_e36962.txt
c.699+3331G>A,"...n PMS1 (rs5742938, c. −21+639G>A; and rs13404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191...",204,1123,PLoS_One_2012_May_18_7(5)_e36962.txt
c.699+3331G>A,"...n PMS1 (rs5742938, c. −21+639G>A; and rs13404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191...",204,1123,PLoS_One_2012_May_18_7(5)_e36962.txt
c.699+3331G>A,"...n PMS1 (rs5742938, c. −21+639G>A; and rs13404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191...",204,1123,PLoS_One_2012_May_18_7(5)_e36962.txt
c.546-191T>C,"...3404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191T>C), and one in MLH3 (rs28756991, Arg797...",204,1164,PLoS_One_2012_May_18_7(5)_e36962.txt
c.546-191T>C,"...3404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191T>C), and one in MLH3 (rs28756991, Arg797...",204,1164,PLoS_One_2012_May_18_7(5)_e36962.txt
c.546-191T>C,"...3404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191T>C), and one in MLH3 (rs28756991, Arg797...",204,1164,PLoS_One_2012_May_18_7(5)_e36962.txt
c.546-191T>C,"...3404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191T>C), and one in MLH3 (rs28756991, Arg797...",204,1164,PLoS_One_2012_May_18_7(5)_e36962.txt
c.1091-2A>G,".... Compound heterozygous c.802-8_810del17insGC and c.1091-2A>G mutations of the CYP4V2 gene, known as...",5,1451,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"Mutation(s)	c.802-8_810del17insGC	c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.8...",76,35,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"Mutation(s)	c.802-8_810del17insGC	c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.8...",76,35,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.8...",76,140,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC	c.1091-2A>G	c.80...",76,175,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC	c.1091-2A>G	c.80...",76,175,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC	c.1091-2A>G	c.80...",76,175,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"..._810del17insGC, c.1091-2A>G	c.802-8_810del17insGC	c.1091-2A>G	c.802-8_810del17insGC	–	–	c.802-8_810d...",76,209,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,...ase-associationMutation	–	–	c.802-8_810del17insGC	c.1091-2A>G,90,55,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...02-8_810del17insGC was carried by the mother II2. c.1091-2A>G mutation was carried by II3, the broth...",96,179,PLoS_One_2012_May_31_7(5)_e33673.txt
c.802-7C>T,...ents in the fourth generation. Intronic variation c.802-7C>T is non-pathogenic,96,379,PLoS_One_2012_May_31_7(5)_e33673.txt
c.802-7C>T,...ents in the fourth generation. Intronic variation c.802-7C>T is non-pathogenic,96,379,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...tified, since only the four patients carried both c.1091-2A>G and c.802-8_810del17insGC in CYP4V2",109,975,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...tified, since only the four patients carried both c.1091-2A>G and c.802-8_810del17insGC in CYP4V2",109,975,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"...tified, since only the four patients carried both c.1091-2A>G and c.802-8_810del17insGC in CYP4V2",109,975,PLoS_One_2012_May_31_7(5)_e33673.txt
c.1091-2A>G,"Among the mutations identified in this pedigree, c.1091-2A>G of CYP4V2 was predicted to disrupt the...",111,50,PLoS_One_2012_May_31_7(5)_e33673.txt
c.4022T>C,"... by the following dysferlin mutations: homozygous c.4022T>C (patient 1), compound heterozygous c.855...",88,529,PLoS_One_2012_Nov_20_7(11)_e49603.txt
c.895G>A,"...>C (patient 1), compound heterozygous c.855+1delG/c.895G>A (patient 2)",88,586,PLoS_One_2012_Nov_20_7(11)_e49603.txt
c.4022T>C,...delG and c.895G>A; p.G299R; homozygosity for DYSF c.4022T>C; p.L1341P. Muscle specimens were placed ...,91,495,PLoS_One_2012_Nov_20_7(11)_e49603.txt
c.436A>G,...e identification of PD-specific SLC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting...,19,137,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.436A>G,...e identification of PD-specific SLC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting...,19,137,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1440A>G,... SLC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) i...,19,168,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1440A>G,... SLC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) i...,19,168,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.552+50G>A,...g in p.K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) in the Chinese population [24] and of...,19,204,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...1A1 carrying the amino acid substitution p.A350V (c.1049C>T) in one PD patient of Caucasian origin [...,19,324,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...) with an N-terminal HA-strep tag. Point mutation c.1049C>T (p.A350V) was introduced by PCR-site-dir...,27,336,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...) with an N-terminal HA-strep tag. Point mutation c.1049C>T (p.A350V) was introduced by PCR-site-dir...,27,336,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...) Quantitative real time PCR analysis of SLC41A1-(c.1049C>T) expression in -tet and +tet cells. The ...,75,364,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,... significantly higher amount of ∼14.25 fold (+tet c.1049C>T ddCt mean 144.9±34.62/-tet c.1049C>T ddC...,76,335,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,"...dCt mean 10.17±0.79; P = 1.84e-08) of the SLC41A1-c.1049C>T transcript was detected, when compared w...",76,433,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...know whether the over-expression of wt SLC41A1 or c.1049C>T mutant could influence the expression of...,76,707,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.1049C>T,...know whether the over-expression of wt SLC41A1 or c.1049C>T mutant could influence the expression of...,76,707,PLoS_One_2013_Aug_15_8(8)_e71096.txt
c.-14C>T,...ining candidate gene for IO type V. The mutation (c.-14C>T) was predicted to generate an in-frame tr...,69,740,PLoS_One_2013_Aug_20_8(8)_e72337.txt
c.-14C>T,"...nger sequencing, we identified the same mutation (c.-14C>T) in proband 4 (Figure 3). Furthermore, it...",69,958,PLoS_One_2013_Aug_20_8(8)_e72337.txt
c.-14C>T,...g of IFITM5 identified the identical heterozygous c.-14C>T mutation (black arrow) in all the affecte...,71,109,PLoS_One_2013_Aug_20_8(8)_e72337.txt
c.-14C>T,...ic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients . J Med Genet 50...,121,171,PLoS_One_2013_Aug_20_8(8)_e72337.txt
c.-14C>T,...ic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients . J Med Genet 50...,121,171,PLoS_One_2013_Aug_20_8(8)_e72337.txt
c.-14C>T,...ic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients . J Med Genet 50...,121,171,PLoS_One_2013_Aug_20_8(8)_e72337.txt
c.6107C>A,"...t (III-6). We found nonsense mutation in CACNA1A (c.6107C>A, exon 40, NM_001127221.1) in all three p...",56,384,PLoS_One_2013_Feb_18_8(2)_e56362.txt
c.6107C>A,"...nfirmation of a heterozygous mutation in CACNA1A (c.6107C>A, NM_001127221.1, p.Tyr1957Ter, NP_001120...",59,346,PLoS_One_2013_Feb_18_8(2)_e56362.txt
c.6107C>A,"...nfirmation of a heterozygous mutation in CACNA1A (c.6107C>A, NM_001127221.1, p.Tyr1957Ter, NP_001120...",59,346,PLoS_One_2013_Feb_18_8(2)_e56362.txt
c.441+2T>G,IVS7+2T>G	c.441+2T>G	D	skipping of 62 bp at the3′-end of exo...,61,11,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.547+2T>A,IVS8+2T>Ac	c.547+2T>A	D	skipping of exon 8	r.[442_547del]	mon...,62,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+1G>T,IVS16+1G>T	c.4986+1G>T	D	retention of 65 bp at the5′-end of i...,63,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.5332+1G>A,IVS21+1G>A	c.5332+1G>A	D	skipping of exon 21	r.[5278_5332del]...,66,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.475+1G>A,IVS5+1G>A	c.475+1G>A	D	skipping of exon 5	r.[426_475del]	mon...,68,11,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.475+1G>A,IVS5+1G>A	c.475+1G>A	D	skipping of exon 5	r.[426_475del]	mon...,68,11,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,331G>Ac	c.212G>A	D	up-regulation of Δexon5q isoform	r.[191...,92,9,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4484G>T,4603G>Te	c.4484G>T	D	skipping of exon 14	r.[4358_4484del]	m...,97,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4484G>T,4603G>Te	c.4484G>T	D	skipping of exon 14	r.[4358_4484del]	m...,97,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+5G>A,IVS16+5G>A	c.4986+5G>A	D	retention of 65 bp atthe 5′-end of i...,98,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.5333A>G,5452A>Gf	c.5333A>G	A	none	r.[5333a>g]	bi-allelic	aa change ...,99,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.5333A>G,5452A>Gf	c.5333A>G	A	none	r.[5333a>g]	bi-allelic	aa change ...,99,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.5333A>G,5452A>Gf	c.5333A>G	A	none	r.[5333a>g]	bi-allelic	aa change ...,99,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.631G>A,859G>Ag*	c.631G>A	D	skipping of exon 7	r.[517_631del]	mono-...,101,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9117G>A,9345G>Aj	c.9117G>A	D	skipping of exon 23	r.[8954_9117del]	m...,104,10,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.547+2T>A,"...at had been already analyzed in previous studies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, ...",125,98,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+1G>T,"...45] and 6 not previously characterized (441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.5332+1G>...",125,267,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.475+1G>A,"....4987−1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2...",125,331,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.475+1G>A,"....4987−1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2...",125,331,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.475+1G>A,"...8, 17 and 21, respectively (Fig. 1A–C), and BRCA2 c.475+1G>A resulted in the loss of exon 5 (Fig. 1D...",125,499,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.475+1G>A,"...8, 17 and 21, respectively (Fig. 1A–C), and BRCA2 c.475+1G>A resulted in the loss of exon 5 (Fig. 1D...",125,499,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.441+2T>G,...al loss of exon 7 (62 bp at the 3′-end) for BRCA1 c.441+2T>G (Fig. 1E) and partial retention of intr...,125,672,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+1G>T,...tion of intron 16 (65 bp at the 5′-end) for BRCA1 c.4986+1G>T (Fig. 1F). BRCA2 c.476−2A>G was found ...,125,760,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+1G>T,...tion of intron 16 (65 bp at the 5′-end) for BRCA1 c.4986+1G>T (Fig. 1F). BRCA2 c.476−2A>G was found ...,125,760,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+1G>T,...tion of intron 16 (65 bp at the 5′-end) for BRCA1 c.4986+1G>T (Fig. 1F). BRCA2 c.476−2A>G was found ...,125,760,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"...ons of group B included 6 already analyzed (BRCA1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c....",130,70,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"...ons of group B included 6 already analyzed (BRCA1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c....",130,70,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.631G>A,"...1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c.9117G>A) [11], [18], ...",130,118,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.631G>A,"...1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c.9117G>A) [11], [18], ...",130,118,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.8754+3G>C,"..., c.213−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c.9117G>A) [11], [18], [19], [21]...",130,128,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4484G>T,"...ions caused the skipping of an entire exon: BRCA1 c.4484G>T (exon 14) (Fig. 2A), BRCA2 c.631G>A (exo...",130,335,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9117G>A,"... 2A), BRCA2 c.631G>A (exon 7) (Fig. 2B) and BRCA2 c.9117G>A (exon 23) (Fig. 2C). Conversely, partial...",130,410,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+5G>A,"...59 bp at the 3′-end of intron 5) (Fig. 2D), BRCA1 c.4986+5G>A (65 bp at the 5′-end of intron 16) (Fi...",130,615,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.8754+3G>C,"...the 5′-end of intron 16) (Fig. 2E), and for BRCA2 c.8754+3G>C (46 bp at the 5′-end of intron 21) (Fi...",130,687,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"... 2F). Finally, the BRCA1 c.134+3_134+6delAAGT and c.212G>A variants were associated with a relevant ...",130,789,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.1114C>A,...ance of the constitutional heterozygosity for the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>...,135,517,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9876G>A,"...for the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>A synonymous change (exon 27), respectivel...",135,559,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9876G>A,"...for the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>A synonymous change (exon 27), respectivel...",135,559,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9876G>A,"...for the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>A synonymous change (exon 27), respectivel...",135,559,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.5333A>G,"... remaining 5 variants of group B, including BRCA1 c.5333A>G and BRCA2 c.9116C>T, already analyzed [2...",139,92,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9116C>T,"...s of group B, including BRCA1 c.5333A>G and BRCA2 c.9116C>T, already analyzed [20]–[22] and BRCA1 c....",139,112,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4097G>A,c.4097G>A	NO	−4.4%; NS (C)	−23.4%; NS (C)	−13.9%; ...,164,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4097G>A,c.4097G>A	NO	−4.4%; NS (C)	−23.4%; NS (C)	−13.9%; ...,164,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4484G>T,c.4484G>T	YES	−13.4%; S (C)	−47.4%; S (C)	−9.8%; S...,165,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4484G>T,c.4484G>T	YES	−13.4%; S (C)	−47.4%; S (C)	−9.8%; S...,165,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.4986+5G>A,c.4986+5G>A	YES	−100%; S (C)	−100%; S (C)	−100%; S...,166,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.8754+3G>C,c.8754+3G>C	YES	−6.3%; S (C)	−31.5; S (C)	−35.5%; ...,170,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.9117G>A,c.9117G>A	YES		−100%; S (C)	−100%; S (C)		−14.7%; ...,172,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"...ontaining PTCs, 2 (BRCA1 c.134+3_134+6delAAGT and c.212G>A) to the up-regulation of naturally occurr...",179,463,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"...ontaining PTCs, 2 (BRCA1 c.134+3_134+6delAAGT and c.212G>A) to the up-regulation of naturally occurr...",179,463,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.212G>A,"...ontaining PTCs, 2 (BRCA1 c.134+3_134+6delAAGT and c.212G>A) to the up-regulation of naturally occurr...",179,463,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.6853A>G,"...is is supported by the observation that the BRCA2 c.6853A>G variant, resulting in increased exclusio...",191,431,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.6853A>G,...BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant . Hum Mutat 30 : 1543...,293,158,PLoS_One_2013_Feb_22_8(2)_e57173.txt
c.2289C>T,"...s (7 novel polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), ...",73,106,PLoS_One_2013_Jul_2_8(7)_e66526.txt
c.2289C>T,"...s (7 novel polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), ...",73,106,PLoS_One_2013_Jul_2_8(7)_e66526.txt
c.2502C>G,"... c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu),...",73,131,PLoS_One_2013_Jul_2_8(7)_e66526.txt
c.2502C>G,"... c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu),...",73,131,PLoS_One_2013_Jul_2_8(7)_e66526.txt
c.1708-1G>C,"...etion mutation (c.2659delG), one splice mutation (c.1708-1G>C) and 15 missense mutations (p.Val145Ph...",73,494,PLoS_One_2013_Jul_2_8(7)_e66526.txt
c.1A>G,...cted with HSCR and meningocele. + indicates EDNRB c.1A>G; * indicates EDN3 c.-248G>A,27,204,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.-248G>A,...ocele. + indicates EDNRB c.1A>G; * indicates EDN3 c.-248G>A,27,229,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.927T>C,"Exon 4	c.927T>C (rs139884)	H309H	II-6, II-4, III-6, III-7...",82,8,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.927T>C,"Exon 4	c.927T>C (rs139884)	H309H	II-6, II-4, III-6, III-7...",82,8,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.1A>G,... of the complete CDS of the EDNRB gene revealed a c.1A>G heterozygous DNA change in the NM_000115.3 ...,86,61,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.1A>G,"...ividuals (I-2, III-5, III-7) (Table 1; Figure 1). c.1A>G was passed down to the family members by th...",86,304,PLoS_One_2013_Jun_26_8(6)_e66631.txt
c.217C>T,"... for a variant in RGS6: c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c....",99,384,PLoS_One_2013_Oct_29_8(10)_e76973.txt
c.217C>T,"... for a variant in RGS6: c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c....",99,384,PLoS_One_2013_Oct_29_8(10)_e76973.txt
c.217C>T,"... for a variant in RGS6: c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c....",99,384,PLoS_One_2013_Oct_29_8(10)_e76973.txt
c.808G>T,"...: c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val w...",99,406,PLoS_One_2013_Oct_29_8(10)_e76973.txt
c.1382C>T,"..., c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val were evaluated in parallel ...",99,432,PLoS_One_2013_Oct_29_8(10)_e76973.txt
c.184C>T,"... NL , Kay GW , et al (2006 ) A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lip...",159,100,PLoS_One_2013_Oct_4_8(10)_e75963.txt
c.184C>T,"... NL , Kay GW , et al (2006 ) A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lip...",159,100,PLoS_One_2013_Oct_4_8(10)_e75963.txt
c.1129T>G,I-2	57	M	5.20	0.93	1.09	3.10	p.Cys356Gly (c.1129T>G),107,43,PLoS_One_2014_Apr_10_9(4)_e94697.txt
c.1268T>C,I-3	66	F	4.75	1.21	1.13	3.87	p.IIe402Thr (c.1268T>C),108,43,PLoS_One_2014_Apr_10_9(4)_e94697.txt
c.1268T>C,II-2	34	M	5.10	0.96	1.53	3.41	p.IIe402Thr (c.1268T>C),110,44,PLoS_One_2014_Apr_10_9(4)_e94697.txt
c.1268T>C,III-3	23	M	3.87	1.19	1.67	3.17	p.IIe402Thr (c.1268T>C),112,45,PLoS_One_2014_Apr_10_9(4)_e94697.txt
c.793C>T,...umor IHC and the hotspot mutation testing at MLH1 c.793C>T followed by comprehensive mutation scanni...,17,401,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.790+1G>A,"MLH1/Intron 9	c.790+1G>A	Splicing change, skipping of exons 9 an...",80,15,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041G>A,MLH1/Exon 18	c.2041G>A	p.Ala681Thr	Chinese	1	1	Pathogenic	Dis c...,85,14,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041G>A,MLH1/Exon 18	c.2041G>A	p.Ala681Thr	Chinese	1	1	Pathogenic	Dis c...,85,14,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041G>A,MLH1/Exon 18	c.2041G>A	p.Ala681Thr	Chinese	1	1	Pathogenic	Dis c...,85,14,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.508C>T,MSH2/Exon 3	c.508C>T	p.Gln170X	Chinese	1	1	Pathogenic	Dis caus...,87,13,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.793C>T,"32	MLH1/Exon 10, c.793C>T, p.Arg265Cys	Pathogenic	Lost	Normal	Norma...",110,18,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041C>T,"52	MSH2/Exon 13, c.2041C>T, p.Gln681X	Novel Pathogenic	Normal	Lost	...",117,18,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041C>T,"52	MSH2/Exon 13, c.2041C>T, p.Gln681X	Novel Pathogenic	Normal	Lost	...",117,18,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041C>T,"52	MSH2/Exon 13, c.2041C>T, p.Gln681X	Novel Pathogenic	Normal	Lost	...",117,18,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2041G>A,"393	MLH1/Exon 18, c.2041G>A, p.Ala681Thr	Pathogenic	Normal	Normal	No...",125,19,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.1558+14G>A,"368	MLH1/Intron 13, c.1558+14G>A; PMS2/Intron 11, c.2006 +6 G>A	MLH1, ...",129,21,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.2246G>C,"8	MSH6/Exon 4, c.2246G>C, p.Gly749Ala	Novel VUS	Normal	Normal	Nor...",132,16,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.793C>T,...and the germline hotspot mutation testing at MLH1 c.793C>T. This is followed by thorough mutation sc...,203,994,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.793C>T,...and the germline hotspot mutation testing at MLH1 c.793C>T. This is followed by thorough mutation sc...,203,994,PLoS_One_2014_Apr_7_9(4)_e94170.txt
c.803G>A,"...c), and we identified a novel causative mutation, c.803G>A, p.R268Q in the PMCA4 gene",15,212,PLoS_One_2014_Aug_13_9(8)_e104790.txt
c.280G>C,exon 3	c.280G>C	p.A94P	28	M	—	—	—	rs201350646,53,9,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.280G>C,exon 3	c.280G>C	p.A94P	28	M	—	—	—	rs201350646,53,9,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.1334A>G,c.1334A>G	p.Y445C	35	—	—	—	—	—,56,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.583C>G,FOXC2	exon 1	c.583C>G	p.P195A	78	P	0.2	—	—	rs200751941,62,14,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.338G>C,exon 3	c.338G>C	p.S113T	500	—	0.8	0.66	0.2	rs144830740,69,9,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.909+25G>A,intron 3-4	c.909+25G>A	n/a	507	—	0.9	0.72	0.003	rs147860174,71,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.909+25G>A,intron 3-4	c.909+25G>A	n/a	507	—	0.9	0.72	0.003	rs147860174,71,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.909+25G>A,intron 3-4	c.909+25G>A	n/a	507	—	0.9	0.72	0.003	rs147860174,71,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.1037C>T,exon 5	c.1037C>T	p.A346V	59	—	0.4	0.31	0.13	rs115372595,74,9,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.1037C>T,exon 5	c.1037C>T	p.A346V	59	—	0.4	0.31	0.13	rs115372595,74,9,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*979G>C,c.*979G>C	n/a (3'UTR)	73	M	0.1	—	0.13	rs182365313,78,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*979G>C,c.*979G>C	n/a (3'UTR)	73	M	0.1	—	0.13	rs182365313,78,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.219-3C>T,ISL1	intron 2-3	c.219-3C>T	n/a	514	M	—	—	—	—,82,17,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.219-3C>T,ISL1	intron 2-3	c.219-3C>T	n/a	514	M	—	—	—	—,82,17,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.219-3C>T,ISL1	intron 2-3	c.219-3C>T	n/a	514	M	—	—	—	—,82,17,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*651A>G,c.*651A>G	n/a	39	M	0.5	—	—	—,84,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*140T>C,BOP/SMYD	3'UTR	c.*140T>C	n/a	30	P	—	—	—	—,85,16,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*140T>C,BOP/SMYD	3'UTR	c.*140T>C	n/a	30	P	—	—	—	—,85,16,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*140T>C,BOP/SMYD	3'UTR	c.*140T>C	n/a	30	P	—	—	—	—,85,16,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*699C>T,c.*699C>T	n/a	32	M	0.9	—	0.5	rs150572228,87,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*2435C>T,c.*2435C>T	n/a	28	P	—	—	—	rs142969860,88,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*2435C>T,c.*2435C>T	n/a	28	P	—	—	—	rs142969860,88,3,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.115G>A,TBX1	exon 3	c.115G>A	p.G39S	31	M	—	—	—	—,91,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*11C>T,exon 9a	c.*11C>T	n/a (3'UTR)	57	M	0.1	0.16	—	rs72646973,93,10,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*11C>T,exon 9a	c.*11C>T	n/a (3'UTR)	57	M	0.1	0.16	—	rs72646973,93,10,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*1074G>A,exon 9c	c.*1074G>A	n/a (3'UTR)	319	M	—	—	—	—,95,10,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.1037C>T,... was present in a single patient apart from GATA4 c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-3...,98,217,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.909+25G>A,"...ound in two patients each, and the intronic GATA4 c.909+25G>A that was found in 3 patients. We inclu...",98,334,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*1074G>A,...rst patient carried both GATA4 c.*886G>A and TBX1 c.*1074G>A (both maternal in origin); the second c...,98,701,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*1074G>A,...rst patient carried both GATA4 c.*886G>A and TBX1 c.*1074G>A (both maternal in origin); the second c...,98,701,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*979G>C,"...A94P (maternal). The second patient carried GATA4 c.*979G>C (maternal) FOXA2 c.872C>T, p.A291V (pate...",98,1249,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*979G>C,"...A94P (maternal). The second patient carried GATA4 c.*979G>C (maternal) FOXA2 c.872C>T, p.A291V (pate...",98,1249,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.*979G>C,"...A94P (maternal). The second patient carried GATA4 c.*979G>C (maternal) FOXA2 c.872C>T, p.A291V (pate...",98,1249,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.219-3C>T,The mutant minigene constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an ...,119,41,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.219-3C>T,The mutant minigene constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an ...,119,41,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.699G>A,...minigene constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an RNA profile identical...,119,62,PLoS_One_2014_Aug_5_9(8)_e95453.txt
c.446G>T,...sis primers (Table 1) in wild type allele but not c.446G>T mutant allele of NOTCH3 gene,64,232,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,... with respect to the normal control (B). P.G149V (c.446G>T) was indicated with an arrow,76,729,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,"...ve been screened by MscI digestion, however, this c.446G>T mutation was not found in these individua...",81,931,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,"...ve been screened by MscI digestion, however, this c.446G>T mutation was not found in these individua...",81,931,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.446G>T,"...) domain. By genetic testing, we revealed a novel c.446G>T (p.G149V) mutation located in exon 4 of t...",91,861,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.445G>T,"...the phenotype of CADASIL. Similarly, the mutation c.445G>T (p.G149C) was reported in 5 individuals w...",91,1496,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.445G>T,"...the phenotype of CADASIL. Similarly, the mutation c.445G>T (p.G149C) was reported in 5 individuals w...",91,1496,PLoS_One_2014_Aug_6_9(8)_e104533.txt
c.131T>C,"... we identified a novel heterozygous mutation, the c.131T>C (p.V44A) mutation, in exon2 of GJA8 in a ...",28,65,PLoS_One_2014_Dec_17_9(12)_e115406.txt
c.131T>C,...ual. The black box shows a heterozygous mutation (c.131T>C) in exon 2. E: Conservation analysis of p...,73,568,PLoS_One_2014_Dec_17_9(12)_e115406.txt
c.131T>C,"In summary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of ...",116,48,PLoS_One_2014_Dec_17_9(12)_e115406.txt
c.1064G>A,...a compound heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mutation. An aberrant tran...,11,147,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...cession number KJ128074), which was resulted from c.615+5G>A, was detected by RT-PCR and cDNA sequen...",11,337,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...cession number KJ128074), which was resulted from c.615+5G>A, was detected by RT-PCR and cDNA sequen...",11,337,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...cession number KJ128074), which was resulted from c.615+5G>A, was detected by RT-PCR and cDNA sequen...",11,337,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"...nformatic analyses of the novel missense mutation c.1064G>A, the growth abilities of three agc1Δ yea...",11,453,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...mutations, i.e. c.851_854delGTAT, c.1638_1660dup, c.615+5G>A and IVS16ins3kb, were screened by PCR/L...",30,163,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...mutations, i.e. c.851_854delGTAT, c.1638_1660dup, c.615+5G>A and IVS16ins3kb, were screened by PCR/L...",30,163,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...hen sequenced to explore aberrant transcript with c.615+5G>A,40,911,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...hen sequenced to explore aberrant transcript with c.615+5G>A,40,911,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"...mutation c.615+5G>A and a novel missense mutation c.1064G>A (p.Arg355Gln), which was inherited from ...",103,178,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...esis on the left illustrated the screening of the c.615+5G>A mutation by mean of a PCR-RFLP approach...,106,66,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...esis on the left illustrated the screening of the c.615+5G>A mutation by mean of a PCR-RFLP approach...,106,66,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...esis on the left illustrated the screening of the c.615+5G>A mutation by mean of a PCR-RFLP approach...,106,66,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...e patient carried a maternally-inherited mutation c.615+5G>A. SLC25A13 gene sequencing results on th...,106,484,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,...the right demonstrated that the patient habored a c.1064G>A mutation which was inherited from his fa...,106,582,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,...ranscripts from the SLC25A13 Allele Harboring the c.615+5G>A Mutatio,114,52,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...789 bp) of SLC25A13 gene, along with the mutation c.615+5G>A, was retained in the 2292 bp product (F...",115,335,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...789 bp) of SLC25A13 gene, along with the mutation c.615+5G>A, was retained in the 2292 bp product (F...",115,335,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...hus the transcripts from the SLC25A13 allele with c.615+5G>A were degraded soon after transcription,...",134,1004,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,... in our study to analyzed the effect of the novel c.1064G>A mutation on AGC2 function of citrin prot...,137,220,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,... in our study to analyzed the effect of the novel c.1064G>A mutation on AGC2 function of citrin prot...,137,220,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.615+5G>A,"...vidences supporting the splice-site nature of the c.615+5G>A mutation, and the novel c.1064G>A varia...",139,298,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.1064G>A,"... nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mut...",139,333,PLoS_One_2014_Feb_21_9(2)_e89267.txt
c.171-20A>G,...49	rs10501986	T	T/C	0.480	0.495	0.71	0.492	0.81	A	c.171-20A>G		intron,94,61,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.945+129C>T,...626	rs4542378	G	G/A	0.480	0.490	0.80	0.492	0.81	C	c.945+129C>T		intron,96,60,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.1211C>T,...	rs36111323	G	G/A	0.135**	0.165	0.24	0.156	0.52	C	c.1211C>T	p.Ala404Val	missense	4	linker region bet...,97,63,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2115C>T,...58	rs61743044	G	G/A	0.020	0.020	1.00	0.024	0.75	C	c.2115C>T	p.Tyr705Tyr	synonymous	8	linker region b...,99,61,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2142G>T,...42931	rs144891994	C	C/A	0.008	0.005	0.66	0	0.32	G	c.2142G>T	p.Thr714Thr	synonymous	8	TMD 6,100,58,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2485-138C>T,...970	rs7105083	G	G/A	0.263	0.238	0.47	0.266	0.93	C	c.2485-138C>T		intron,101,60,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2529C>T,...88	rs72984209	G	G/A	0.077	0.054	0.28	0.081	0.87	C	c.2529C>T	p.Phe843Phe	synonymous	11,102,61,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.2712G>A,...	rs12805398	C	C/T	0.140**	0.158	0.49	0.153	0.69	G	c.2712G>A	p.Gln904Gln	synonymous	13,103,63,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.888G>A,...ee Methods for definitions). These rare variants (c.888G>A and c.2142G>T) were both encountered once...,117,244,PLoS_One_2014_Jul_14_9(7)_e102065.txt
c.1601G>A,".... Regarding the genetic factors, factor V Leiden (c.1601G>A, p.R534Q) and prothrombin G20210A mutati...",17,146,PLoS_One_2015_Jul_17_10(7)_e0133196.txt
c.1601G>A,".... Regarding the genetic factors, factor V Leiden (c.1601G>A, p.R534Q) and prothrombin G20210A mutati...",17,146,PLoS_One_2015_Jul_17_10(7)_e0133196.txt
c.1601G>A,".... Regarding the genetic factors, factor V Leiden (c.1601G>A, p.R534Q) and prothrombin G20210A mutati...",17,146,PLoS_One_2015_Jul_17_10(7)_e0133196.txt
c.586A>G,"...other researchers identified a missense mutation (c.586A>G, p.K196E) in the PS gene as a genetic ris...",17,381,PLoS_One_2015_Jul_17_10(7)_e0133196.txt
c.521C>G,"c.521C>G, p.P174T	c.949_950insC	-",18,1,PLoS_One_2015_Jul_29_10(7)_e0134748.txt
c.448G>C,"...nes revealed a missense mutation at position 448 (c.448G>C) of MIP, which resulted in the substituti...",7,986,PLoS_One_2015_May_6_10(5)_e0126679.txt
c.448G>C,"...nes revealed a missense mutation at position 448 (c.448G>C) of MIP, which resulted in the substituti...",7,986,PLoS_One_2015_May_6_10(5)_e0126679.txt
c.448G>C,"...nes revealed a missense mutation at position 448 (c.448G>C) of MIP, which resulted in the substituti...",7,986,PLoS_One_2015_May_6_10(5)_e0126679.txt
c.448G>C,"MIP: c.448G>C, p.D150H		1.628	1.718	1.797	1.806",77,6,PLoS_One_2015_May_6_10(5)_e0126679.txt
c.448G>C,"MIP: c.448G>C, p.D150H		1.628	1.718	1.797	1.806",77,6,PLoS_One_2015_May_6_10(5)_e0126679.txt
c.7613C>G,"...r point mutations p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.126...",31,378,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.7613C>G,"...r point mutations p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.126...",31,378,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.12343C>T,"...328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c....",31,400,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.12343C>T,"...328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c....",31,400,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.12343C>T,"...328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c....",31,400,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.12343C>T,"...328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c....",31,400,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.12602A>G,"...38R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mutation nom...",31,423,PLoS_One_2015_May_8_10(5)_e0125366.txt
c.2168A>G,"...tions in three genes associated with HL. Mutation c.2168A>G (SLC26A4) was found in one family, a nov...",7,1133,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"...tions in three genes associated with HL. Mutation c.2168A>G (SLC26A4) was found in one family, a nov...",7,1133,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111G>C,"...LC26A4) was found in one family, a novel mutation c.1111G>C (OTOF) was revealed in another family, a...",7,1195,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...sociation of homozygosity for discovered variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G ...",7,1641,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...ndrome. Presumed association of RAI1 gene variant c.5254G>A with isolated HL needs to be proved by f...,7,2092,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...dividuals heterozygous or homozygous for mutation c.5254G>A (RAI1). Primers and PCR conditions are a...,36,229,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...F38 and F40; a novel homozygous missense mutation c.1111C>G (p.Gly371Arg) in gene OTOF (otoferlin, M...",44,362,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...F38 and F40; a novel homozygous missense mutation c.1111C>G (p.Gly371Arg) in gene OTOF (otoferlin, M...",44,362,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...d a previously known homozygous missense mutation c.2168A>G (p.His723Arg) was found in gene SLC26A4 ...,44,526,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...d a previously known homozygous missense mutation c.2168A>G (p.His723Arg) was found in gene SLC26A4 ...,44,526,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,Nucleotide change (Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg)...,63,39,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,Nucleotide change (Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg)...,63,39,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...ge (Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,66,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...ge (Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,66,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,Cosegregation of homozygosity for mutation c.5254G>A in the RAI1 gene with congenital bilater...,79,44,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,Cosegregation of homozygosity for mutation c.5254G>A in the RAI1 gene with congenital bilater...,79,44,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...rnal.pone.0153841.g001Fig 1 Identification of the c.5254G>A (p.Gly1752Arg) mutation in the RAI1 gene...,81,62,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...ian families F18, F37, F42, and F43 with mutation c.5254G>A (p.Gly1752Arg) in the RAI1 gene. (B) Val...",82,119,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...ian families F18, F37, F42, and F43 with mutation c.5254G>A (p.Gly1752Arg) in the RAI1 gene. (B) Val...",82,119,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...individuals is marked by grey symbols. M—mutation c.5254G>A (p.Gly1752Arg), wt—wild type",82,417,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...individuals is marked by grey symbols. M—mutation c.5254G>A (p.Gly1752Arg), wt—wild type",82,417,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,Affected members from families F38 and F40 with c.5254G>A (RAI1) were originally examined in 2002....,84,49,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...t. Mother in family F38 (38-I-1) heterozygous for c.5254G>A (Fig 1) had no hearing complaints during...,84,1261,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,Mutation c.5254G>A was also found in additional five patien...,86,10,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...37, F42, and F43 (Fig 1). Subjects homozygous for c.5254G>A (42-II-1 and 43-III-1) had congenital pr...",86,156,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...37, F42, and F43 (Fig 1). Subjects homozygous for c.5254G>A (42-II-1 and 43-III-1) had congenital pr...",86,156,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...37, F42, and F43 (Fig 1). Subjects homozygous for c.5254G>A (42-II-1 and 43-III-1) had congenital pr...",86,156,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...found sensorineural HL. Subjects heterozygous for c.5254G>A (18-II-1, 37-II-1, and 43-II-2) had vary...",86,257,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...found sensorineural HL. Subjects heterozygous for c.5254G>A (18-II-1, 37-II-1, and 43-II-2) had vary...",86,257,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...aring Altaians four individuals were heterozygous c.5254G>A carriers (4/120, 3.33%)",86,860,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...aring Altaians four individuals were heterozygous c.5254G>A carriers (4/120, 3.33%)",86,860,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,... additional deleterious variants in compound with c.5254G>A in affected heterozygotes for c.5254G>A ...,88,70,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"... and to evaluate the RAI1 allelic variations with c.5254G>A, we sequenced the RAI1 gene coding regio...",88,169,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"... and to evaluate the RAI1 allelic variations with c.5254G>A, we sequenced the RAI1 gene coding regio...",88,169,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...3-II-3, 38-II-1) (see Fig 1), and two carriers of c.5254G>A from Altaian controls whose DNAs were av...",88,635,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...3-II-3, 38-II-1) (see Fig 1), and two carriers of c.5254G>A from Altaian controls whose DNAs were av...",88,635,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...terious RAI1 variants were found in compound with c.5254G>A in affected heterozygotes for c.5254G>A ...,88,827,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...ound with c.5254G>A in affected heterozygotes for c.5254G>A (18-II-1, 37-II-1, 38-I-1, and 43-II-2)....",88,867,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...ound with c.5254G>A in affected heterozygotes for c.5254G>A (18-II-1, 37-II-1, 38-I-1, and 43-II-2)....",88,867,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...lelesmut: C-A-Q13[CAG CAA (CAG)10 del(CAG) CAA]-G-c.5254G>A was observed in all c.5254G>A homozygote...,88,1205,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...)10 del(CAG) CAA]-G-c.5254G>A was observed in all c.5254G>A homozygote which was suggested as the co...,88,1235,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...was suggested as the common allelic haplotype for c.5254G>A. For all c.5254G>A heterozygotes, the ha...",88,1312,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...was suggested as the common allelic haplotype for c.5254G>A. For all c.5254G>A heterozygotes, the ha...",88,1312,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...(S3 Table). All studied individuals with mutation c.5254G>A share a specific allelemut: C-A-Q13[CAG ...,88,1748,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...(S3 Table). All studied individuals with mutation c.5254G>A share a specific allelemut: C-A-Q13[CAG ...,88,1748,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...(S3 Table). All studied individuals with mutation c.5254G>A share a specific allelemut: C-A-Q13[CAG ...,88,1748,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...llelemut: C-A-Q13[CAG CAA (CAG)10 del(CAG) CAA]-G-c.5254G>A suggesting the common origin of c.5254G>...,88,1826,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,... CAA]-G-c.5254G>A suggesting the common origin of c.5254G>A in Altaians,88,1868,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"... of Altaian ethnicity. For accurate estimation of c.5254G>A allelic frequency, we also screened this...",90,110,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...aian patients with HL. Nobody from this group had c.5254G>A. We compared frequency of c.5254G>A in a...,90,240,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...his group had c.5254G>A. We compared frequency of c.5254G>A in a total sample of Altaian patients (0...,90,276,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,... found significantly (p<10−5) higher frequency of c.5254G>A in Altaian patients. To avoid probable b...,90,482,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...the control sample. Again, a statistically higher c.5254G>A frequency (p = 0.0026) was observed amon...",90,839,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...the control sample. Again, a statistically higher c.5254G>A frequency (p = 0.0026) was observed amon...",90,839,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,Variant c.1111C>G (p.Gly371Arg) in the OTOF gen,92,9,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,We found a novel mutation c.1111C>G (p.Gly371Arg) in the OTOF gene in two si...,93,27,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...G (p.Gly371Arg) mutation in the OTOF gene and the c.2168A>G (p.His723Arg) mutation in the SLC26A4 ge...,95,120,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,... (C) Pedigree of the WES family F53 with mutation c.2168A>G (p.His723Arg) in the SLC26A4 gene which ...,96,248,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,... (C) Pedigree of the WES family F53 with mutation c.2168A>G (p.His723Arg) in the SLC26A4 gene which ...,96,248,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...6A4 gene which is denoted as M. (D) Validation of c.2168A>G by Sanger sequencing. WES was performed ...,96,333,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...6A4 gene which is denoted as M. (D) Validation of c.2168A>G by Sanger sequencing. WES was performed ...,96,333,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,... associated with the presence of a single copy of c.1111C>G: the only individual 24-II-2 out of seve...,98,389,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,... associated with the presence of a single copy of c.1111C>G: the only individual 24-II-2 out of seve...,98,389,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...-1, 54-II-4, 54-II-7, 54-III-1,) was affected and c.1111C>G was absent in his relatives 24–1 (with c...",98,555,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...-1, 54-II-4, 54-II-7, 54-III-1,) was affected and c.1111C>G was absent in his relatives 24–1 (with c...",98,555,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...erate HL). On the other hand, all homozygotes for c.1111C>G (54-II-2, 54-II-3, 54-II-5, 54-II-6) wer...",98,699,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...erate HL). On the other hand, all homozygotes for c.1111C>G (54-II-2, 54-II-3, 54-II-5, 54-II-6) wer...",98,699,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...branch F24 of combined pedigree F24-F54. Mutation c.1111C>G was not found among 120 normal hearing A...,98,931,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,Variant c.2168A>G (p.His723Arg) in gene SLC26A,100,9,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,Homozygous mutation c.2168A>G (p.His723Arg) in gene SLC26A4 was found ...,101,21,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...Subsequent Sanger sequencing confirmed homozygous c.2168A>G in his affected sister (53-II-2) and het...,101,207,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,".... Mondini dysplasia) [23,24]. Both homozygous for c.2168A>G siblings (53-II-1 and 53-II-2, born in 1...",103,468,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...st of the NGS annotations pipelines. All detected c.5254G>A homozygotes (in total, 10 patients from ...",114,882,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...er allelic mutation in RAI1 gene in four affected c.5254G>A heterozygous individuals (from total 20 ...,114,1199,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...er allelic mutation in RAI1 gene in four affected c.5254G>A heterozygous individuals (from total 20 ...,114,1199,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...indeed detected significantly higher frequency of c.5254G>A in Altaian patients compared with Altaia...,114,1634,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...indeed detected significantly higher frequency of c.5254G>A in Altaian patients compared with Altaia...,114,1634,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,"...controls. In addition, high prevalence of variant c.5254G>A in the Altaians is probably due to found...",114,1736,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...llelemut: C-A-Q13[CAG CAA (CAG)10 del(CAG) CAA]-G-c.5254G>A was shared by all studied carriers of c....,114,1911,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...s of c.5254G>A that supports the common origin of c.5254G>A in Altaians,114,2004,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.3650G>A,"...of RAI1 protein with missense mutations p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685...",116,1314,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.4166A>G,"...issense mutations p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5...",116,1336,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.4685A>G,"...217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all are in C-...",116,1358,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.4685A>G,"...217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all are in C-...",116,1358,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5423G>A,"...R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all are in C-terminal half of the RAI1...",116,1383,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.4685A>G,...1 amino acid sequence between mutations p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) studied by Car...,116,2179,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.4685A>G,...1 amino acid sequence between mutations p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) studied by Car...,116,2179,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.4685A>G,...1 amino acid sequence between mutations p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) studied by Car...,116,2179,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5423G>A,...ween mutations p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) studied by Carmona-Mora et al [47] ther...,116,2204,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,... families; (ii) significantly higher frequency of c.5254G>A in patients compared with ethnically mat...,118,293,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1194T>A,"...4delinsC (p.G368AfsX2), c.1180dupG (p.E394GfsX6), c.1194T>A (p.D398E), and c.1236delC (p.E413NfsX90)...",124,347,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,Variant c.1111C>G found in this study has been predicted ‘...,126,9,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...2). We also found segregation of homozygosity for c.1111C>G with recessive HL in Altaian family F54:...,126,242,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...1C>G with recessive HL in Altaian family F54: all c.1111C>G homozygous siblings from this family wer...,126,297,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...support plausible association of homozygosity for c.1111C>G with recessive HL in Altaian patients. T...,126,528,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...support plausible association of homozygosity for c.1111C>G with recessive HL in Altaian patients. T...,126,528,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...support plausible association of homozygosity for c.1111C>G with recessive HL in Altaian patients. T...,126,528,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...g 2) with one c.1111C>G copy (24-II-2) or without c.1111C>G (24–1 and 24-II-1). Presence of other de...,126,730,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...g 2) with one c.1111C>G copy (24-II-2) or without c.1111C>G (24–1 and 24-II-1). Presence of other de...,126,730,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,...A4 mutations differs across populations. Mutation c.2168A>G (p.His723Arg) found in Altaian family F5...,128,410,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"...mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) identified in Altaian patients...",130,84,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,...ionally occupied these territories. Prevalence of c.1111C>G (OTOF) is restricted to one extended Alt...,130,922,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"...tern district of the Altai Republic, and mutation c.2168A>G (SLC26A4) was found in the only Altaian ...",130,1061,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"...tern district of the Altai Republic, and mutation c.2168A>G (SLC26A4) was found in the only Altaian ...",130,1061,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...03Fig 3 Prevalence of mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) on the t...",132,82,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"...mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) on the territory of the Altai ...",132,104,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"...mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) on the territory of the Altai ...",132,104,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,....5254G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue; c.2168A>G (SLC26A4)–by green. (B) Distribution of ...,133,195,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.1111C>G,"...ygosity for identified variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL ...",136,421,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"... variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. L...",136,443,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"... variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. L...",136,443,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.2168A>G,"... variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. L...",136,443,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...ndrome. Presumed association of RAI1 gene variant c.5254G>A with isolated HL needs to be proved by f...,136,842,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.5254G>A,...ng in individuals homozygous and heterozygous for c.5254G>A,164,131,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
c.293A>G,...C_000002.11:g.47388990T>C; cDNA code: NM_001743.4:c.293A>G),37,1969,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
c.-938C>A,"...e functional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter reg...",7,718,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
c.1399G>A,...hange at nucleotide position (np) 1399 in exon 7 (c.1399G>A; p.A467T) in all four individuals,93,532,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
c.454T>C,"... In the FOXC1 gene, a novel heterozygous variant (c.454T>C; p.Trp152Arg) segregated with the disease...",14,386,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.225C>A,...oth eyes. A novel heterozygous nonsense mutation (c.225C>A; p.Tyr75*) in the PAX6 gene was identifie...,41,359,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.225C>A,...oth eyes. A novel heterozygous nonsense mutation (c.225C>A; p.Tyr75*) in the PAX6 gene was identifie...,41,359,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.225C>A,The same variation (c.225C>A; p.Tyr75*) was identified in another unre...,46,21,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.454T>C,...ree and segregation of a novel missense mutation (c.454T>C; p.Trp152Arg) in the FOXC1 gene. (B). Sys...,57,60,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.454T>C,...ree and segregation of a novel missense mutation (c.454T>C; p.Trp152Arg) in the FOXC1 gene. (B). Sys...,57,60,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.649C>T,"...dia. In addition, a previously reported mutation (c.649C>T; p.Arg217*) was identified in the PAX6 ge...",69,327,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.649C>T,"...dia. In addition, a previously reported mutation (c.649C>T; p.Arg217*) was identified in the PAX6 ge...",69,327,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
c.946G>A,"ATP1A3	19	NM_152296.3	[c.946G>A, p.Gly316Ser]	A/G	G/G	G/G	G/G	G/G",60,24,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
c.946G>A,"ATP1A3	19	NM_152296.3	[c.946G>A, p.Gly316Ser]	A/G	G/G	G/G	G/G	G/G",60,24,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
c.1444G>A,"UBQLN4	1	NM_020131.3	[c.1444G>A, p.Glu482Lys]	A/G	G/G	G/G	G/G	G/G",61,23,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
c.1373C>A,"SRPK3	X	NM_014370.2	[c.1373C>A, p.Thr458Asn]	hemiA	A/C	hemi C	hemi C	C/...",63,22,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
c.1373C>A,"SRPK3	X	NM_014370.2	[c.1373C>A, p.Thr458Asn]	hemiA	A/C	hemi C	hemi C	C/...",63,22,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
c.357-2A>G,"...% for family studies. The results identified LMNA c.357-2A>G, a novel heterozygous splice-site mutat...",7,1871,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.625G>A,1. ACADS	chr12:121176083	c.625G>A	Gly209Ser; splicing	rs1799958	18	26	Risk ...,82,26,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.1616C>T,4. DMPKc	chr19:46274624	c.1616C>T	Thr544Met	rs146680240	0.9	1.3	-,85,25,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.340+4T>C,7. HFE	chr6:26091336	c.340+4T>C	Splicing	rs2071303	46	33	-,88,22,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,12. LMNAc	chr1:156100406	c.357-2A>G	Splicing	rs113610699	nd	nd	-,93,26,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.1698C>T,13. LMNA	chr1:156107534	c.1698C>T	His566His; splicing	rs4641	20	25	-,94,25,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.732C>T,15. MYH7	chr14:23900794	c.732C>T	Phe244Phe; splicing	rs2069542	23	18	-,96,25,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.2068C>T,19. TMPOc	chr12:98928103	c.2068C>T	Arg690Cys	rs17028450	0.1	0.1	Mutation fo...,100,26,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.2068C>T,19. TMPOc	chr12:98928103	c.2068C>T	Arg690Cys	rs17028450	0.1	0.1	Mutation fo...,100,26,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.18053G>C,20. TTNc	chr2:179587949	c.18053G>C	Thr6018Ser	novel	nd	nd	-,101,25,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.18053G>C,20. TTNc	chr2:179587949	c.18053G>C	Thr6018Ser	novel	nd	nd	-,101,25,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.18053G>C,20. TTNc	chr2:179587949	c.18053G>C	Thr6018Ser	novel	nd	nd	-,101,25,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.18053G>C,20. TTNc	chr2:179587949	c.18053G>C	Thr6018Ser	novel	nd	nd	-,101,25,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,"...Table 2 and Fig 4). These results identified LMNA c.357-2A>G (p.N120Lfs*5) (NM_170707.3), a novel he...",119,598,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,...ournal.pone.0155421.g005Fig 5 Novel LMNA mutation c.357-2A>G (p.N120Lfs*5),127,60,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.1698C>T,... variant located in exon 10 (rs4641: NM_1701707.3:c.1698C>T). These findings are consistent with the...,136,432,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,Lamin A/C and the predicted impact of LMNA c.357-2A>,154,44,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,"We report LMNA c.357-2A>G, a novel transition at the splice accep...",157,16,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,"We report LMNA c.357-2A>G, a novel transition at the splice accep...",157,16,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,"...nucleotide in the same splice acceptor site, LMNA c.357-1G>T was reported in three patients with arr...",157,226,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,"...nucleotide in the same splice acceptor site, LMNA c.357-1G>T was reported in three patients with arr...",157,226,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,"...nucleotide in the same splice acceptor site, LMNA c.357-1G>T was reported in three patients with arr...",157,226,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,...investigate the molecular mechanism by which LMNA c.357-2A>G leads to adult-onset SSS and DCM in our...,159,54,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,...investigate the molecular mechanism by which LMNA c.357-2A>G leads to adult-onset SSS and DCM in our...,159,54,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,...icted with the RNA studies conducted for the LMNA c.357-1G>T family [31]. Since both mutations are a...,161,139,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,"...ons are at the same splice site, we expected LMNA c.357-1G>T and LMNA c.357-2A>G to both produce the...",161,230,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,"...ons are at the same splice site, we expected LMNA c.357-1G>T and LMNA c.357-2A>G to both produce the...",161,230,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-2A>G,"...splice site, we expected LMNA c.357-1G>T and LMNA c.357-2A>G to both produce the same aberrant produ...",161,250,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.357-1G>T,"...at would be subject to NMD. However, for the LMNA c.357-1G>T, RNA studies showed skipping of exon 2 ...",161,356,PLoS_One_2016_May_16_11(5)_e0155421.txt
c.2173C>T,...+ respiratory insufficiency	IVS1-13T>G IVS1-13T>G	c.2173C>T	779	Yes	39	Y	Y,108,94,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.2173C>T,...+ respiratory insufficiency	IVS1-13T>G IVS1-13T>G	c.2173C>T	779	Yes	39	Y	Y,108,94,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1889-1G>A,3	F	26	HyperCKemia	IVS1-13T>G	c.1889-1G>A	779	No	-	N	N,109,31,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.573C>A,5	M	11	HyperCKemia	IVS1-13T>G	c.573C>A	276	No	-	N	N,111,31,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1637A>G,9	F	59	Proximal weakness LL	IVS1-13T>G	c.1637A>G	341	Yes	52	N	N,115,40,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1637A>G,9	F	59	Proximal weakness LL	IVS1-13T>G	c.1637A>G	341	Yes	52	N	N,115,40,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1637A>G,9	F	59	Proximal weakness LL	IVS1-13T>G	c.1637A>G	341	Yes	52	N	N,115,40,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.2173C>T,10	F	55	Proximal weakness LL	IVS1-13T>G	c.2173C>T	359	Yes	48	N	N,116,41,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.2173C>T,10	F	55	Proximal weakness LL	IVS1-13T>G	c.2173C>T	359	Yes	48	N	N,116,41,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.573C>A,...LL + axial + respiratory insufficiency	IVS1-13T>G	c.573C>A	606	Yes	39	N	Y,117,77,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.573C>A,...LL + axial + respiratory insufficiency	IVS1-13T>G	c.573C>A	606	Yes	39	N	Y,117,77,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.2173C>T,...	Proximal weakness LL + respiratory insufficiency	c.2173C>T	c.2173C>T	508	Yes	45	N	Y,120,58,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1657C>T,...eakness LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	709	Yes	45	N	Y,121,69,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1657C>T,... UL and LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	458	Yes	46	N	Y,122,76,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1781G>A,17	M	22	HyperCKemia	IVS1-13T>G	c.1781G>A	1268	No	-	N	N,123,32,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.271G>A,18	M	49	HyperCKemia	c.271G>A	c.2510G>A	641	No	-	N	N,124,21,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.573C>A,19	M	14	HyperCKemia	IVS1-13T>G	c.573C>A	660	No	-	N	N,125,32,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.573C>A,19	M	14	HyperCKemia	IVS1-13T>G	c.573C>A	660	No	-	N	N,125,32,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1781G>A,...	Proximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	68	Yes	64	N	N,126,58,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1781G>A,...	Proximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	68	Yes	64	N	N,126,58,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1781G>A,...	Proximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	68	Yes	64	N	N,126,58,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1889-1G>A,22	F	40	Proximal weakness LL	IVS1-13T>G	c.1889-1G>A	831	No	-	N	Y,128,41,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.1889-1G>A,25	M	8	HyperCKemia	IVS1-13T>G	c.1889-1G>A	1077	No	-	N	N,131,31,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.655G>A,32	M	42	Proximal weakness UL + LL	IVS1-13T>G	c.655G>A	886	No	-	N	N,138,46,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.655G>A,32	M	42	Proximal weakness UL + LL	IVS1-13T>G	c.655G>A	886	No	-	N	N,138,46,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
c.66G>A,ER23/23EK	c.66G>A (p.Glu22Glu)	rs6189	2.19%	2.98% (ss1317539...,129,11,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
c.1088A>G,N363S	c.1088A>G (p.Asn363Ser)	rs56149945 (former rs6195 ...,131,7,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
c.1055T>G,...pound homo-/heterozygous variants for [rs2229291; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p....,56,926,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
c.1102G>A,... [rs2229291; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p.V368I)] of CPT II and mitochondrial e...,56,963,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
c.1102G>A,... [rs2229291; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p.V368I)] of CPT II and mitochondrial e...,56,963,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
c.20A>T,...sence of a sickle hemoglobin (Hb S) mutation (HBB:c.20A>T). People with SCD can be homozygous for Hb...,5,128,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
c.67G>C,"...ions in the β-globin gene, such as Hb D-Iran (HBB:c.67G>C) and Hb D-Ibadan (HBB:c.263C>A). However, ...",13,109,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
c.220G>A,Hb Korle-Bu (Hb KB) or Hb G-Accra (HBB:c.220G>A) is a frequent mutation in Sub-Saharan Af...,15,40,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
c.220G>A,"...b C-Harlem (or Hb C-Georgetown) (HBB:c.20A>T, HBB:c.220G>A), because it migrates to the position of ...",17,255,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
c.329A>G,...-sequencing detected a homozygous novel mutation (c.329A>G; p.Y110C) in the MUT gene in patient 1 an...,3,1715,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
c.2200C>T,...we detected a novel homozygous nonsense mutation (c.2200C>T; p.Q734X) and a heterozygous in parents....,3,1950,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
c.329A>G,"In patient 1, we detected a homozygous mutation (c.329A>G;p.Y110C) and heterozygous in both his par...",23,50,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
c.329A>G,"In patient 1, we detected a homozygous mutation (c.329A>G;p.Y110C) and heterozygous in both his par...",23,50,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
c.2200C>T,"...nt 2, we detected a homozygous nonsense mutation (c.2200C>T;p.Q734X) in the patient and heterozygous...",25,59,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
c.975T>G,...els (Fig. 1). Each additional LoF allele in CD36 (c.975T>G) had a lowering effect on octanoylcarniti...,50,353,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.481+1G>T,"...evels, and each additional LoF allele in SLCO1B1 (c.481+1G>T) demonstrated an increasing effect on h...",50,479,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.481+1G>T,...10−9). We next genotyped the LoF site in SLCO1B1 (c.481+1G>T) among the entire ARIC participants (10...,57,726,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.481+1G>T,"...cation, three LoF sites—CD36 (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both ...",77,75,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.975T>G,"Three LoF sites—CD36 (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933...",86,23,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.481+1G>T,"Three LoF sites—CD36 (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both ...",86,43,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
c.2284C>T,"...Table 1). Interestingly, a single CNGB1 mutation (c.2284C>T) was detected in a homozygous state in 4...",18,474,Sci_Rep_2015_Aug_26_5_13187.txt
c.1349G>A,"...at revealed a TULP1 homozygous nonsense mutation (c.1349G>A, p.W450*) which cosegregated with LCA in...",25,368,Sci_Rep_2015_Aug_26_5_13187.txt
c.1349G>A,"...at revealed a TULP1 homozygous nonsense mutation (c.1349G>A, p.W450*) which cosegregated with LCA in...",25,368,Sci_Rep_2015_Aug_26_5_13187.txt
c.1494C>A,"...and identified a novel missense sequence variant (c.1494C>A, p.D498E) in the CNNM4 gene which is loc...",25,766,Sci_Rep_2015_Aug_26_5_13187.txt
c.1087T>A,ADAM9	c.1087T>A	p.C363S	0	arRP	Iraqi Jew	MOL0827 MOL0838...,85,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1087T>A,ADAM9	c.1087T>A	p.C363S	0	arRP	Iraqi Jew	MOL0827 MOL0838...,85,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.211G>T,AIPL1	c.211G>T	p.V71F	8*10−6	arLCA	Mix Jew	MOL0113	—	Hom...,86,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.479G>A,BBS1	c.479G>A	p.R160Q	4*10−5	arRP	Arab Muslim	MOL0745	—...,87,6,Sci_Rep_2015_Aug_26_5_13187.txt
c.479G>A,BBS1	c.479G>A	p.R160Q	4*10−5	arRP	Arab Muslim	MOL0745	—...,87,6,Sci_Rep_2015_Aug_26_5_13187.txt
c.94C>T,CNGA1	c.94C>T	p.R32*	0	arRP	Moroccan Jew	MOL0927	—	Heter...,89,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.94C>T,CNGA1	c.94C>T	p.R32*	0	arRP	Moroccan Jew	MOL0927	—	Heter...,89,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1494C>A,CNNM4	c.1494C>A	p.D498E	0	ar Jalili syndrome	Druze	MOL03...,93,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.2950C>T,"C2ORF71	c.2950C>T	p.R984*	2*10−5	arRP	Jew (Iran, Turkey)	M...",95,9,Sci_Rep_2015_Aug_26_5_13187.txt
c.119-2A>C,NR2E3	c.119-2A>C	 	8*10−6	arRP	Arab Muslim	MOL1266	1	Hom...,100,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.119-2A>C,NR2E3	c.119-2A>C	 	8*10−6	arRP	Arab Muslim	MOL1266	1	Hom...,100,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1481C>T,PRPF3	c.1481C>T	p.T494M	0	adRP	Yemenite Jew	MOL0108	—	He...,102,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.377C>T,RDH12	c.377C>T	p.A126V	8*10−6	arRP	Arab Muslim	MOL1389	—...,106,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.722A>T,RPE65	c.722A>T	p.H241L	0	arRP	Ashkenazi Jew	MOL0942	—	Ho...,107,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.288T>A,SPATA7	c.288T>A	p.C96*	3*10−5	arLCA	Arab Muslim	MOL0758	—...,109,8,Sci_Rep_2015_Aug_26_5_13187.txt
c.542G>T,TSPAN12	c.542G>T	p.C181F	0	arFEVR	Beduin	MOL0513	—	Homozyg...,110,9,Sci_Rep_2015_Aug_26_5_13187.txt
c.542G>T,TSPAN12	c.542G>T	p.C181F	0	arFEVR	Beduin	MOL0513	—	Homozyg...,110,9,Sci_Rep_2015_Aug_26_5_13187.txt
c.542G>T,TSPAN12	c.542G>T	p.C181F	0	arFEVR	Beduin	MOL0513	—	Homozyg...,110,9,Sci_Rep_2015_Aug_26_5_13187.txt
c.1T>G,CDHR1	c.1T>G	p.M1L	0	arRP	Druze	MOL1275	—	Homozygous	 ,123,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.227A>C,RPE65	c.227A>C	p.H76P	0	arRP	Arab Muslim	MOL1026	—	Homoz...,124,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.227A>C,RPE65	c.227A>C	p.H76P	0	arRP	Arab Muslim	MOL1026	—	Homoz...,124,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1087T>A,ADAM9	c.1087T>A	p.C363S	Disease causing	1	0.00 Damaging	...,131,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.2200G>A,CDH3	c.2200G>A	p.V734M	Disease causing	1	0.06 Tolerated...,132,6,Sci_Rep_2015_Aug_26_5_13187.txt
c.2200G>A,CDH3	c.2200G>A	p.V734M	Disease causing	1	0.06 Tolerated...,132,6,Sci_Rep_2015_Aug_26_5_13187.txt
c.1494C>A,CNNM4	c.1494C>A	p.D498E	Disease causing	1	0.00 Damaging	...,134,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1494C>A,CNNM4	c.1494C>A	p.D498E	Disease causing	1	0.00 Damaging	...,134,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.227A>C,RPE65	c.227A>C	p.H76P	Disease causing	0.059	0.11 Tolerat...,135,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.227A>C,RPE65	c.227A>C	p.H76P	Disease causing	0.059	0.11 Tolerat...,135,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.6937G>T,USH2A	c.6937G>T	p.G2313C	Disease causing	1	0.00 Damaging...,137,7,Sci_Rep_2015_Aug_26_5_13187.txt
c.1871G>A,...we found a homozygous single-nucleotide mutation (c.1871G>A (p.S624L)) (Table 2) in ARRP-206. To con...,36,1347,Sci_Rep_2016_Jan_20_6_19432.txt
c.7868G>A,"...ated that the parents were unaffected carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A280...",36,1637,Sci_Rep_2016_Jan_20_6_19432.txt
c.8422G>A,"...cted carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A2808T, mother) in family ARRP-49 and...",36,1670,Sci_Rep_2016_Jan_20_6_19432.txt
c.1871G>A,"....8422G>A (p.A2808T, mother) in family ARRP-49 and c.1871G>A (p.S624L, father) in family ARRP-206. Th...",36,1721,Sci_Rep_2016_Jan_20_6_19432.txt
c.1871G>A,"....8422G>A (p.A2808T, mother) in family ARRP-49 and c.1871G>A (p.S624L, father) in family ARRP-206. Th...",36,1721,Sci_Rep_2016_Jan_20_6_19432.txt
c.8422G>T,"...., et al. reported the same heterozygous mutation c.8422G>T in a French RP patient18. This French RP...",48,819,Sci_Rep_2016_Jan_20_6_19432.txt
c.8388C>A,"...e found two novel homozygous stop-gain mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), res...",52,94,Sci_Rep_2016_Jan_20_6_19432.txt
c.8388C>A,"...e found two novel homozygous stop-gain mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), res...",52,94,Sci_Rep_2016_Jan_20_6_19432.txt
c.3024C>A,"...ous stop-gain mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), respectively, and these muta...",52,119,Sci_Rep_2016_Jan_20_6_19432.txt
c.1871G>A,A shows the segregation of a homozygous mutation c.1871G>A (MU3). The proband is indicated by an ar...,79,50,Sci_Rep_2016_Jan_20_6_19432.txt
c.1871G>A,ARRP-206	12	c.1871G>A	hom	p.S624L	missense	novel	Unknown regio...,106,13,Sci_Rep_2016_Jan_20_6_19432.txt
c.1871G>A,ARRP-206	12	c.1871G>A	hom	p.S624L	missense	novel	Unknown regio...,106,13,Sci_Rep_2016_Jan_20_6_19432.txt
c.4606C>G,RP:S-10	26	c.4606C>G	het	p.Q1536E	missense	novel	Unknown regi...,108,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.5038A>G,RP:S-10	26	c.5038A>G	het	p.N1680D	missense	novel	Unknown regi...,109,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.1418G>T,RP:S-18	9	c.1418G>T	het	p.G473V	missense	novel	Unknown regio...,111,11,Sci_Rep_2016_Jan_20_6_19432.txt
c.7187G>C,RP:S-34	36	c.7187G>C	hom	p.C2396S	missense	novel	EGF	Damaging...,114,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.7187G>C,RP:S-34	36	c.7187G>C	hom	p.C2396S	missense	novel	EGF	Damaging...,114,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.7187G>C,RP:S-34	36	c.7187G>C	hom	p.C2396S	missense	novel	EGF	Damaging...,114,12,Sci_Rep_2016_Jan_20_6_19432.txt
c.3584G>A,"... Hereinafter, the patient carrying the c.1253del, c.3584G>A and c.5720+1G>A (r.5720_5721ins148) muta...",15,233,Sci_Rep_2016_Mar_18_6_23213.txt
c.6652G>T,"...tified as #1; the patient carrying the c.5572C>T, c.6652G>T and c.7033C>T mutations will be identifi...",15,351,Sci_Rep_2016_Mar_18_6_23213.txt
c.6652G>T,"...tified as #1; the patient carrying the c.5572C>T, c.6652G>T and c.7033C>T mutations will be identifi...",15,351,Sci_Rep_2016_Mar_18_6_23213.txt
c.7033C>T,"...the patient carrying the c.5572C>T, c.6652G>T and c.7033C>T mutations will be identified as #2; the ...",15,365,Sci_Rep_2016_Mar_18_6_23213.txt
c.7033C>T,c.7033C>T	45	p.Arg2345Trp	Missense	Maternal,114,1,Sci_Rep_2016_Mar_18_6_23213.txt
c.2187C>A,Patients 3A and 3B Buenos Aires (Argentina)**	c.2187C>A	#3	16	p.Tyr729*	Nonsense	Maternal and Pa...,115,47,Sci_Rep_2016_Mar_18_6_23213.txt
c.2187C>A,Patients 3A and 3B Buenos Aires (Argentina)**	c.2187C>A	#3	16	p.Tyr729*	Nonsense	Maternal and Pa...,115,47,Sci_Rep_2016_Mar_18_6_23213.txt
c.667T>G,"...ssion	multiple missense mutationsc.602C>G (T201R),c.667T>G (F223V),c.819G>A,c.872C>G (P291R)	6",166,95,Sci_Rep_2016_Sep_1_6_32317.txt
c.872C>G,"...tationsc.602C>G (T201R),c.667T>G (F223V),c.819G>A,c.872C>G (P291R)	6",166,121,Sci_Rep_2016_Sep_1_6_32317.txt
c.872C>G,"...tationsc.602C>G (T201R),c.667T>G (F223V),c.819G>A,c.872C>G (P291R)	6",166,121,Sci_Rep_2016_Sep_1_6_32317.txt
c.826C>A,"For the FKRP gene, the c.826C>A (p. Leu276Ile) mutation is particularly c...",90,24,Semin_Pediatr_Neurol_2011_Dec_18(4)_277-288.txt
c.769C>T,...tation in Slovenian APS-1 population was p.R257* (c.769C>T) present in 63.3 % of pathological allele...,54,198,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
c.769C>T,...tation in Slovenian APS-1 population was p.R257* (c.769C>T) present in 63.3 % of pathological allele...,54,198,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
c.769C>T,...tation in Slovenian APS-1 population was p.R257* (c.769C>T) present in 63.3 % of pathological allele...,54,198,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
c.769C>T,"...an, British and Norwegian patients (23), p.R257* (c.769C>T) is present in more than 85 % of the Finn...",69,245,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
